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DNA methylation is an epigenetic mechanism known to play roles in regulating 
gene expression in various developmental and disease contexts. However, little is known 
about its function during eye development. Two types of methylation marks, 5-
methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), are thought to serve as 
silencing and activating signals for gene regulation, respectively. De novo 
methyltransferases (dnmt3 family) are responsible for the establishment of 5mC, while 
cytosine dioxygenases (tet family) convert 5mC into 5hmC, a stable epigenetic mark that 
can either remain on the genome or undergo subsequent demethylation.  Here I 
performed gene expression and functional tests to elucidate the roles for both of these 
cytosine-modifying enzyme families during development, with an emphasis on the eye. 
All dnmt3-family and tet-family genes are expressed tissue-specifically in relevant 
domains during eye development. Single and double mutants for genes within dnmt3 
family develop normally without any overt eye phenotype, indicating that these genes 
possess redundant functions during eye development.  In contrast, in tet2-/-;tet3-/- mutants, 
retinal neurons are specified but most fail to terminally differentiate. Retinal ganglion 
 vii 
cells lack a proper retino-tectal projection, and photoreceptors fail to generate outer 
segments. Mechanistically, mosaic analyses revealed a surprising cell non-autonomous 
requirement for tet activity during retinal neurogenesis. Through a combination of 
candidate gene analysis, transcriptomics and pharmacological manipulations, I identified 
candidate cell-extrinsic pathways regulated by tet2 and tet3.  Additionally, genome-wide 
5mC and 5hmC distribution profiles for retinal progenitor cells (RPCs) and differentiated 
retinal neurons are still currently unknown. To this end, I performed parallel bisulfite and 
oxidative bisulfite reactions followed by next-generation sequencing (BS/OXBS-seq) to 
generate the first nucleotide-resolution combined methylome/hydroxymethylome map of 
retinal cells during development and correlated these with gene expression. This genome-
wide approach revealed expected 5mC/5hmC profiles of candidate retinal developmental 
genes, and identified several novel, uncharacterized genes with potential roles during 
RPC differentiation. These genes are candidates for further investigation to determine 
their functions during retinal neurogenesis. Data presented in this Dissertation uncover 
the role of DNA methylation and hydroxymethylation during eye development and 
provide the first epigenomic maps of 5mC/5hmC dynamics during retina formation. 
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Retinal Ganglion Cell RGC 
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1.1 DEVELOPMENT AND FUNCTION OF THE NEURAL RETINA  
The vertebrate neural retina (NR) is a complex structure consisting of six major 
neuronal types and one glial cell type that work together to perform phototransduction 
and transmit visual information to the brain. These cells are organized into three 
histologically distinct retinal layers: the ganglion cell layer (GCL), outer nuclear layer 
(ONL), and inner nuclear layer (INL). All seven retinal cell types are born in a highly 
stereotyped chronological order, a process called neurogenesis, with the first-born cell 
type being retinal ganglion cells (RGC), followed by horizontal cells (HC), cone 
photoreceptors, amacrine cells (AC), rod photoreceptors, bipolar cells (BP), and lastly 
Müller Glia cells (MG) [reviewed in (Bassett and Wallace, 2012)]. Functionally, rods and 
cones (collectively referred to as photoreceptors: PRs) detect and convert photons of light 
into synaptic signals, which are transmitted through a series of interneurons (HC, BP, 
AC) to RGCs, which relay this signal, via the optic nerve (ON), to the optic tectum of the 
brain. Additionally, some vertebrate species, such as frogs and teleost fishes, also possess 
a unique niche of retinal stem cells (RSCs) located in a region of the peripheral retina 
called the ciliary marginal zone (CMZ). This structure persists throughout the life of the 
animal and continuously adds more differentiated cells as the eye continues to grow 
(Raymond et al., 2006). 
 
1.1.1 Early retinal development   
The onset of NR development in vertebrates begins as the optic vesicles (OV) 
evaginate as pouches from each side of the neural plate, then undergo elongation, 
forming wing-like structures attached to the brain via the optic stalk (Walls, 1963). Each 
OV then invaginates to surround the emerging lens originating from the surface 
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ectoderm, thus completing the morphogenesis of the optic cup (OC), the basic structure 
of the embryonic eye (Fig 1.1) (Schmitt and Dowling, 1994). During this process, the 
optic vesicle, composed of the lateral layer (LL) and medial later (ML), undergoes 
morphogenetic movement to form the presumptive NR and retinal pigmented epithelium 
(RPE) (Li et al., 2000). Patterning of the early eye is established and maintained by key 
transcription factors (TFs) such as Vsx2 (formerly Chx10) and Mitfa, for NR and RPE, 
respectively (Horsford et al., 2004). Cell tracking data showed that the process of OC 
morphogenesis involves an intricate and well-orchestrated cell movement between RPE 
and NR surrounding the lens (Kwan et al., 2012). In zebrafish, formation of the OC is 
completed by 24-hours post-fertilization (hpf) and the first RGCs become 




Figure 1.1: Schematic of optic cup morphogenesis during early eye development. OV, 
optic vesicle; LL, lateral layer; ML, medial layer; L, lens; NR, neural retina; 








Figure 1.2: Retina progenitor cells (RPCs) give rise to all differentiated retinal neurons 
and Müller Glial cells. Image modified from Bibliowicz et al., 2011.  
 
1.1.2 Retinal cell type determination  
During neurogenesis, all seven retinal cell types arise from a common pool of 
retinal progenitor cells (RPCs), a population of seemingly indistinguishable multipotent 
cells organized as a pseudostratified epithelial layer (Fig 1.2) [reviewed in (Centanin and 
Wittbrodt, 2014)]. The first evidence that RPCs are capable of giving rise to all 
differentiated cell types in the mature retina comes from early lineage tracing 
experiments, where any single labeled RPCs in the OV can proliferate and differentiate 
into clones composed of all seven cell types (Wetts and Fraser, 1988). How a 
homogeneous population of RPCs undergoes transformation into diverse cell types that 
together build such an elegant and complex structure as the retina has been a subject of 
intense investigation. To explain this phenomenon, two distinct but not mutually 
exclusive models have been proposed. 
First, the Competency Model builds upon the observation that retinal cells are 
born in a histologically and chronologically stereotyped fashion, and posits that RPCs 
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gradually become more restricted in their differentiation potential over time (Belliveau 
and Cepko, 1999; Wong and Rapaport, 2009). In other words, the earliest RPCs are 
competent to generate all seven cell types, while later RPCs can only generate a few late-
born cell types as the developing retina reaches the final phases of neurogenesis, 
becoming fully mature and functional. The competency model is consistent with the idea 
that RPCs are pre-programmed by an intrinsic circuitry that operates internally on a cell-
autonomous schedule and are largely uninfluenced by any external environmental cues. 
This is supported by early mixed-age cell culture experiments where undifferentiated 
RPCs progress down the predetermined path and differentiate into all seven cell types 
even when co-cultured among already differentiated cells from a mature retina, relatively 
unaffected by their extracellular environment (Cayouette et al., 2003; Rapaport et al., 
2001; Watanabe and Raff, 1990). The competency model is reminiscent of the neuroblast 
developmental program in Drosophila, where Hunchback triggers a cascade of TFs to 
generate neurons in a temporally restricted lineage (Isshiki et al., 2001).  In vertebrates, 
Ikaros is a Hunchback ortholog that performs a similar role in early-born retinal cell 
differentiation (Elliott et al., 2008) suggesting that this intrinsic transcriptional cascade is 
a highly conserved mechanism for neuronal specification.  
 
Alternatively, the Stochastic Model was more recently developed based on 
observations from lineage tracing experiments that show individual RPCs differentiate 
into clones of variable sizes and cell types (Gomes et al., 2011; He et al., 2012). 
However, collectively as a population, the final number and composition of differentiated 
cells among these clones can be explained by a mathematical model based purely on 
probability and stochasticity (Slater et al., 2009). For example, if the final retina is 
composed of 70% PRs and 5% RGCs, the probability of generating PRs and RGCs from 
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any given RPC is 70% and 5%, respectively. Additionally, these lineage tracing 
experiments detected some RPCs giving rise to neurons in a reverse order (i.e. late-born 
cells before early-born cells), reinforcing the idea that fate commitment, though set by 
cell-intrinsic properties, possesses a certain degree of stochasticity that is somehow 
regulated and not random. Finally, the model has been directly tested and verified 
experimentally by knocking down individual key TFs (atoh7, ptf1a, vsx1) followed by 
blastomere transplantation and a careful clonal analysis of RPC daughters (Boije et al., 
2015). Therefore, the invariant retinal cellular composition may simply be the result of 
independent probabilistic and combinatorial transcription of a few key TFs at the core of 
retinal cell fate determination network.  Nonetheless, relatively little is known about the 
factors that regulate the activity of these TFs in such a way that the correct cell types are 





Figure 1.3: Retinal neurons and Müller glial cells undergo differentiation in a 
chronologically stereotyped fashion from retinal progenitor cells (RPCs) via 
a cascade of transcriptional activity.   
 
1.1.3 Intrinsic and extrinsic factors regulating retinal development  
A multitude of intrinsic and extrinsic signals, are known to regulate retinal 
development from the establishment and maintenance of the RPC pool to the 
specification and terminal differentiation of neuronal and glial cells (Fig 1.3).  First, the 
existing RPC population expands in order to reach sufficient numbers before beginning to 
differentiate. Numerous TFs are known to intrinsically regulate RPC multipotency and 
proliferation capacity, the most well-characterized being Pax6 (Marquardt et al., 2001), 
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Vsx2 (Vitorino et al., 2009), and Sox2 (Matsushima et al., 2011).  Loss of Pax6 in RPCs 
results in a hypocellular retina that lacked virtually all subsequent differentiation events 
(Klimova and Kozmik, 2014), while loss of Sox2 leads to decreased RPC neurogenic 
competency and conversion of RPCs to undifferentiated ciliary epithelium (Matsushima 
et al., 2011). In addition to their roles in RPCs, Pax6 and Vsx2 also have neurogenic roles 
later in differentiating retinal neurons, where Pax6 is required for RGC and AC 
differentiation (Oron-Karni et al., 2008) and Vsx2 is required for BP and MG 
differentiation (Vitorino et al., 2009).   
Downstream of RPC-specific genes are a cascade of TFs required for 
specification of each retinal cell type. For example, the proneural TF, Atoh7 (formerly 
Ath5), is expressed during the last division of RPCs and is required for RGC 
specification; inactivation of Atoh7 results in a near complete loss of RGCs and an 
increase of later born cell types (Kay et al., 2001). Atoh7, in turn, activates other TFs 
such as Pou4f1-3/Brn3a-c (Liu et al., 2000) and Isl2 (Pan et al., 2008), which are required 
for expression of subsequent RGC terminal differentiation genes including components 
of neurotransmission, axonal growth, and pathfinding. Similar scenarios occur in other 
retinal cells where a combination of key TFs specific to each cell type activate a cascade 
of downstream TFs and specialized cell-specific molecules. These include Crx for rod 
and cone photoreceptors (Furukawa et al., 1997), Ptf1a for ACs (Jusuf and Harris, 2009), 
and NeuroD4 for HCs and BPs (Wang et al., 2003).   
In addition to the intrinsic signals above, many extrinsic signaling molecules also 
act upon RPCs during neurogenesis. For example, the Wnt and Notch pathways are both 
required for inhibiting RPC differentiation and maintaining RPCs in a proliferative state. 
Inactivating Notch signaling triggers early RPC exit from the cell cycle, and premature 
differentiation into the first retinal cell fate available, the RGCs, (Bernardos et al., 2005; 
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Perron and Harris, 2000). Conversely, over-activation of Wnt components results in 
enhanced RPC proliferation and down-regulation of proneural bHLH TFs, thus 
preventing exit from the cell cycle and subsequent differentiation (Kubo et al., 2005). 
Aside from Notch and Wnt, many other extracellular signaling pathways such as 
Hedgehog, FGF, VEGF, BMP, and neurotransmitters such as Ach, GABA, glutamate, 
and dopamine are also involved in retinal neurogenesis [reviewed in (Agathocleous and 
Harris, 2009)].  Despite the breadth of knowledge about the roles of intrinsic and 
extrinsic factors during retinal development, relatively little is known about how these 
factors are regulated initially. Increasing amounts of data are pointing to epigenetic 
mechanisms, including histone modification (via enzymes such as Hdac1 (Yamaguchi et 
al., 2005), Brg1 (Das et al., 2007)), and DNA methylation and hydroxymethylation 
(Merbs et al., 2012; Rhee et al., 2012) as potential regulators of these intrinsic and 
extrinsic factors, thus adding an extra layer of control to an already complex system.  
 
1.2 DEVELOPMENT AND FUNCTION OF THE LENS 
The vertebrate lens is composed of only two cell types: lens epithelial (LE) and 
lens fiber (LF) cells. During development and continuously throughout life, proliferative 
LE cells in the anterior layer of the lens undergo differentiation within the transition zone 
(TZ) along the lens equator, giving rise to elongated LFs, which are then arranged in an 
orderly fashion into the outermost lens cortex and comprise the bulk of the lens material 
(Fig 1.4) (Greiling and Clark, 2009; Greiling et al., 2010). LFs are transparent, highly 
organized, and organelle-free. To obtain these unique biophysical properties, LFs 
undergo drastic morphological changes during differentiation that include a massive 
elongation and complete elimination of all light-scattering organelles, including the 
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nucleus (Bassnett et al., 2011; Wride, 2011). Failure of LF cells to achieve their final 
shape and organization have been shown to cause congenital cataracts in human and 
other model organisms (Hejtmancik, 2009; Santana and Waiswol, 2011).  
 
 
Figure 1.4: Lens epithelial (LE) cells continuously give rise to lens fiber (LF) cells, 
which are packed into the bulk of the lens cortex.  
 
1.3 DNA METHYLATION PATHWAY   
DNA methylation is an epigenetic mechanism by which methyl groups are added 
to the 5th carbon of cytosine residues (5mC), predominantly at CpG dinucleotides (Jones, 
2012; Suzuki and Bird, 2008). Genomic regions rich in CpG dinucleotids (CpG islands) 
are often associated with gene promoters, and their 5mC methylation statuses are often 
inversely correlated with gene expression levels (Deaton and Bird, 2011; Illingworth and 
Bird, 2009; Meissner et al., 2008; VanderKraats et al., 2013; Yamaguchi et al., 2012). 
Hypermethylation within promoters and enhancers is associated with reduced gene 
transcription (Wu et al., 2010), while gene body methylation directly correlates with 
expression (Jin et al., 2012). Indeed, DNA methylation is critical for silencing of 
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imprinted genes and transposons (Bird, 2002; Li et al., 1993; Walsh et al., 1998). Subsets 
of genes are differentially methylated according to tissue and cell type, and DNA 
methylation is thought to be a mechanism whereby cell type-specific expression patterns 
are set during terminal differentiation (Ehrlich, 2003; Illingworth and Bird, 2009), and by 
which some somatic progenitor cell populations are maintained (Bröske et al., 2009; 
Meissner et al., 2008; Sen et al., 2010; Trowbridge et al., 2009). 
 
Three main biochemical events orchestrate DNA methylation (Fig 1.5-6). First, de 
novo methylation, mediated by DNA methyltransferase (Dnmt3-family) proteins, 
functions to methylate regions of hypomethylated DNA and is required for tissue-specific 
differentiation during development (Feng et al., 2010; Hu et al., 2012; Illingworth and 
Bird, 2009; Merbs et al., 2012). Second, maintenance methylation, mediated by Dnmt1, 
copies the methylation pattern from existing DNA strands on to nascent daughter strands 
during DNA replication, a process that is important for maintaining the identities of 
actively proliferating cell populations (Sen et al., 2010; Tittle et al., 2011). Third, 
demethylation is the mechanism by which 5mC is removed from the genome. Far less is 
known about the DNA demethylation process but several biochemical pathways have 
been proposed to be involved and these include: replication-dependent passive dilution, 
direct base excision by the DNA repair machinery, and active enzymatic conversion of 
5mC [reviewed in (Wu and Zhang, 2014)]. Of these pathways, most evidence supports 
the latter and a role for members of the Ten-eleven Translocation (Tet) family of 
methylcytosine dioxygenases. These enzymes mediate the conversion of 5mC to 5-
hydroxymethylcytosine (5hmC), which can then be converted to non-methylated cytosine 




Figure 1.5: DNA methylation pathway. De novo DNA methyltransferases (Dnmt3-8) 
add new methyl groups onto cytosine (5mC) which is maintained through 
DNA replication by Maintenance methyltransferase (Dnmt1). 
Methylcytosine dioxygenases (Tet1-3) oxidize 5mC into 5-hydroxymethyl 




Figure 1.6: 5mC and 5hmC cytosine modifications are generated by Dnmt and Tet 
enzymes, respectively.  
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1.4 DNA METHYLATION AND HYDROXYMETHYLATION DURING DEVELOPMENT 
Evidence from studies within the past decade points to DNA methylation as an 
important mechanism for the regulation of development in various contexts.  Inactivation 
of de novo and/or maintenance methyltransferases causes phenotype associated with 
tissue-specific gene expression in various organisms. In humans, somatic mutations in 
DNMT3A are associated with acute leukemia and certain types of solid cancer (Kim et al., 
2013a). In mouse, Dnmt3a null embryos develop normally but die soon after birth, 
Dnmt3b null embryos display neural tube defects, and Dnmt3a/b double mutants show 
early and severe phenotypes such as growth and morphogenesis arrest and lack of 
somites (Okano et al., 1999; Smith and Meissner, 2013; Wu et al., 2012). Embryonic 
stem (ES) cell lines deficient in all dnmt3-family genes exhibit global hypomethylation 
and premature differentiation into glial-like cells (Wu et al., 2012).  Within the eye, 
mutations in dnmt1, and its recruitment factor, uhrf1, are required for normal 
development and maintenance of the zebrafish lens, and loss-of-function mutations in 
either results in reduced proliferation and loss of tissue integrity of the LE (Tittle et al., 
2011). Tissue-specific combinatorial mutants for Dnmt1, Dnmt3a and Dnmt3b in mouse 
display global hypomethylation, reduction in terminally differentiated PRs, and 
disorganized synaptic formation (Singh et al., 2016).  
Similar to Dnmt-family genes, mutations in Tet genes also cause a multitude of 
developmental defects. In mouse, Tet1 knockout embryos show forebrain defects at late 
gastrulation and high mortality (Khoueiry et al., 2017); Tet2 knockouts develop normally 
and are fertile, but Tet1-/-;Tet2-/- double knockouts show a perinatal lethality associated 
with imprinting abnormalities (Dawlaty et al., 2013); Tet1/2/3 triple knockout ES cells 
possess a massive loss of 5hmC, deregulated gene expression, and are less competent to 
differentiate (Dawlaty et al., 2014). Depletion of tet3 by morpholino (MO) causes an 
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eyeless phenotype in Xenopus (Xu et al., 2012). In zebrafish, tet2 MO knockdown results 
in mild erythropoiesis defects (Ge et al., 2014). However, somatic mutations in tet2 do 
not cause any overt embryonic phenotype, although tet2-/- adults develop progressive age-
related clonal myelodysplasia (Gjini et al., 2015). A recent study shows overlapping roles 
for tet2 and tet3 during hematopoietic stem cell differentiation (Li et al., 2015).   
Within the nervous system, Tet expression and 5hmC enrichment is detected in 
the developing vertebrate brain and retina (Almeida et al., 2012b; Perera et al., 2015), and 
this coincides with the increase in 5hmC levels during neuronal differentiation at 
enhancers and also within gene bodies of neuronal genes (Hahn et al., 2013). 
Overexpression of Tet3 in mouse olfactory neurons results in increased 5hmC levels and 
defects in axon targeting (Colquitt et al., 2013). Although both DNA methylation and 
hydroxymethylation have been studied extensively in the context of hematopoiesis, stem 
cell programming and disease, far less is known about their roles during development and 
in regulating cellular differentiation to create a complex structure like the eye.  
 
1.5 ZEBRAFISH AS A MODEL FOR EYE DEVELOPMENTAL EPIGENETICS      
Zebrafish is a powerful vertebrate model system with unique attributes preferable 
for studying complex biological processes such as the epigenetic control of eye 
development, these include: amenability to genetic and biochemical manipulation, high 
fecundity, transparent and rapidly developing embryos, fully sequenced and well 
annotated genome, and extensive availability of recombinant constructs, mutants, and 
transgenic lines. Minor differences exist between zebrafish and human eye development. 
In zebrafish, the lens placode delaminates from the surface ectoderm as a solid mass of 
cells, rather than as a hollow vesicle as it does in mammals (Greiling and Clark, 2009; 
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Greiling et al., 2010). In the retina, the CMZ enables zebrafish retinae to continuously 
grow throughout life and regenerate in response to an injury, a phenomenon not observed 
in mammals (Raymond et al., 2006). Beyond these differences, all other aspects of lens 
and retina development appear to be identical between zebrafish and mammals, and the 
overall architecture of zebrafish and mammalian retinae and lenses are virtually identical 
(Bibliowicz et al., 2011; Gestri et al., 2012). This suggests that well conserved genetic 
and epigenetic mechanisms regulate vertebrate eye development and growth. Given its 
amenability to forward and reverse genetics (Auer and Del Bene, 2014; Bedell et al., 
2012a; Cade et al., 2012; Donato et al., 2016; Hwang et al., 2013; Lee et al., 2012), 
zebrafish is an attractive model system in which to study the epigenetic regulation of eye 
development.  
 
The goals of my thesis research were to investigate the roles of DNA methylation 
and hydroxymethylation during eye development, using zebrafish as a model organism.  
Utilizing a combination of classical embryology techniques, targeted genome editing, and 
genome-wide profiling approaches, I performed functional tests for genes within the 
dnmt3 family (Chapter 2) and tet family (Chapter 3) during eye development, and 
generated the first combined methylome and hydroxymethylome maps of RPCs during 








Chapter 2:  Gene expression and Functional Analysis of the de novo 
DNA Methyltransferases (dnmt3-dnmt8) during eye development 
Portions of this Chapter are modified from the following article, with permission from the 
authors: Seritrakul, P., Gross, J.M., 2014. Expression of the De Novo DNA 
Methyltransferases (dnmt3 – dnmt8) During Zebrafish Lens Development. 
Developmental Dynamics. 243:350–356.  
Seritrakul, P. and Gross, J.M. conceived the experiments and interpreted the data. 
Seritrakul, P. performed the experiments, collected and analyzed the data. 
2.1 INTRODUCTION 
De novo DNA methylation, mediated by Dnmt3a and Dnmt3b in mammals, is a 
process in which unmethylated CpG sites become methylated, and has been shown to 
play critical roles during development of plants and animals, particularly in tissue 
differentiation when cells undergo epigenetic reprogramming to adopt new identities 
(Feng et al., 2010; Hu et al., 2012; Illingworth et al., 2008; Merbs et al., 2012). Defects 
in, or loss of, de novo methyltransferase function cause a multitude of phenotypes 
associated with aberrant tissue-specific gene expression, and in a variety of animal model 
systems (e.g., (Gao et al., 2011; Okano et al., 1999; Wu et al., 2012)). Additionally, in 
humans, somatic mutations in DNMT3A are associated with acute leukemia and certain 
types of solid cancer (Kim et al., 2013b).   
Previous work in our laboratory has shown that the functions of maintenance 
methyltransferase, dnmt1, and its recruitment factor, uhrf1, are required for normal 
development and maintenance of the zebrafish lens (Tittle et al., 2011). Both genes are 
expressed in an overlapping domain in the lens epithelium that correlates with regions of 
proliferation, and loss-of-function mutations in either results in altered LE gene 
expression, reduced proliferation, and loss of tissue integrity in the lens epithelium. 
While these data support a role for the maintenance methyltransferase dnmt1, during lens 
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development, little is known regarding the roles of de novo DNA methylation during 
vertebrate eye development. 
Zebrafish possess six “dnmt3 family” de novo methyltransferase genes, dnmt3 – 
dnmt8 (reviewed in (Goll and Halpern, 2011)). This group includes both orthologs of 
mammalian dnmt3A and dnmt3B as well as fish-specific genes with no obvious 
mammalian orthologs (Campos et al., 2012; Shimoda et al., 2005). Despite our 
understanding of their evolutionary history and their likely functional importance in 
regulating de novo methylation during organ and tissue development, the tissue-specific 
expression of these dnmt3-family genes is largely unknown. This is particularly true in 
the vertebrate eye, where we have a poor understanding of how DNA methylation 
regulates retina and lens development.  
In mammals, loss-of-function alleles have already been generated: Dnmt3a null 
mouse embryos develop normally but die soon after birth; Dnmt3b null mutants display 
neural tube defects and die before birth; and Dnmt3a/b double mutants show a more 
severe early phenotypes than single mutants (Okano et al., 1999; Smith and Meissner, 
2013; Wu et al., 2012). However, these early defects occur prior to eye development, thus 
preventing analysis of ocular phenotypes. Mouse embryonic stem cell lines deficient in 
de novo methyltransferases exhibit global hypomethylation, increased proliferation and 
precocious differentiation into glial-like cells (Wu et al., 2012). However, these 
phenotypes may not reflect dnmt3-specific phenotypes in developing vertebrate eyes in 
vivo.  Functional studies in non-mammalian model organisms such as frog and zebrafish 
have so far relied heavily on morpholino-mediated knockdown of single dnmt genes, a 
relatively ineffective approach for interrogating families of proteins with potential for 
functional redundancy (Rai et al., 2010; Shimoda et al., 2005).  
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To facilitate functional studies of de novo methylation in the lens and retina, we 
have catalogued the distribution of dnmt3- family genes in the developing zebrafish eye 
over time and generated single and double knockout for dnmt3-family genes.  To 
investigate the roles of de novo DNA methylation during zebrafish eye development, we 
utilized gene targeting strategies to create site-specific loss-of-function mutations in 
dnmt3-family genes that are expressed during the development of zebrafish lens and 
retina.  Our data demonstrate that dnmt3-family genes are expressed in both unique and 
overlapping patterns, and in several ocular structures, supporting a model in which they 
likely play functional roles in regulating numerous aspects of normal eye development. 
 
2.2 RESULTS 
2.2.1 Phylogenetic Analysis of Zebrafish De Novo Methyltransferases  
To examine the phylogenetic relationship among DNA methyltransferases in 
zebrafish and mammals, we constructed a phylogenetic tree using zebrafish, mouse, and 
human de novo and maintenance DNA methyltransferase proteins. Using dnmt2 RNA 
methyltransferase as an outgroup, de novo and maintenance methyltransferases cluster 
into two distinct clades, with all Dnmt1 orthologs in one and all Dnmt3 proteins in the 
other. Within the dnmt3 clade, dnmt3 and dnmt5 form a distinct branch with no 
mammalian ortholog, while dnmt6 and dnmt8 closely cluster with mouse Dnmt3A, 
consistent with previous studies (Campos et al., 2012; Goll and Halpern, 2011; Shimoda 
et al., 2005). The rest of the de novo methyltransferase clade includes zebrafish dnmt4, 
dnmt7, and mouse Dnmt3B. Within this group, dnmt4 branches with mouse Dnmt3B, 
while dnmt7 does not (Fig. 2.1). Therefore, zebrafish dnmt3, dnmt5, and dnmt7 appear to 





Figure 2.1: Phylogenetic relationship between DNA methyltransferases and their 
corresponding expression patterns. Tree was constructed using Geneious 
Tree Builder from an alignment of DNA methyltransferase amino acid 
sequences (zebrafish dnmt1, 3-8; mouse and human Dnmt1, 3A and 3B), 
with zebrafish RNA methyltransferase (dnmt2) as an outgroup. 
 
2.2.2 Expression of Zebrafish De Novo Methyltransferases 
All dnmt3-family genes show ubiquitous expression throughout the anterior 
region of the embryo at 24 hr postfertilization (hpf), after which, expression patterns 
begin to resolve into distinct, spatially restricted domains. Within the developing eye, 
expression domains can be categorized into three general groups, with each group 
constituted by two dnmt3-family genes (summarized in Fig 2.5). 
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2.2.2.1 CMZ expression: dnmt3 and dnmt5 
At 24 hpf, dnmt3 and dnmt5 are expressed in the eye, as well as broadly 
throughout the embryonic head, and weakly in the posterior part of the embryo (Fig. 
2.2A,F). Beginning at 36 hpf, and lasting through 72 hpf, transcripts of both genes are no 
longer detected throughout most of the embryo except for the ciliary marginal zone 
(CMZ) of the retina, where expression remains relatively high (Fig. 2.2B– D,G–I), and 
the optic tectum and pectoral fin. Transverse sections through the eyes highlight the CMZ 
expression of these two genes, and this is most pronounced at 48 hpf (Fig. 2.2K,L). At 4 
days postfertilization (dpf), transcripts are still detected in the CMZ (Fig. 2.2E,J), but are 
no longer apparent in other parts of the eye or embryo. dnmt3 and dnmt5 transcripts are 





Figure 2.2: dnmt3 and dnmt5 expression is enriched in the ciliary marginal zone. A,F: In 
situ hybridization shows dnmt3 and dnmt5 expression throughout the 
anterior region of the embryo at 24 hr postfertilization (hpf). B–D,G–I: 
Expression becomes restricted to the CMZ, tectum, pectoral fins, and 
pharyngeal arches between 36 and 72 hpf. E,J: At 4 days postfertilization 
(dpf), ocular expression is only detected in the CMZ. Transverse sections, 




2.2.2.2 CMZ and LE expression: dnmt4 and dnmt7 
At 24 hpf, dnmt4 and dnmt7 expression resembles that of dnmt3 and dnmt5, 
where transcripts are observed broadly throughout the anterior part of the embryo (Fig. 
2.3A,F). In the eye, both genes are expressed within the CMZ, and throughout the lens 
epithelium (Fig. 2.3K,L). From 36 hpf to 4 dpf, dnmt4 is also expressed in the optic 
tectum, pharyngeal arches, and posterior border of the developing pectoral fins (Fig. 
2.3B–E). From 36 hpf on, outside of the eye, dnmt7 expression appears to be overlapping 






Figure 2.3: dnmt4 and dnmt7 expression in the lens epithelium and ciliary marginal 
zone. A–E,K: In situ hybridization shows broad dnmt4 expression in the 
developing eye at 24 hr postfertilization (hpf) (A), which later becomes 
localized in the CMZ and lens epithelium (B–E, K, arrow points to LE). 
dnmt4 expression is also observed in the tectum, developing pectoral fin, 
and pharyngeal arches (A–E). F: dnmt7 is expressed ubiquitously at 24 hpf. 
G–J,L: At 36 hpf, expression remains diffuse in the anterior part of the 
embryo, and surrounding of the eye, while expression within the eye is only 
observed in the CMZ and LE (L, arrow points to LE). Transverse sections, 




2.2.2.3 Inner Retina (GCL and INL) expression: dnmt6 and dnmt8 
 
dnmt6 and dnmt8 share a similar and overlapping expression pattern throughout 
embryogenesis, with both genes expressed ubiquitously at 24 hpf (Fig. 2.4A,F). 
Expression remains broad throughout the anterior of the embryo outside of the eye up to 
4dpf (Fig. 2.4B– E,G–J). Within the eye, the expression appears to be dynamic. At 48 
hpf, both genes are weakly expressed in the LE, CMZ, and developing ganglion cell layer 
(GCL) and inner nuclear layer (INL; Fig. 2.4C,H,K,L). However, at 72 hpf, expression is 






Figure 2.4: dnmt6 and dnmt8 expression in lens epithelial (LE), ciliary marginal zone 
(CMZ), ganglion cell layer (GCL), and inner nuclear layer (INL). In situ 
hybridization shows similar expression patterns between dnmt6 and dnmt8. 
A,B,F,G: At 24–36 hr postfertilization (hpf), both genes are expressed 
ubiquitously throughout the anterior part of embryo. C,H,K,L: At 48 hpf, 
expression is detected specifically in LE and CMZ, and weakly in the 
developing GCL and INL. D,I,M,N: At 72 hpf, expression is only detected 
within the GCL and INL. E,J: At 4dpf, expression is faint in the GCL. K-N: 






Figure 2.5: Summary of dnmt3-family gene expression in the developing zebrafish eye. 
Cartoon depicting a transverse section through an eye of a 48–72 hr 
postfertilization (hpf) embryo. Expression domains are marked in blue for 
dnmt3 and dnmt5, green for dnmt4 and dnmt7, and red for dnmt6 and 
dnmt8. LE, lens epithelial cells; LF, lens fibers; CMZ, ciliary marginal zone; 







2.2.3 Functional analysis of Zebrafish De Novo Methyltransferases 
2.2.3.1 Characterization of dnmt4 and dnmt7 null mutants 
To investigate roles of de novo methyltransferases in LE and CMZ, we generated 
site-specific heritable mutations in dnmt4 and dnmt7 using transcription activator-like 
effector nucleases (TALENs), a high-efficiency genome editing tool widely utilized in 
many model organisms (Carlson et al., 2012; Huang et al., 2011; Miller et al., 2011; 
Sakuma et al., 2013). TALENs were targeted to within a short distance from the start 
codon of dnmt4 and dnmt7, mutations were validated by sequencing and are predicted to 
cause frame shift and premature stop codon, resulting in truncated, non-functional mutant 
proteins. Moreover, to eliminate the possibility of a second, alternate start codon re-
initiating translation of the mutant protein, we also generated an additional dnmt4 whole-
gene knockout line utilizing two CRISPR guide RNAs (Auer et al., 2014; Irion et al., 
2014).  This mutant carries a large deletion between exon 3 and exon 22, knocking out 






Figure 2.6: Generation of dnmt3-family mutant zebrafish lines. Single mutant lines 
were generated using TALENs, targeting sequences shortly downstream of 
the start codon. Mutant sequences for dnmt4, dnmt6, and dnmt7 show out-
of-frame deletion and are predicted to be null alleles (A). dnmt8 mutant 
lines obtained from Zebrafish Mutation Project shows a GàT point 
mutation that introduces an early stop codon (B). Whole-gene deletion of 
dnmt4 shows large deletion from exon 3-22 (C). Chromatograms were 
obtained by amplicon Sanger sequencing.   
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Mutant embryos were individually genotyped by restriction fragment length 
polymorphism (RFLP) and recovered at the expected Mendelian ratio (25%), but the 
overall phenotype is indistinguishable from wildtype and heterozygous siblings.  Further 
analysis of cryosectioned and immunostained eyes revealed normal development up to at 
least 7dpf for both dnmt4 and dnmt7 (Fig 2.7). Because mutant embryos carrying 
mutations in either dnmt4 or dnmt7 alone appear to develop normally and survive past 
early stages of development, and dnmt4 and dnmt7 are both expressed nearly identically 
in the CMZ and LE, we reasoned that these two proteins have redundant functions and 
thus compensate for each other in both mutant lines. To address this, we generated double 
heterozygous zebrafish, which were incrossed to generate dnmt4/7 double mutant 
embryos at expected frequency of 6.25% (1 out of every 16 embryos).  Double mutant 
also showed normal eye and general development and are viable to adulthood. Thus, 
dnmt4 and dnmt7 are likely not essential for normal development, and other dnmt3-











2.2.3.2 Characterization of dnmt6 and dnmt8 null mutants 
To investigate roles of de novo methyltransferases in the inner retina (GCL and 
INL), we generated a zebrafish mutant line carrying loss-of-function alleles in the dnmt6 
gene using TALENs as described. For dnmt8, a loss-of-function allele (dnmt8sa617) was 
independently isolated by TILLING screening approach in the Zebrafish Mutation 
Project by the Sanger Institute but was not yet characterized (Kettleborough et al., 2013). 
We obtained this line and characterize the mutants for eye-specific phenotypes.  
Similar to the scenario in dnmt4 and dnmt7, analysis of cryosectioned and 
immunostained of either dnmt6 or dnmt8 single mutant embryos or dnmt6/8 double 
mutant embryos showed no eye-specific defects in overall lens or retinal morphology or 
cell type differentiation. All homozygous mutant larvae are viable, and adult mutants are 
fertile. Thus, dnmt6 and dnmt8 mutations do not appear to affect normal development or 
growth, again highlighting genetic redundancy between multiple genes within de novo 




Figure 2.7: All dnmt3-family single and double mutants show normal eye development. 
4dpf mutants were individually genotyped, sectioned, and stained with 
Sytox green for nuclei (green) and Phalloidin for F-actin (blue). All single 
and double homozygous mutants show normal eye morphology without 






Our in situ hybridization analysis reveals dynamic and spatiotemporally restricted 
patterns of de novo DNA methyltransferase gene expression during zebrafish eye 
development. These distributions suggest distinct, but possibly redundant, functions for 
dnmt3 family proteins during lens and retina development in vertebrates. Additionally, 
we generated and characterized mutants for dnmt-3 family genes, and double mutants for 
genes with overlapping expression domain. None of the single or double mutants show 
any developmental defect, indicating that these genes are highly functionally redundant, 
and can compensate for each other, even outside of their normal expression domains. 
This necessitate the generation of triple and/or quadruple mutants where all de novo 
methyltransferase function is abolished. 
2.3.1 De novo DNA methyltransferases and Lens Development  
The LE-specific expression of dnmt4/dnmt7 (from 36 hpf onward) and 
dnmt6/dnmt8 (at 48 hpf) suggest possible functions for the proteins they encode in 1) 
maintenance of the continuously proliferating LE cell population and/or 2) during the 
reprogramming of LE cells to become LF cells in the transition zone, a process that 
involves genome-wide changes in expression of numerous genes including activation of 
LF- specific genes and silencing of LE- specific genes (e.g., (Cvekl and Duncan, 2007; 
Hayes et al., 2012; Wride, 2011). For example, delta-crystallin genes (CRYD1/2) in the 
embryonic chicken lens undergoes changes in methylation status and transcription levels 
as LE cells differentiate into LFs (Sullivan and Grainger, 1986; Sullivan et al., 1989), 
suggesting that LE and LF cells are epigenetically distinct cell populations. Interestingly, 
these de novo methyltransferase transcripts are distributed throughout the entire LE, a 
domain that is broader than that of the maintenance methyltransferase (dnmt1), which is 
expressed solely in the proliferative regions of the LE (Tittle et al., 2011). Beyond the 
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regulation of gene expression during the LE to LF transition, de novo DNA methylation 
machinery could cooperate with chromatin-remodeling enzymes in the LE cells to 
mediate chromatin compaction in preparation for DNA degradation that occurs during LF 
terminal differentiation (Appleby and Modak, 1977; Bassnett et al., 2009; He et al., 
2010). Lack of proper DNA degradation causes nuclear cataract in mouse (Nishimoto et 
al., 2003), and hypermethylation of a LF-specific aA-crystallin (CRYAA) contributes to 
age- related cataract in human (Zhou et al., 2012). These examples also suggest that 
defects in de novo DNA methylation may play a role in the progression of ocular 
diseases. 
 
2.3.2 De novo DNA methyltransferases and Retinal Development  
All six members of the dnmt3 gene family are expressed within the retina in two 
distinct domains: the CMZ and the GCL-INL layers. Because the CMZ is an area of 
active cell proliferation and a known niche for retinal stem cells (Raymond et al., 2006), 
it is possible that these de novo DNA methyltransferases function in maintaining the 
proliferative properties of CMZ cells and/or in the reprogramming of retinal precursors 
destined to exit the CMZ and differentiate into retinal neurons. Consistent with this 
possibility, a recent study in Xenopus demonstrated that the transcripts for all core 
components of the polycomb repressive complex 2 (PRC2), a chromatin remodeling 
complex that catalyzes histone H3 lysine 27 tri-methylation (H3K27me3), are also 
expressed within the CMZ (Aldiri et al., 2013). These data suggest that the CMZ is an 
area of highly active epigenetic modifications, and that de novo DNA methylation may 
cooperate with histone-modifying enzymes to facilitate stem cell maintenance or 
reprogramming during differentiation.  
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The distribution of dnmt6 and dnmt8 in the GCL and INL of the retina, as well as 
the absence of dnmt3 family gene expression in other regions of the differentiated retina 
suggest that GCL and INL cells may undergo additional epigenetic modification before 
they terminally differentiate. These two layers of the retina are also where 5- 
hydroxymethylcytosine (5hmC), a mark of active cytosine demethylation and gene 
activation (Pastor et al., 2013), is enriched (Almeida et al., 2012a). Recent findings 
suggest that Tet enzymes, which are responsible for 5mC to 5hmC conversion, are 
expressed in the eye and likely facilitate neurogenesis (Li et al., 2014; Santiago et al., 
2014; Xu et al., 2012).  Therefore, it is likely that Tet enzymes play roles in terminal 
differentiation of inner retinal neuron.  Experiments in Chapter 3 directly test this 
hypothesis. 
 
2.3.2 Functional Redundancy in zebrafish De novo DNA methyltransferases  
Given our current understanding of the evolutionary history of genes in the dnmt3 
family and the overlapping distributions reported here (Fig 2.5), it is very likely that the 
encoded proteins have redundant roles during zebrafish lens and retinal development, 
with genes that are most closely related phylogenetically sharing expression domains and 
possible functions. This overlap in expression also highlights potential difficulties in 
performing functional experiments due to the possibility of genetic redundancy within 
this group of genes. Therefore, it is not surprising to see that neither the single or double 
mutant for dnmt3-family genes show any developmental defects.  
It is important to note that our double mutants were generated between pairs of 
dnmt3-family genes that are expressed in the same domains, in the hope that the lack of 
both gene in each domain will lead to a developmental phenotype.  However, it is 
possible that, because these genes share nearly identical catalytic domains (Goll and 
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Halpern, 2011), they may compensate for each other even outside of their normal 
expression domain. For example, dnmt6/8 could compensate for dnmt4/7 in the LE, even 
though dnmt6/8 transcripts are not normally detected there. Additionally, dnmt1 also 
possess a fully functional methyltransferase domain, and could also perform functional 
compensation. In mouse, recent finding demonstrate that tissue-specific triple knockout 
of Dnmt1, Dnmt3A and Dnmt3B lead to defects in the differentiation of photoreceptor and 
formation of outer plexiform layer (Singh et al., 2016). Moving forward, functional 
analyses will necessitate the generation of combinatorial loss-of-function animals where 
more than two dnmt3-family gene is simultaneously perturbed.  Current work in our 
laboratory is aimed at simultaneously deleting or inactivating all members of the dnmt3-
family, utilizing a combination of individual mutations and large chromosomal deletion 















Chapter 3:  Tet-mediated DNA hydroxymethylation regulates retinal 
neurogenesis by modulating cell extrinsic signaling pathways 
Portions of this Chapter are modified from the following article, with permission from the 
authors: Seritrakul, P., Gross, J.M., 2017. Tet-mediated DNA hydroxymethylation 
regulates retinal neurogenesis by modulating cell-extrinsic signaling pathways. PLOS 
Genetics. 13(9): e1006987.  
Seritrakul, P. and Gross, J.M. conceived the experiments and interpreted the data. 
Seritrakul, P. performed the experiments, collected and analyzed the data. 
3.1 INTRODUCTION 
Recent studies have identified roles for Tet proteins and DNA 
hydroxymethylation during vertebrate development, stem cell maintenance and in 
diseases such as cancer. In mouse, Tet1 and Tet2 knockouts are viable and fertile, while 
Tet1-/-;Tet2-/- double knockouts show a partially penetrant perinatal lethality associated 
with imprinting abnormalities (Dawlaty et al., 2013). A recently generated Tet1 knockout 
mouse showed forebrain defects at late gastrulation and high mortality (Khoueiry et al., 
2017). Tet1/2/3 triple knockout ES cells possess a massive loss of 5hmC, deregulated 
gene expression, and an impaired ability to differentiate (Dawlaty et al., 2014). In frog, 
depletion of Tet3 by a translation-blocking morpholino (MO) affects early neural 
development and causes an eyeless phenotype (Xu et al., 2012).  tet2 MO-based 
knockdown in zebrafish results in mild defects in erythropoiesis (Ge et al., 2014); 
however, mutations in tet2 do not cause any overt embryonic phenotype, although tet2-/- 
adults develop progressive age-related clonal myelodysplasia (Gjini et al., 2015). More 
recently, overlapping roles for tet2 and tet3 during hematopoietic stem cell differentiation 
have been identified (Li et al., 2015).  Likely related to their functions during 
hematopoiesis, Tet proteins are also associated with a number of hematological 
malignancies in humans [reviewed in (Ko et al., 2015)].  
Within the nervous system, Tet expression and 5hmC enrichment is detected in 
the developing mouse brain (Almeida et al., 2012b; Hahn et al., 2013). 5hmC levels 
increase during neuronal differentiation, with enrichment at enhancers and also within 
gene bodies of neuronal genes  (Hahn et al., 2013).  This enrichment is interesting 
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because it is not associated with subsequent demethylation, in agreement with a study 
that shows biochemical stability of 5hmC marks within the genome (Bachman et al., 
2014). Beyond loss-of-function experiments, Tet3 overexpression in mouse olfactory 
neurons results in an increase in 5hmC levels, altered gene expression, and defects in 
axon targeting (Colquitt et al., 2013), and tet3 activity is upregulated in dorsal root 
ganglia neurons during axon regeneration (Loh et al., 2016).  
More recent work has shown that Tet proteins regulate both intrinsic and extrinsic 
pathways during development. Intrinsically, Tet activity is required during hematopoiesis 
(Madzo et al., 2014) and B-cell development (Orlanski et al., 2016). Tets also modulate 
the activity of extrinsic signaling pathways in a variety of contexts.  Tets suppress Wnt 
pathway activity during early mouse development to balance mesoderm and 
neuroectoderm fates (Li et al., 2016), while at later stages in the intestinal epithelium, 
Tet1 is required for Wnt pathway activation (Kim et al., 2016).  During gastrulation, Tet 
activity regulates the Nodal pathway by suppressing the expression of Nodal inhibitors 
(Dai et al., 2016). 
Although DNA methylation and hydroxymethylation have been studied 
extensively in the context of stem cell programming and disease, far less is known about 
their roles during development and in regulating organogenesis to create a complex 
structure like the retina. The vertebrate retina consists of seven main cell types that 
perform distinct functions in phototransduction and visual signal transmission [reviewed 
in (Bassett and Wallace, 2012)]. These cells are organized in the three retinal layers: the 
ganglion cell layer (GCL), outer nuclear layer (ONL), and inner nuclear layer (INL). The 
retina develops from a common pool of seemingly indistinguishable multipotent retinal 
progenitor cells (RPCs), which ultimately give rise to all retinal cells in a stereotyped 
time order [reviewed in (Centanin and Wittbrodt, 2014)].  
While much has been learned regarding the specification events that direct RPCs 
to distinct retinal cell fates, we know little about the epigenetic regulation of these events, 
or the mechanisms underlying terminal differentiation and morphogenesis of retinal 
neurons and glia. Indeed, no studies have determined whether Tet function or DNA 
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hydroxymethylation are required during retinal development. To address this topic we 
functionally inactivated the tet2 and tet3 genes in zebrafish and identified defects in 
retinal development that resulted from deregulated gene expression in tet2-/-;tet3-/- mutants. 
This is the first detailed analysis of Tet function during vertebrate retinal development, 
and our data support a model in which Tet-mediated regulation of 5hmC levels is critical 
for retinal neurogenesis.   
3.2 RESULTS 
3.2.1 tet2 and tet3 expression and functional inactivation 
 
Several studies have reported the expression of Tet-family genes in developing 
embryos and in tissues, including the eye (e.g. (Almeida et al., 2012b; Xu et al., 2012)).  
Zebrafish possess three Tet-family genes (tet1, tet2 and tet3), and these are orthologous 
to mouse and human Tet1-3 (Fig. 3.1A). At 24 hours post fertilization (hpf) all three tet 
genes are expressed broadly throughout the embryo, including the eye (Fig. 3.1B-D). At 
48 and 72hpf, tet1 expression is faint in the head and is expressed at comparatively lower 
levels in the eye than tet2 and tet3 (Fig. 3.1E,H). At 48 and 72hpf, tet2 and tet3 are 
strongly expressed in the anterior of the embryo and, in the eye, transcripts are enriched 




Figure 3.1: Tet-family gene expression and phylogenetic analyses. (A) An unrooted 
phylogenetic tree constructed from mouse, human and zebrafish Tet1, 2 and 
3 proteins.  (B-D) tet1, tet2 and tet3 are ubiquitously expressed at 24hpf.  At 
48 (E-G) and 72hpf (H-J) tet2 and tet3 are expressed in the inner nuclear 
layer (INL; arrowhead) and ganglion cell layer (GCL; arrows), and faintly in 




Because tet2 and tet3 were the only Tet-family genes that showed prominent 
retinal expression past 24hpf, and a recent report demonstrated that tet1 was dispensable 
for normal zebrafish development and for DNA hydroxymethylation (Li et al., 2015), we 
focused on tet2 and tet3 for functional perturbations. Mutant alleles were created by 
designing transcription activator-like effector nucleases (TALENs) targeting the first 
exon of tet2 and the sixth exon of tet3 (Bedell et al., 2012b). Injected mosaic founders 
were screened for germline transmission, and mutant alleles were detected and sorted by 
restriction fragment length polymorphisms (RFLP) and then sequenced (Fig. 3.2A,B; Fig 
3.3A). Two alleles were identified and maintained: tet2au59 mutants possess a 10bp deletion 
which is predicted to cause a frameshift beginning at amino acid (aa) 407, inserting 37 
incorrect amino acids and truncating the protein at aa 444 out of 1,716  
[c.1,219_1,229delATAGATTTAA, p.Ile407Thrfs*37], and tet3au60 mutants possess a 22bp 
deletion mutation, which is predicted to cause a frameshift beginning at aa 1,212, 
inserting 92 incorrect aa and truncating the tet3 protein at aa 1,304 out of 2,052 







Figure 3.2: tet2-/-;tet3-/- mutants are deficient in 5mC  5hmC conversion and display 
abnormalities in retinal development.  
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 (Figure 3.2 - continued) (A) tet2au59 mutants possess a 10bp deletion 
resulting in a frameshift, insertion of 37 incorrect aa’s (red), and a premature 
stop codon, truncating the protein at amino acid (aa) 444 of 1,716aa.  (B) 
tet3au60 mutants possess a 22bp deletion, resulting in a frameshift, insertion of 
92 incorrect aa’s (red), and a premature stop codon, truncating the protein at 
aa 1,304 of 2,052.  (C) Genomic DNA isolated from 2dpf tet2-/-;tet3-/- mutants 
shows a >9 fold reduction in global 5hmC levels when compared to 
phenotypically wild-type siblings and genetically wild-type embryos in an 
ELISA (n=20 embryos, p=0.004 and p=0.0005, respectively; Error bars = ± 
1 S.D.).  (D) At 36hpf, tet2-/-;tet3-/- mutants are identifiable based on a kinked 
head and slightly enlarged brain (arrow).  (E,F) Retinae of 36hpf tet2-/-;tet3-/- 
mutants are morphologically similar to wild-types.  (G) At 2dpf, tet2-/-;tet3-/-  
mutants are microphthalmic, possess cardiac edema and their heads are 
smaller than phenotypically wildtype siblings.  (H-I) The retina is not 
laminated, with retinal cells appearing progenitor-like in morphology when 
compared to phenotypically wild-type siblings.  (J) Cardiac edema becomes 
progressively enlarged at 3dpf in tet2-/-; tet3-/- embryos.   (K,L) The retina 
remains poorly laminated in tet2-/-;tet3-/- mutants, and they lack a 
morphologically obvious optic nerve (arrowhead in sibling).  (M) A 4dpf 
tet2-/-; tet3-/- embryos do not possess an inflated swim bladder (arrow). (N,O) 
The retina remains poorly laminated and they lack a morphologically 
obvious optic nerve (arrowhead in sibling). DNA (green), F-actin (cyan). 














tet2-/- and tet3-/- mutants develop normally with no visible phenotype and they are 
homozygous viable (Fig. 3.3B).  This is an unsurprising result given their close 
phylogenetic relationship and overlapping expression domains, and it is consistent with 
recent reports (Gjini et al., 2015; Li et al., 2015). Thus, tet2-/-;tet3-/-  mutants were 
generated by in-crossing double heterozygous adults (tet2+/-;tet3+/-).  tet2-/-;tet3-/- mutants 
were recovered at an expected Mendelian ratio (6.62%; n=103 mutants/1,554 embryos). 
At 36hpf, tet2-/-;tet3-/- mutants displayed a distinct morphological phenotype where the 
anterior portion of the brain was enlarged and kinked when compared to wild-type 
siblings (Fig. 3.2D). At 2 days post-fertilization (dpf), tet2-/-;tet3-/- mutants were 
microphthalmic, mildly hypopigmented, and displayed deformed craniofacial features, 
cardiac edema, and blood pooling, phenotypes that perdure through 4dpf (Fig. 3.2G,J,M).  
 
tet2au59 and tet3au60 mutations are predicted to truncate the proteins upstream of the C-
terminal catalytic domain (Pastor et al., 2013) and therefore encode null or severe loss of 
function alleles. At 2dpf and 5dpf, tet2 transcripts were detectable in phenotypically wild-
type siblings, but not in tet2-/-; tet3-/- mutants, indicating that tet2 transcripts are degraded 
through nonsense-mediated decay (NMD) (Fig. 3.4A). tet3 transcripts were still present 
in both sibling and tet2-/-;tet3-/- mutants (Fig. 3.4B). To assess tet3 protein, Western blots 
were performed on 3dpf phenotypically wild-type siblings and tet2-/-;tet3-/- mutants (Fig. 
3.4C,D). tet3 protein was undetectable in tet2-/-;tet3-/- mutants. These data indicate that 
tet2au59 and tet3au60 are null alleles.  To experimentally validate the loss of catalytic function 
in tet2-/-;tet3-/- mutants, we utilized a sensitive enzyme-linked immunosorbent assay 
(ELISA) to quantify whole embryo 5hmC levels.  At 2dpf, genetically wild-type and 
phenotypically wild-type siblings possessed genome-wide 5hmC levels of 0.30% and 
0.28%, respectively, consistent with published levels in various isolated mouse tissues 
(Khoueiry et al., 2017; Szwagierczak et al., 2010). By comparison, tet2-/-;tet3-/-  mutants 
possessed a significant reduction in 5hmC levels (0.03%, p<0.005) indicating that tet2au59 





Figure 3.3: tet2 and tet3 RFLP genotyping and genotypic distribution in adults. (A) 
Mutations were detected by restriction fragment length polymorphism 
(RFLP). Mutant alleles lack the recognition site for DraI (for tet2) and RsaI 
(for tet3), and are therefore undigested. (B) At 3-months, 96 fish were 
individually genotyped by RFLP. The genotypic distribution follows a 
Mendelian distribution for a dihybrid cross, except for the absence of tet2-/-






Figure 3.4: tet2 transcript and tet3 protein are undetectable in tet2-/-;tet3-/- mutants. 
(A) At 2dpf and 5dpf, tet2 transcripts are present in sibling but undetectable 
by RT-PCR in tet2-/-;tet3-/- mutants indicating degradation, presumably via 
nonsense-mediated decay. (B) tet3 transcripts are present in both sibling and 
tet2-/-;tet3-/- at both time points. N=20 embryos per condition, and 
experiments done in biological triplicates. RT-PCRs for tet2 and tet3 were 
done in parallel from the same cDNA pools.  (C,D) At 3dpf, tet3 protein 
(225 kDa) is absent from tet2-/-;tet3-/- mutants. N=40 embryos per condition, 








To analyze retinal development in tet2-/-;tet3-/-  mutants, we performed histology 
from 36hpf to 4dpf and assessed overall retinal structure. At 36hpf, no obvious 
differences between retinal morphology in tet2-/-;tet3-/- mutants and wild-type siblings were 
evident (Fig. 3.2E,F). At 2dpf, tet2-/-;tet3-/- mutant retinae appeared progenitor-like in 
morphology, as little evidence of lamination or neuronal differentiation was evident (Fig. 
3.2H,I). At 3dpf, tet2-/-;tet3-/- mutant retinae displayed some evidence of lamination, 
though this was reduced when compared to that in phenotypically wild-type siblings.  
Moreover, while cells populated the inner retina, and a GCL and INL were discernable, 
all tet2-/-;tet3-/- mutants lacked a morphologically obvious optic nerve (Fig. 3.2K,L). 
Retinal defects remained prevalent at 4dpf with tet2-/-;tet3-/- mutant retinae continuing to 
possess lamination defects and no apparent formation of an optic nerve, despite the 
presence of cells in the inner retinal area normally occupied by RGCs (Fig. 3.2N,O). 
 
3.2.2 Cell cycle dynamics in early progenitor cells are disrupted in tet2-/-;tet3-/-  
 
Because retinal cells in tet2-/-;tet3-/- mutants appeared to be progenitor-like in 
morphology at 2dpf, and lamination defects persisted at 3dpf and 4dpf, a phenotype 
associated with elongated proliferation and/or defects in cell cycle exit in zebrafish 
(Cerveny et al., 2010; Uribe and Gross, 2010; Yamaguchi et al., 2005), we next 
determined cell cycle dynamics in tet2-/-;tet3-/- mutant retinal cells.  First we assayed the S 
to M phase progression by utilizing the percent labeled mitoses (PLM) assay (Locker et 
al., 2006; Quastler and Sherman, 1959; Uribe and Gross, 2010).  Embryos were treated 
with a 15-minute bromodeoxyuridine (BrdU) pulse at 32hpf, washed, fixed at 30, 60, 90, 
and 120 minutes post-treatment, and immunostained for BrdU and phosphohistone H3 
(pH3) (Fig. 3.5A). Cells in S-phase during the BrdU pulse (BrdU+) and cells in late 
G2/M-phase at the time of fixation (pH3+) were quantified. Cells that were proliferative 
during the BrdU pulse and then undergo mitosis are double positive (BrdU+,pH3+). In 
contrast, cells that were not in S-phase during the BrdU pulse, but still undergo mitosis, 
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are only pH3+. Thus, the proportion of these cells {(BrdU+pH3+)/pH3+} represent the 
‘labeled’ mitotic events.  In tet2-/-;tet3-/- mutants, the percent labeled mitoses are 
significantly lower than sibling at all time points examined (Fig. 3.5B-D). Nearly 100% 
of ‘labeled’ RPCs in wild-type embryos completed the S to M phase transition by the end 
of 120-minute time window, while only 50% of tet2-/-;tet3-/- mutants competed this 
transition. This indicates that between 32-34hpf, tet2-/-;tet3-/- RPCs are progressing from S 




Figure 3.5: RPC cell cycle dynamics are disrupted in tet2-/-;tet3-/-.  
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 (Figure 3.5 - continued) (A) Percent labeled mitoses (PLM) assay was 
performed by treating embryos for 15 minutes in bromodeoxyuridine 
(BrdU) pulse at 32hpf, rinsed, fixed at 30, 60, 90, and 120 minutes post-
treatment for immunostaining.  (B,C) Cells in S-phase during BrdU pulse 
(BrdU+; red) and cells in G2/M-phase at fixation (pH3+; green) were counted. 
Cells that were proliferative during the BrdU pulse and then undergo mitosis 
are double positive (BrdU+,pH3+; yellow; arrows).  (D) tet2-/-;tet3-/- retinae 
show significantly lower proportion of labeled mitotic events 
([BrdU+pH3+]/pH3+) at all four time points.  By the end of 120-minute 
window, nearly all ‘labeled’ RPCs completed S to M phase transition in 
wild-type siblings, compared to only 50% in tet2-/-;tet3-/- mutants (n=5 
embryos per condition per time point analyzed). (E-M) At later time points, 
BrdU incorporation assays over 2-hour time windows revealed that retinal 
progenitor cells remain proliferative longer and proliferate ectopically in 
tet2-/-;tet3-/- mutants. (E,F) At 2dpf, cells within the central retina of wild-type 
sibling embryos (dotted line) are no longer proliferative, correlating with 
cell cycle exit and differentiation.  (G,H) At 3dpf, the only proliferative cells 
in the wild-type retina are located in the CMZ (outlined). In tet2-/-;tet3-/- 
mutants, this proliferative region is significantly expanded.  Ectopically 
proliferating cells are also observed outside of the CMZ at significantly 
higher numbers than wild-type siblings (arrowheads).  (I,J) At 5dpf, both 
sibling and tet2-/-;tet3-/- eyes possess proliferative CMZs.  (K) Total retinal 
cell count per section is significantly lower in tet2-/-;tet3-/- mutant compared to 
sibling at all time points, correlating with microphthalmia. (L) tet2-/-;tet3-/- 
mutant retinae possess a significantly higher percentage of proliferative 
(BrdU+) cells at 2 and 3dpf, but lower at 5dpf.  (M) Percentage of CMZ area 
per total retina is significantly higher in tet2-/-;tet3-/- mutant at 3dpf, but not 
significantly different at 5dpf. N=3 embryos per condition per time point for 
E-M. Dorsal is up and anterior to the left in all images. All error bars = ± 1 
S.D. All p-values calculated using two-tailed, unpaired t-test. Scale bar = 









At later time points, BrdU incorporation assays over 2-hour pulse windows 
showed that, although tet2-/-;tet3-/- mutant eyes were smaller and contained fewer cells 
(Fig. 3.5E-K), they contained a significantly higher percentage of BrdU+ cells at both 
2dpf and 3dpf (Fig. 3.5L). At 2dpf, central retinal cells of wildtype embryos have exited 
the cell cycle and differentiated, while in tet2-/-;tet3-/- mutant eyes the central retina 
remained proliferative (Fig. 3.5E,F). By 3dpf, cells of the wildtype retina have exited the 
cell cycle and differentiated except for those in the ciliary marginal zone (CMZ) at the 
retinal periphery which remains proliferative throughout the life of the animal (Fig. 
3.5G,H) (Marcus et al., 1999).    In tet2-/-;tet3-/- mutants, most cells within the central retina 
were no longer BrdU+, but the peripheral (CMZ) domain was significantly expanded (Fig. 
3.5M).  Moreover, ectopic proliferative cells were detected in the inner retina, outside of 
the tet2-/-;tet3-/- CMZ (Fig. 3.5H), a phenotype not observed in wildtype siblings. The 
identity of these cells remains unclear, although we have ruled out the possibility of these 
being Müller glia (MG) cells, as they do not co-stain with the MG-specific marker, zrf-
1/gfap (Fig. 3.5J).  By 5dpf, a distinct zone of proliferation is present in tet2-/-;tet3-/- 
mutants, indicating that the mutant RPCs eventually completed cell cycle exit, and that 
ectopically proliferative cells are no longer present (Fig 3.5I,J). 
While the PLM and BrdU incorporation results suggest that elongation of the cell 
cycle during early retinal development underlies microphthalmia in tet2-/-;tet3-/- mutants, 
apoptosis of RPCs or newly differentiated neurons could also contribute. To determine 
whether apoptosis plays a role in tet2-/-;tet3-/- mutant retinal defects, we performed terminal 
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assays.  No increase in 
apoptotic cells was detected in tet2-/-;tet3-/- mutant until after 3dpf (Fig 3.6), indicating that 
apoptosis is unlikely to account for microphthalmia in tet2-/-;tet3-/- mutants.  
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Figure 3.6: tet2-/-;tet3-/- embryos possesses few apoptotic cells prior to 3dpf. TUNEL 
labeling was performed on cryosections of tet2-/-;tet3-/- and sibling embryos at 
36hpf, 3dpf, 4dpf, and 5dpf. No difference was observed at 36hpf (A,E), and 
few apoptotic cells are observed in tet2-/-;tet3-/- at 3dpf (B,F; arrows). More 
apoptotic cells are observed in tet2-/-;tet3-/- at 4dpf and 5dpf (C-D; G-H). 
Images are representatives of at least n=3 embryos examined. DNA (blue), 
TUNEL signal (red). 
 
3.2.3 Retinal cell differentiation is impaired in tet2-/-;tet3-/-  embryos 
 
Given the impaired retinal lamination and cell cycle progression defects in tet2-/-
;tet3-/- mutants, we next asked whether tet2-/-;tet3-/- retinal cells differentiate into neurons 
and Müller glia. In wild-type embryos, all retinal neuron and glial cell types are 
differentiated by 72hpf [i.e. (He et al., 2012; Schmitt and Dowling, 1999; Uribe and 
Gross, 2010)]. An early neuronal marker, HuC/D, detects RGCs and amacrine cells 
(ACs) (Kay et al., 2001; Kim et al., 1996); in tet2-/-;tet3-/- mutants, while HuC/D+ cells were 
detected in the GCL and INL, their number in the INL was significantly lower and the 
few HuC/D+ cells present were restricted to the central-most region of the retina (Fig. 
3.7A,F; Fig. 3.8). tet2-/-;tet3-/- mutants almost entirely lacked zpr1-expressing red/green 
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double cones (Fig. 3.7B,G), zpr-3-expressing rods (Fig. 3.7C,D, H,I), and zrf-1/gfap-
expressing Müller glia (Fig. 3.7E,J). tet2-/-;tet3-/- mutants possess positive 
immunoreactivity to Zn8/neurolin, which detects differentiated RGCs (Trevarrow and 
Kimmel, 1990), although the region of Zn8+ RGCs does not extend as far to the retinal 
periphery as in wild-type siblings (Fig. 3.7K,P). For each of the markers tested, 
immunoreactive cells were restricted to the central-most retina and none were detected 
more peripherally, corresponding with the expanded zone of proliferation detected at 
3dpf in BrdU assays (Fig. 3.5).  
In sections of tet2-/-;tet3-/- mutant eyes, no optic nerve was detected (Figs. 3.2, 3.5, 
3.6). It was formally possible that an optic nerve was present, but that axons were 
misrouted inside of the retina, a phenotype associated with defects in axonal pathfinding 
(Karlstrom et al., 1996).  To exclude this possibility, we performed whole-mount 
chromogenic labeling using the Zn8/neurolin antibody to label RGC axons (Karlstrom et 
al., 1996). In 3dpf phenotypically wild-type siblings, Zn8 labeled intra-retinal RGC axons 
that extend along the vitreal surface of the eye to generate the optic nerve, as well as the 
optic nerve itself as it passes through the choroid fissure (CF) and into the optic chiasm 
(Fig. 3.7L). In tet2-/-;tet3-/- mutants, Zn8 was only detected within the GCL and in a few 
axons within the choroid fissure (Fig. 3.7Q).  As a more sensitive optic nerve labeling 
assay, we utilized a transgenic reporter, Tg(isl2b:GFP)zc7, which expresses GFP in RGCs, 
and a subset of developing PRs (Pittman et al., 2008).  Sibling embryos possessed a 
strong GFP signal in RGC cell bodies and axons along the entire length of the optic 
nerve, clearly visible in both section and whole-mount preparations (Fig. 3.7M-O). In 
tet2-/-;tet3-/- mutants, while 12% of 41 mutant embryos lacked an optic nerve entirely, the 
remainder possessed an optic nerve, formed either bilaterally (39%) or unilaterally 
(49%); however, in these embryos, the optic nerve was thin and appeared to be composed 
of very few axons (Fig. 3.7M,R).  For the few axons that did leave the eye, retinotectal 
projections appeared to be normal, even in embryos with unilateral optic nerves (Fig. 
3.7R). Taken together, these data indicate that the terminal differentiation and 
morphogenesis of RGCs is affected in tet2-/-;tet3-/- mutants, and not axon pathfinding.  
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Photoreceptors (PRs) undergo terminal differentiation and morphogenesis to form 
outer segments rich in photoreceptive molecules for phototransduction; this starts in the 
ventro-nasal patch and spreads through the retina (Fig. 3.7B-D) (Brzezinski and Reh, 
2015; Schmitt and Dowling, 1996; Schmitt and Dowling, 1999). Sporadic rods and cones 
are detected in the central region of the retina in tet2-/-;tet3-/- mutants, likely the earliest 
born PRs, but none are detected more peripherally (Fig. 3.7G-I). Moreover, in sibling 
embryos, while outer segments are well formed by 72hpf and highly immuoreactive to 
zpr-1 (arrestin3a) and zpr-3 (rhodopsin), the few PRs that differentiate in tet2-/-;tet3-/- 
mutants possess little to no outer segment material (Fig. 3.7D,I). This is further 
highlighted by staining isl2b:GFP embryos with zpr-3. Only a few isl2b:GFP+ PRs 
express zpr-3 and of those that do, they have nearly undetectable outer segments (Fig. 
3.7O,T).  Given the dramatic reductions in optic nerve size and in PR outer segment 
formation, we conclude that RGCs and PRs of tet2-/-;tet3-/- mutants, despite expressing 






Figure 3.7: tet2-/-;tet3-/-  retinal cells do not undergo terminal differentiation.  
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 (Figure 3.7 - continued) (A,F) HuC/D labels RGCs and amacrine cells 
(ACs), which are reduced in number and located only in the central region 
of the INL in tet2-/-;tet3-/- retinae (arrow).  (B,G) tet2-/-;tet3-/- mutant retinae 
almost entirely lack zpr-1+ red/green cones (arrow); (C,D,H,I) possess few 
zpr-3+ rods (arrow), and of those that are zpr-3+, outer segments are severely 
attenuated or almost absent (arrow). (E,J) tet2-/-;tet3-/- retinae also possess few 
zrf-1+  Müller glia (arrows in wild-type).  In all cases, marker+ cells are 
located in the central/ventral part of the retina. (K,P) Zn8 detects neurolin, a 
protein enriched on RGCs and the optic nerve (arrow in K).  (L,Q) Zn8 
staining reveals the optic nerve in the choroid fissure and optic chiasm 
(arrow) of wild-type embryos but not in tet2-/-;tet3-/- mutants.  (M-N) 
isl2b:GFP transgenics express GFP in RGCs and PRs, clearly labeling the 
optic nerve in whole-mount and section views (arrowhead). (R,S) The tet2-/-
;tet3-/- optic nerve is very thin, often unilaterally formed, but, when present, 
correctly routed to the brain.  (O,T) The isl2b:GFP signal overlaps zpr-3 
(rod) marker in the cell body and outer segments in siblings (arrows). In tet2-
/-;tet3-/-, few isl2b:GFP+ cells are zpr-3+ (arrows), further suggesting that 
specified cells are not terminally differentiated.  Few outer segments have 
also formed in tet2-/-;tet3-/- mutants. DNA (blue), antibody stain (red). All 
images are 3dpf. n>5 for each marker. Dorsal is up and anterior to the left. 
Scale bar = 80μm in A-K, P. 
 
 
Figure 3.8: tet2-/-;tet3-/- embryos possesses fewer amacrine cells at 3dpf. Number of 
HuC/D-positive neurons in the INL (amacrine cells) is significantly lower in 
tet2-/-;tet3-/- eyes than in sibling, although the number of HuC/D-positive cells 
in the GCL (consisting of ganglion and displaced amacrine cells) is not 
significantly different. Error bars = ± 1 S.D. Significance cut-off for p-value 
= 0.05 (two-tailed, unpaired t-test). 
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3.2.4 Neuronal specification occurs normally in tet2-/-;tet3-/- mutants 
To begin to determine the molecular mechanism responsible for the reduction of 
terminally differentiated retinal neurons in tet2-/-;tet3-/- mutants, we next asked if neuronal 
specification factors were properly expressed (Fig. 3.9). At 36hpf, vsx2 is expressed in 
proliferative RPCs, and turned off as these cells exit the cell cycle and begin to 
differentiate (Fig. 3.9A, dotted area). In tet2-/-;tet3-/- mutants, this zone of differentiation is 
noticeably smaller (Fig. 3.9F).  At 48hpf, vsx2 expression is localized in proliferative 
cells at the periphery of the retina (Fig. 3.9K) (Vitorino et al., 2009). This zone of vsx2 
expression was expanded in tet2-/-;tet3-/- mutants when compared to wild-type siblings 
(Fig. 3.9P), corresponding to the expanded zone of proliferation observed in the BrdU 
labeling assay (Fig 3.5). 
pax6a is normally expressed in RPCs, in addition to RGCs and ACs (Klimova and 
Kozmik, 2014); neurod4 is expressed in ACs, horizontal and bipolar cells (Wang et al., 
2003); atoh7 is expressed in the committed precursor undergoing specification to become 
RGCs (Kay et al., 2001), and crx is expressed in specified PRs (Liu et al., 2001) (Fig. 
3.9B-E, L-O).  Despite terminal differentiation defects observed in retinae of tet2-/-;tet3-/- 
mutants, they retain relatively normal spatial and temporal expression of specification 
markers at 36hpf and 48hpf (Fig. 3.9G-J, Q-T, respectively), suggesting that RPC 





Figure 3.9: Expression of retinal cell fate specification markers is largely normal in 
tet2-/-;tet3-/- embryos.  
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 (Figure 3.9 – continued) Expression of genes involved in retinal 
neurogenesis was detected by in situ hybridization at 36hpf and 48hpf.  
(A,F) At 36hpf, vsx2 is expressed in the retinal progenitor cells (RPCs) and 
turned off as they differentiate, first in the central retina (A, dotted area). 
This zone of differentiation is still present in tet2-/-;tet3-/- mutant (F, dotted 
area).  (K,P) At 48hpf, expression of vsx2 is slightly expanded in tet2-/-;tet3-/- 
mutants (K,P arrows) but otherwise appears in a normal pattern.  (B,G,L,Q) 
Expression of pax6a (marker for RPC, amacrine, and ganglion cells) and 
neuroD4 (marker for amacrine, horizontal, and bipolar cells) is relatively 
normal in tet2-/-;tet3-/- mutants when compared to sibling embryos at both 
36hpf and 48hpf.  (D,I,N,S) Ganglion cell precursors express atoh7 as they 
exit the RPC pool, become specified and start undergo differentiation. atoh7 
expression is present in the correct location in tet2-/-;tet3-/- mutants, compared 
to sibling embryos at both 36hpf and 48hpf.  (E,J,O,T) crx is expressed in 
cells fated to become photoreceptors (rods and cones) and this expression 
pattern appears relatively normal in tet2-/-;tet3-/- mutants. Scale bar = 20μm. 
n>8 per gene for each time point. Drawings on bottom row represent cell 
type detected in each corresponding column.  
 
3.2.5 tet2 and tet3 regulate cell non-autonomous effects during retinal neuron 
differentiation 
Tet proteins are known to regulate both intrinsic and extrinsic pathways during 
development and differentiation events in a range of tissues. For example, tet activity is 
required intrinsically during hematopoiesis (Madzo et al., 2014) and B-cell differentiation 
(Orlanski et al., 2016). Recent studies have shown that Tet activity also modulates 
extrinsic pathways during development. In mouse embryos and embryonic stem cells, 
Tets function to negatively regulate Wnt pathway activity to balance mesoderm vs 
neuroectoderm fate choices (Li et al., 2016), and during mouse gastrulation, they 
modulate Nodal pathway activity by controlling the expression of Lefty1, a nodal 
inhibitor (Dai et al., 2016).  Retinal cell type specification and differentiation depend on a 
multitude of intrinsic and extrinsic pathways [reviewed in (Bassett and Wallace, 2012; 
Yang, 2004)], and given that Tet activity can modulate both intrinsic and extrinsic 
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pathways during development, we next sought to determine whether tet2 and tet3 
activities were required cell autonomously or cell non-autonomously during retinal 
neurogenesis. Chimeric embryos were generated by blastomere transplantation 
(Carmany-Rampey and Moens, 2006) to generate embryos whose retinae were composed 
of clones of wild-type and tet2-/-;tet3-/- mutant cells. Donor embryos were injected with 
fluorescent dextran and clones were transplanted from labeled donors into unlabeled 
hosts at shield stage, targeting specifically to the retinal field where cells later develop 
into the retina (Woo and Fraser, 1995). At 3dpf, host embryos were analyzed through a 
combination of HuC/D and zpr-3 staining, to detect differentiated RGCs, ACs and/or rods 
(Fig. 3.10A). Sibling to wild-type transplants yielded clones of cells that differentiated 
normally (Fig. 3.10B).  tet2-/-;tet3-/- mutant cells transplanted into genetically wildtype 
hosts also differentiated normally into retinal neurons including RGCs, ACs, and rods, 
and the regions of the retina containing mutant clones were also properly laminated  (Fig. 
3.10C). Genetically wildtype cells transplanted into tet2-/-;tet3-/- mutant host retinae failed 
to undergo neurogenesis and remained undifferentiated (Fig. 3.10D). Thus, the wild-type 
retina was able to support normal neurogenesis of tet2-/-;tet3-/- mutant cells, while wild-
type cells in a tet2-/-;tet3-/- mutant retina did not differentiate properly.  Taken together, 
these data demonstrate that tet2 and tet3 activity regulates retinal neuron differentiation 
via cell non-autonomous pathways, potentially by modulating the expression or activity 









Figure 3.10: Tet2 and tet3 regulate retinal neurogenesis cell non-autonomously. (A) 
Chimeric embryos were generated by blastomere transplantation from 
fluorescent dextran-labeled donor into unlabeled host.  Retinae composed of 
clones from wild-type and tet2-/-;tet3-/- mutant cells were analyzed at 3dpf.  
(B) Sibling donor to wildtype host transplants yielded clones of donor cells 
(green; arrows) that differentiated normally into retinal neurons including 
AC, RGC, rods (red), and display proper lamination (n=5).  (C) Similarly, 
tet2-/-;tet3-/- mutant cells transplanted into genetically wildtype hosts also 
differentiated normally, and the regions of the retina containing mutant 
clones were also properly laminated (n=3).  (D). Genetically wild-type 
donor cells transplanted into tet2-/-;tet3-/- mutant host retinae failed to undergo 
neurogenesis and remained undifferentiated (green, arrows) (n=3).  DNA 
(blue), HuC/D + zpr-3 antibody stain (red), transplanted donor clones 






3.2.6 The Notch and Wnt pathways function downstream of tet2 and tet3 
 Because tet2 and tet3 appear to regulate retinal cell differentiation in a cell non-
autonomous fashion, we next sought to identify potential factors responsible for these 
effects, utilizing both a candidate gene approach and an unbiased transcriptomic analysis. 
The Notch and Wnt pathways regulate retinal neurogenesis in mouse, zebrafish and 
Xenopus (Chiodini et al., 2013; Kubo et al., 2005; Uribe et al., 2012; Yaron et al., 2006); 
upregulation of these pathways prevents neuronal differentiation in a variety of contexts 
and resultant phenotypes resemble those in tet2-/-;tet3-/- mutants (Bernardos et al., 2005; 
Meyers et al., 2012; Yamaguchi et al., 2005; Yaron et al., 2006).  Thus, to determine 
whether the expression of Notch and Wnt pathway components, or the overall activities 
of the pathways, are regulated by tet2 and tet3, we first performed in situ hybridizations 
using probes specific to candidate genes in each pathway. In wild-type sibling embryos at 
36hpf, notch1a, deltaA, and ascl1a are expressed in the eye but excluded from the inner 
part of central retina where RGCs, ACs and PRs are differentiating (Fig. 3.11A-C). 
However, in tet2-/-;tet3-/- mutants, these genes are expressed uniformly throughout the 
retina, without a clear ‘zone’ of differentiation (Fig. 3.11D-F).  Similarly, lef1, a 
downstream readout of the Wnt pathway (Borday et al., 2012), is expressed in the 
peripheral part of the retina of wild-type embryos at 36hpf (Fig. 3.11I), and this zone of 
expression is expanded in tet2-/-;tet3-/- mutants (Fig. 3.11L). These expression patterns 
suggest that the Notch and Wnt pathways could have elevated activity in the tet2-/-;tet3-/- 
mutant retina.  
To complement these candidate gene studies, we performed RNA-seq using 
dissected tet2-/-;tet3-/- mutant and phenotypically wildtype sibling eyes at 36hpf. 
Approximately 450 million reads were generated and mapped to GRCz10 (Trapnell et al., 
2010; Trapnell et al., 2012) at 85.1% mapping efficiency.   In tet2-/-;tet3-/- mutants, 278 
genes were downregulated and 489 genes were upregulated (log2 fold-change above 2) as 
compared to wild-type siblings (Supplemental Table 1 in (Seritrakul and Gross, 2017)). 
Gene ontology (GO) analysis for biological pathways categorized many of the 
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differentially expressed genes in the development of the visual perception, GPCR and 
cytokine-mediated signaling pathways, and ion transport (Fig. 3.11M,N). Notably, the 
highest upregulated gene was wnt9b (log2 fold-change=9.89), and many other members of 
the Wnt family were also upregulated (wnt1, wnt3, wnt11r, wnt10a) in tet2-/-;tet3-/- mutant 
eyes. In situ hybridization using antisense probes for wnt1 and wnt9b revealed that at 
36hpf, while both genes showed faint expression at the peripheral edge of the retina in 
sibling embryos (Fig. 3.11G,H, n=7 for wnt1, n=10 for wnt9b), in tet2-/-;tet3-/- mutants, 
both genes were expressed in expanded domains (Fig. 6J,K, n=7 for wnt1, n=8 for 
wnt9b), and at higher relative intensities, consistent with the RNAseq data. When 
combined with mosaic analyses, these data support a model in which extrinsic signals, 
likely including Notch and Wnt-related pathways, are regulated by tet2 and tet3 activity 
during retinal development and in their absence, these pathways are overactive and 




Figure 3.11: Gene expression is altered in tet2-/-;tet3-/- mutants at 36hpf and 
differentially expressed genes include those encoding components of the 
Notch and Wnt pathways.   
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 (Figure 3.11 – continued) (A-C) In sibling embryos at 36hpf, transcripts 
encoding components of Notch pathway (notch1a, deltaA, and ascl1a) are 
expressed in the eye but excluded from the inner part of central retina where 
cells have exited the cell cycle and differentiated (dotted area).  (D-F) In 
tet2-/-;tet3-/- mutants, these genes are expressed throughout the retina without 
a clear ‘zone’ of differentiation (n>8).  (G,H,J,K) The expression domains of 
wnt1 and wnt9B, are expanded in tet2-/-;tet3-/- mutants (arrows; n=7 for wnt1, 
n=8 for wnt9b), consistent with RNA-Seq data.  (I,L) Similarly, lef1, a 
downstream readout of Wnt pathway activity, is normally expressed in the 
peripheral edge of the retina, and this zone of expression is expanded in tet2-/-
;tet3-/- mutants (dotted areas; n>8).  (M-N) Gene ontology (GO) analysis for 
biological pathways was performed using DAVID. Numbers in parentheses 
indicate number of genes enriched in each pathway. P-value cutoff = 0.01   
 
To further test this model, we utilized pharmacological manipulations to 
determine if blocking Notch or Wnt activity could restore retinal neuron differentiation 
and morphogenesis in tet2-/-;tet3-/- mutants. DAPT is a g–secretase inhibitor that blocks the 
proteolytic cleavage of the intracellular domain of Notch, thus blocking its downstream 
signaling (Geling et al., 2002), and has been used extensively in zebrafish (Dovey et al., 
2001; Geling et al., 2002; Kubo et al., 2005; Uribe et al., 2012). Inhibitor of Wnt 
Response (IWR-1-endo) stabilizes Axin2 and promotes b-catenin degradation, effectively 
inhibiting Wnt signaling (Chen et al., 2009).  We exposed tet2-/-;tet3-/- mutant and sibling 
embryos carrying the isl2b:GFP reporter to 50µM DAPT or 5µM IWR from the onset of 
neurogenesis (24hpf) until fixation at 3dpf.  Interestingly, tet2-/-;tet3-/- mutants treated with 
DAPT showed a significant increase in both the percentage of isl2b:GFP+ RGCs in the 
retina, and in optic nerve diameter, when compared to DMSO-treated controls (p=0.0044 
and p=0.0010, respectively, 2-way ANOVA, Fig. 3.12A-H). No significant increases 
were detected in wild-type sibling embryos treated with either vehicle or DAPT (Fig. 
3.12G-H). Similarly, tet2-/-;tet3-/- embryos treated with IWR also showed a significant 
increase in percentage of isl2b:GFP+ RGCs and optic nerve diameter (p=0.0039 and 
p=0.0002, respectively, 2-way ANOVA, Fig. 3.12A-H).  Neither treatment rescued 
expression of isl2b:GFP+ PRs however, suggesting that other extrinsic pathways are likely 
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regulated by tet2 and tet3 activity.  These data support a model in which overactive Notch 
and/or Wnt signaling are partially responsible for neuronal differentiation/morphogenesis 
defects in tet2-/-;tet3-/- mutants. To further test this model, we upregulated Wnt signaling by 
treating wild-type embryos from 24hpf to 3dpf with 2µM BIO, a GSK3b inhibitor 
(Borday et al., 2012; Nishiya et al., 2014).  BIO-treated embryos showed dramatically 
reduced lamination, and decreases in the percentage of isl2b:GFP+ RGCs, and in optic 
nerve diameter relative to DMSO-treated controls, phenotypes that recapitulate those in 
tet2-/-;tet3-/- mutants (p=0.0024 and p<0.0001, Fig. 3.12I-L).  Taken together, these data 
demonstrate that Wnt and Notch signaling pathways act downstream of tet2 and tet3 




Figure 3.12: Tet2 and Tet3 function upstream of the Notch and Wnt pathways 
during RGC differentiation and morphogenesis.  
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 (Figure 3.12 - continued) tet2-/-;tet3-/- mutant and sibling embryos carrying 
isl2b:GFP were exposed to 50M DAPT, 5M IWR-1-endo, or 1% DMSO, 
during neurogenesis (24hpf to 72hpf) and analyzed for  isl2b:GFP+ RGCs 
and axons.  (A-C, G-H) No significant increases in optic nerve diameter or 
percentage of isl2b:GFP+ RGC per total cells (%RGC) were detected in 
sibling embryos treated with either 1% DMSO (vehicle), DAPT (Notch 
inhibitor), or IWR (Wnt inhibitor).  (E,G,H) tet2-/-;tet3-/- mutants treated with 
50M DAPT showed a significant increase in both the percentage of  
isl2b:GFP+ RGCs per retina and optic nerve diameter, when compared to 
DMSO-treated controls.  (F-H) tet2-/-;tet3-/- embryos treated with 5M IWR 
also showed a significant increase in the percentage of  isl2b:GFP+ RGCs per 
retina and optic nerve diameter.  (I-L) Wnt signaling was upregulated by 
exposing wild-type embryos from 24hpf to 72hpf with 2M BIO, a GSK3 
inhibitor. (I,J) BIO-treated wild-type embryos showed reduced lamination, 
(K) a decreased percentage of  isl2b:GFP+ RGCs per retina, and (L) 
decreased optic nerve diameter relative to DMSO-treated controls, 
(p=0.00236 and p<0.0001). All error bars = ± 1 S.D.; n=5 embryos (A-H) 
and n=6 embryos (I-L) per condition analyzed; P-values calculated using 
two-way ANOVA with multiple comparisons (for G-H) and two-tailed, 
unpaired t-test (for K-L). Scale bar = 50μm 
 
3.2.7 Gene expression and 5hmC distribution is disrupted in tet2-/-;tet3-/- mutants 
 
Despite early specification markers being expressed relatively normally during 
neurogenesis at 36 and 48hpf (Fig. 3.9), retinal neurons still do not terminally 
differentiate.  Thus, we next sought to determine the gene expression signatures of retinal 
cells at 72hpf as a means to infer their identities, and we again utilized RNA-Seq to asses 
these.  Similar to 36hpf assays, total RNA was extracted from dissected 72hpf tet2-/-;tet3-/- 
eyes and used for RNA-seq. Sixty-six million reads were generated and mapped to 
GRCz10 at 88.7% mapping efficiency. Comparisons of wild-type to tet2-/-;tet3-/- mutants 
resulted in the identification of 212 upregulated genes and 451 downregulated genes that 
passed a threshold of at least a 2 log2 fold-change (Fig 3.13A,B; Supplementary Table 2 
in (Seritrakul and Gross, 2017)). GO analysis was performed and, as expected, 
downregulated genes in tet2-/-;tet3-/- mutants are members of pathways tightly linked to 
differentiated PRs; i.e. GPCR signaling, membrane transport and ion transport. Indeed, 
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the most downregulated genes were those encoding proteins required for PR function 
such as opsins (e.g. opn1mw1, opn1sw1) and components of the visual cycle (e.g. 
guca1c, guca1g, gnat2, grk1b), an unsurprising result given the near absence of 
terminally differentiated PRs in tet2-/-;tet3-/- mutants (Fig. 3.7). While the highest number 
of upregulated genes constituted the regulation of transcription category, other 
upregulated GO terms included skeletal muscle contraction and cardiac muscle 
contraction. These GO categories included genes that are not normally expressed in the 
eye; these included nppa, vmhcl, chrng, and ucp1, each of which encodes a protein 
involved in heart and muscle development and/or function (Fig 3.13B).  
To verify RNAseq results, we performed in situ hybridization using probes 
specific to selected differentially expressed genes. Both opn1mw1 and opn1sw1 were 
expressed in PRs at 72hpf of wild-type sibling embryos, and expression was largely 
absent in tet2-/-;tet3-/- mutants, except in a small patch of cells in the ventral retina that 
corresponds to the region where differentiated PRs are detected (Fig. 3.13C-H). nppa 
(natriuretic peptide precursor a) was the most highly upregulated gene in tet2-/-;tet3-/- 
mutant eyes (log2 fold-change = 6.3). nppa encodes the precursor to a peptide required for 
cardiovascular function and is normally only expressed in the embryonic heart (Becker et 
al., 2014). All wild-type and tet2-/-;tet3-/- mutant embryos showed normal heart expression 
of nppa (Fig. 3.13I). Interestingly, however, in tet2-/-;tet3-/- mutants nppa was ectopically 
expressed in the retina and brain of all embryos (n=16/16 embryos), while no nppa 
expression was detected in the retina or brain of wild-type embryos (n=0/7 embryos) 
(Fig. 3.13I-K).  
To gain molecular insight into the epigenetic regulation of the differentially 
expressed genes in tet2-/-;tet3-/- embryos and whether these expression changes correlated 
with changes in 5mC or 5hmC deposition, we performed locus-specific methylation 
analyses, using bisulfite conversion followed by sequencing for 5mC + 5hmC, and a 
glucosylation-digestion assay for 5hmC specifically. We targeted regions surrounding the 
transcription start sites (TSSs) of opn1sw1, opn1mw1, a CpG island near a gene cluster 
that contains multiple opsins, including opn1mw1, as well as the TSS and gene body of 
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nppa (Table A3). Out of eleven targets selected for bisulfite sequencing, we observed no 
difference in methylation status at any CpG sites. In both wild-type and tet2-/-;tet3-/- 
mutants, all TSSs and the nppa gene body were fully methylated, and the opsin cluster 
CpG island was fully unmethylated (Fig 3.13L and Table 3.1).  
Bisulfite sequencing, while providing a nucleotide-resolution view of the 
methylation status of each CpG analyzed, is incapable of detecting differences between 
5mC and 5hmC, meaning any CpG that appeared methylated in bisulfite assays could be 
either 5mC or 5hmC, or a mixture of both. To distinguish between these two epigenetic 
marks, we utilized glucosylation-digestion-based (Quest) assay to probe the presence of 
5hmC at a glucosyl-sensitive restriction site, MspI. We selected targets that were located 
within or adjacent to the bisulfite-probed regions, due to the relatively sparse occurrence 
of MspI sites. Out of nine sites selected for analysis, only one, located in the gene body of 
nppa, showed a significant difference in 5hmC levels (Table 3.1). Interestingly, 5hmC 
was reduced to a nearly undetectable level at this site in tet2-/-;tet3-/- mutants, when 
compared to WT siblings where ~25% of the residues were hydroxymethylated (Fig 
3.13M). These data demonstrate that tet2 and tet3 mutations result in defects in 5mC to 
5hmC conversion within the nppa gene body, which could contribute to misregulated 














Methylation status (Bisulfite sequencing)  5hmC enrichment (Quest) 
Sibling tet2-/-;tet3-/- Sibling tet2-/-;tet3-/- 
opn1sw1 TSS site 1 methylated methylated no no 
opn1sw1 TSS site 2 methylated methylated no no 
opn1mw1 TSS site 1 methylated methylated * * 
opn1mw1 TSS site 2 methylated methylated * * 
opn1mw1 upstream MspI  methylated methylated no no 
opn1mw1-4 CpG island site 1 unmethylated unmethylated no no 
opn1mw1-4 CpG island site 2 unmethylated unmethylated no no 
nppa TSS site 1 methylated methylated no no 
nppa TSS site 2 methylated methylated no no 
nppa gene body site 1 methylated methylated yes no 
nppa gene body site 2 methylated methylated no no 
 
Table 3.1: Methylation status and 5hmC enrichment at candidate loci. * MspI site is 




Figure 3.13: Gene expression and 5hmC levels are abnormal in tet2-/-;tet3-/- mutant 
eyes at 72hpf.   
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 (Figure 3.13 – continued) (A-B) GO analysis for biological pathways was 
performed using DAVID. Numbers in parentheses indicate number of genes 
enriched in each GO term. P-value cutoff = 0.001.   In situ hybridization of 
(C-E) medium-wave sensitive (opn1mw1) and (F-H) short-wave sensitive 
opsin (opn1sw1). Transcripts of both genes are only detected in a few cells 
of the ventral retina in tet2-/-;tet3-/- embryos (arrows in E,H; n>8). natriuretic 
peptide a (nppa) is normally expressed in the heart (I), and is not detected in 
the retina of wild-type embryos (J; n>8). (K) In tet2-/-;tet3-/- embryos, ectopic 
nppa expressing cells were detected throughout the retina and brain (arrows) 
of all embryos examined (n=16/16).   (L) Bisulfite sequencing did not 
identify any changes in DNA methylation in any of the sixteen RNAseq-
identified target loci examined (Supplementary Table 4), including the nppa 
gene body. Bisulfite reads covering part of the first intron and second exon 
of nppa gene body are shown as black (methylated) or white 
(unmethylated).  (M) Site-specific 5hmC quantification detected a 
significant, 20-fold reduction in 5hmC levels in the nppa gene body of 
72hpf tet2-/-;tet3-/- embryonic eye tissue, when compared to phenotypically 
wild-type siblings (p = 0.0038; two-tailed, unpaired t-test).   
 
3.2.8 Overexpression of Tet resulted in retinal differentiation defect  
 
Data from tet2-/-;tet3-/- mutant analyses support a model in which site-specific Tet-
mediated 5hmC formation is required for retinal neurogenesis and to regulate gene 
expression within the developing retina. To independently test this model, we generated 
inducible transgenic Tet overexpression lines to artificially drive 5mC à 5hmC 
conversion. To achieve this, we utilized the mouse Tet2 catalytic domain, which has been 
shown to ectopically generate 5hmC in vitro, along with its catalytically inactive mutant 
counterpart (Ito et al., 2010), and modified these by adding a T2A self-cleaving peptide 
(Kim et al., 2011) and mCherry and Myc tags, and placing them downstream of a 
10xUAS promoter.  The resulting constructs were cloned into a zebrafish Tol2-compatible 
transgenic vector (Kwan et al., 2007) and multiple stable transgenic lines were created for 
each construct (10xUAS:nls-mCherry-t2a-myc-flag-Tet2WTau50; 10xUAS:nls-mCherry-t2a-
myc-flag-Tet2mutau51); only the strongest expressing lines, as evaluated by cmlc2:GFP 
reporter expression, were kept for analysis (Fig 3.14A,B).  
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To induce the transgene expression, adults carrying the Tet2 overexpression allele 
(Tet2-WT) or the catalytically inactive mutant allele (Tet2-mut) were crossed to 
hsp70l:Gal4s1005 heterozygotes (Gabher and Wittbrodt, 2004). Embryos were heat-shocked 
at 39.5°C at 18hpf for 30 minutes. We determined this timepoint based on the 
observation that the mCherry signal is first detectable ~6 hours after heatshock. 
Therefore, we timed this induction to coincide with the time at which RPCs are being 
specified and begin to differentiate (Vitorino et al., 2009). Embryos were sorted at 48-
50hpf based on the expression of cmlc2:GFP from the promoter construct, and mCherry 
expression, indicating expression of the transgene (Fig 3.14C-J).  
Heat-shocked embryos did not show any obvious morphological abnormalities 
(Fig. 3.14C-F), and they survived until at least 72hpf. To assess retinal development, 
embryos were cryosectioned and stained for the retinal cell type-specific markers. Tet2-
WT-expressing embryos possessed relatively normal retinal lamination, and the 
differentiation of early-born cell types (RGCs and ACs) was relatively normal (Fig. 
3.14E). However, most Tet2-WT embryos showed a distinct defect in the differentiation 
of later born rods and red/green cones (Fig 3.14K-R) where photoreceptors were absent 
in the retina except for small patches of cells on the ventral side (n=4/11 eyes) (Fig 
3.14K-N).  Zpr3 distribution was normal in Tet2-mut-expressing embryos (n=11/11 eyes) 
(Fig 3.14O-R). Taken together, these results indicate that, similar to loss of tet activity, 
ectopic or overactive Tet activity also disrupts the terminal differentiation of late born 






Figure 3.14: Overexpression of Tet2 disrupts retinal neuron differentiation. 
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Figure 3.14 – continued) Tol2 transgenic constructs carrying the mouse Tet2-WT 
domain (A) or a catalytically inactive Tet2-mut domain (B) were generated. 
10xUAS-drivenTet2 domains were separated by a T2A self-cleaving peptide 
and an mCherry reporter, and transgenic constructs carried a cmlc2:GFP 
reporter.  Carriers were crossed to hsp70l:Gal4 drivers and embryos were 
heat-shocked at 18hpf for 30min at 39.5°C, and sorted at 48-50hpf (C-F). 
Induced embryos show ubiquitous mCherry expression and heart-specific 
GFP (C,G), while non-induced (non-heat-shocked) carriers express no 
detectable mCherry (H,J). Tet2-WT-expressing embryos are 
microphthalmic and lack differentiated rods (zpr3; red) when compared to 
Tet2-mut-expressing embryos (Q,Y arrows). F-Actin (green) green; DNA 



















DNA hydroxymethylation and demethylation remain somewhat enigmatic 
processes in the field of epigenetics, with Tet protein function having only been identified 
recently [reviewed in (Pastor et al., 2013)]. Tet proteins are the main drivers of 5mC to 
5hmC conversion and thereby key regulators of DNA demethylation (Tahiliani et al., 
2009). However, in recent years, it has also become evident that they play roles in tissue-
specific regulation of gene expression during development (Colquitt et al., 2013; Ge et 
al., 2014; Li et al., 2015; Madzo et al., 2014; Xu et al., 2012).  Despite these studies, we 
still know little about their developmental functions, and we know virtually nothing about 
Tet function during eye development.  
Here, we demonstrate that tet2 and tet3 play a critical role during development of 
the zebrafish retina.  Our data indicate that tet2 and tet3 function redundantly in zebrafish 
to generate 5hmC, consistent with a recent report (Li et al., 2015). We demonstrate that 
tet2 and tet3 are critical regulators of retinal cell differentiation and morphogenesis, and 
that they act during early retinal development by modulating cell non-autonomous 
pathways. Loss of tet2 and tet3 function resulted in specific defects in retinogenesis, 
where the RPC population was transiently expanded.  Despite relatively normal 
specification events, retinal cells failed to differentiate and, in the case of RGCs and PRs, 
failed to undergo terminal morphogenesis.   These defects also correlated with mis-
regulated gene expression and locus-specific defects in 5hmC formation in subsets of 
retinal cells at later stages of development. Based on these results, we propose a model 
wherein Tet proteins function to regulate gene expression during the differentiation of 
retinal cell types. In the absence of tet2 and tet3 function, gene expression is misregulated 





Figure 3.15: Schematic of Tet function during zebrafish retinal development. (A) 
During normal development, Tet proteins mediate epigenetic programming 
in retinal progenitor cells (RPCs; green) as they are specified into retinal 
neurons: retinal ganglion cells (RGCs, red) and photoreceptors (PRs, blue). 
These neurons undergo terminal differentiation and morphogenesis, 
generating axons that bundle into an optic nerve (for RGCs) and outer 
segments (for PRs). (B) In tet2-/-;tet3-/- embryos, the RPC population is 
transiently expanded at early stages, but normal by 5dpf.  Retinal neurons, 
despite being properly specified, fail to undergo terminal differentiation, and 
of those RGCs and PRs that do differentiate, many fail to undergo 
morphogenesis.  These defects are likely caused by misregulation of cell-
extrinsic factors required for terminal differentiation. 
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Similar to the cellular differentiation defects identified here in tet2-/-;tet3-/- retinae, 
loss of Tet2 and/or Tet3 function results in differentiation defects in the hematopoietic 
system of zebrafish (Ge et al., 2014; Li et al., 2015) and humans (Madzo et al., 2014). 
During hematopoiesis, Tet proteins turn on genes involved in erythropoiesis by 
hydroxymethylating and/or demethylating the their promoters, thereby enabling 
expression and ultimately, triggering differentiate.  Conversely, it is well established that 
Tet1 is a critical player in stem cell maintenance where it functions to inhibit 
differentiation potential (Etchegaray et al., 2015; Neri et al., 2015), and loss of Tet1 
impairs ESC self-renewal (Ito et al., 2010).  Therefore, Tet proteins play distinct roles in 
different contexts: the stimulate differentiation in tissue specific contexts (e.g. retinal, 
blood cells), and suppress differentiation in stem cells.  
In tet2-/-;tet3-/- mutants, early-born retinal cell types, RGCs and ACs, were less 
affected than later-born ones (cones, rods and Müller glia), which were almost 
completely absent.  RGCs in tet2-/-;tet3-/- mutants were isl2b:GFP+ and expressed Zn8, a 
marker of terminal differentiation (Trevarrow and Kimmel, 1990). However, Zn8+ RGCs 
were restricted to the central retina, and in a subset of mutants, no optic nerve (ON) was 
present, while in the remainder, a severely attenuated ON formed. In these latter 
embryos, we speculate that the RGCs generating axons are most likely the ‘pioneer’ 
axons (Pittman et al., 2008) that originate from the few early-born RGCs that undergo 
terminal differentiation and morphogenesis, while the majority of RGCs fail to complete 
morphogenesis to form an axon. ACs were detected in fewer number and located in an 
even more limited zone within the central retina of tet2-/-;tet3-/- mutants, and the few 
differentiated red/green double cones, rods or Müller glia detected in tet2-/-;tet3-/- mutant 
retinae were always located in the central retina. Specification and differentiation in the 
zebrafish retina initiates in the ventronasal patch, adjacent to the optic nerve, and 
proceeds in a central to peripheral gradient (Hu and Easter, 1999). That differentiated 
cells in tet2-/-;tet3-/- mutants reside in these retinal regions strongly suggests that they 
represent the first born cells of each retinal cell type. Zebrafish embryos are also 
endowed with a maternally-derived supply of mRNA and protein (reviewed in (Langley 
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et al., 2014)).  Therefore, it is possible that the centrally located and partially 
differentiated early born cell types in tet2-/-;tet3-/- mutants reflect a “maternal rescue”, and 
that defects in later born cell types result from depletion of maternally supplied tet2 
and/or tet3.  However, tet transcripts are not maternally deposited in zebrafish (Almeida 
et al., 2012b), and our 36hpf RNA-Seq analysis from tet2-/-;tet3-/- mutants detects no 
expression of wild-type (maternally derived) tet2 or tet3 transcripts, making this scenario 
unlikely.  
Alternatively, tet activity could become progressively more important in RPCs as 
they transition from producing early born cell types to later born ones, and as the 
specified cells undergo terminal differentiation and morphogenesis.  Moreover, that the 
first born neurons of each class appeared to partially differentiate, tet2 and tet3 activity 
could become more important over time in each class of retinal neuron, where the first 
born neurons of the class develop independent of tet2 and tet3 function, while subsequent 
neurons require it. None-the-less, in this scenario, early born cells (and cell types) still 
require tet activity for terminal differentiation, because the majority of RGCs in tet2-/-;tet3-
/- mutants, though properly specified, do not form axons , and similarly in PRs, centrally-
located cells are specified (crx+) and begin to differentiate (isl2b:GFP+, zpr-1+ or zpr-3+), 
but do not complete outer segment morphogenesis.  These data suggest that while RGCs 
and early born PRs may be refractory to the absence of tet activity during the earliest 
phases of differentiation, tet activity is still required for terminal morphogenesis. Our 
speculation that epigenetic regulation plays an important role in terminal differentiation 
of retinal neurons is also supported by recent evidence in mouse where disruption of 
Dnmt1, 3a and 3b resulted in severe retinal defects in which some PRs were present, but 
they appeared disorganized and failed to form outer segments (Singh et al., 2016), defects 
reminiscent to those in tet2-/-;tet3-/- mutants.  
Mosaic analyses reveal that tet2-/-;tet3-/- retinal phenotype occurs cell non-
autonomously, and thus, that the effects of tet2 and tet3 loss of function during early 
retinal development are mediated by cell extrinsic events.  Through a combination of 
candidate gene assays, transcriptomics and pharmacological manipulations, we 
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demonstrate that elevated Notch and Wnt pathway activity is partially responsible for 
defects in retinal neurogenesis in tet2-/-;tet3-/- mutants.  However, because blocking these 
pathways only provided partial rescue of retinal defects in tet2-/-;tet3-/- mutants, other 
signaling pathways are likely to be involved and modulated by tet activity during early 
retinal development. Hedgehog-PKA, TGFb/BMP, and FGF are all cell-extrinsic 
pathways known to contribute to retinal neurogenesis, making these attractive candidates 
(Davis et al., 2000; Masai et al., 2005; Patel and McFarlane, 2000).  While surprising, 
these cell non-autonomous results are consistent with those from several other recently 
published studies on Tet function.  Indeed, Tet activity was demonstrated to modulate 
Nodal activity during mouse gastrulation by intrinsically regulating the methylation status 
and expression of the Nodal inhibitors, Lefty1 and Lefty2 (Dai et al., 2016).  Tet activity 
has also recently been shown to modulate Wnt ligands or Wnt target gene activity in 
several contexts, either directly or indirectly (Kim et al., 2016; Li et al., 2016).  Perhaps 
the most interesting of these recent studies showed that in mouse ESCs and early 
embryos, Tet activity is required to balance neuroectoderm vs. mesoderm fates and to 
inhibit Wnt signaling (Li et al., 2016).  In Tet1/2/3 deficient ES cells and embryos, neural 
cell fates were lost and instead, mesodermal fates like cardiac muscle were detected.  
These fate changes correlated with increased promoter methylation and decreased 
expression of the Wnt inhibitor, Sfrp4 and hyperactive Wnt pathway activity. This 
parallels what we observe in the tet2-/-;tet3-/- mutant zebrafish retina, and is exciting, 
because it suggests that Tet-mediated modulation of the Wnt pathway, and possibly other 
cell-extrinsic signaling pathways, may be a conserved function for Tets during embryonic 
development and organogenesis. Finally, Tet function may also influence chromatin 
accessibility at the genomic regions surrounding Notch and Wnt genes, enabling other 
transcriptional regulators to access these loci. Tets have been shown to function in 
regulating local chromatin environments (Hahn et al., 2013; Lio et al., 2016; Shen et al., 
2013; Xu et al., 2011).  
From RNA-seq analysis, we detected a suite of cardiac and muscle genes 
ectopically expressed in the retinae of 72hpf tet2-/-;tet3-/- mutants.  Further analysis of one 
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of these, nppa, revealed ectopic expression in the brain and eyes of tet2-/-;tet3-/- mutants. 
This expression change correlated with an almost complete loss of gene body 5hmC 
deposition at the nppa locus.  Locus-specific effects like this indicate that tet2 and tet3 
may also function intrinsically during retinal development, in addition to modulating cell 
extrinsic pathways. Tet-mediated formation of 5hmC serves as a precursor to 
demethylation, or as an activating mark in its own right (Hahn et al., 2013). Tet-mediated 
5hmC formation could play a direct role in silencing ectopic gene expression for genes 
like nppa during retinal development.  Gene body 5mC methylation positively correlates 
with expression (Jin et al., 2012); therefore, in this scenario, Tet-mediated conversion to 
5hmC likely serves as a precursor for subsequent demethylation and silencing.  In tet2-/-
;tet3-/- mutants, 5mC is not converted to 5hmC, and the target locus (nppa) is ectopically 
expressed by retinal and brain cells. However, Tet-activity is also required for gene body 
5hmC formation that is thought to serve as an active mark (Hahn et al., 2013). Thus, an 
alternative model can be envisioned wherein ectopic nppa expression also reflects 
indirect consequences of loss of tet2 and tet3 activity.  In this model, an intermediate 
silencer/repressor gene is not properly expressed by tet2-/-;tet3-/- mutant retinal cells due to 
the absence of activating 5hmC marks.  This scenario is not unprecedented; Li et al 
recently demonstrated that tet2-/-;tet3-/- mutants possess defects in hematopoiesis, but the 
mutants showed no changes in methylation or hydroxymethylation at key genes in the 
hematopoietic network; instead, in this context, Tet-mediated effects are likely the result 
of mis-regulation of the Notch pathway (Li et al., 2015). Similarly, mutation of the de 
novo DNA methyltransferase dnmt3bb1 results in significantly altered expression of 
many hematopoietic and endothelial genes, although very few of these showed any 
changes in DNA methylation (Gore et al., 2016). Therefore, genes identified as 
differentially expressed in tet2-/-;tet3-/- mutants that displayed no changes in 5mC or 5hmC 
may not be direct targets of tet2 and tet3, but rather, reflect complex intrinsic or extrinsic 
regulatory pathways modulated by tet2 and tet3 activity.  Testing this prediction will 
require genome-wide profiling of 5mC and 5hmC in the eye over multiple developmental 
time points and correlating these data with gene expression in a gene-by-gene fashion, as 
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well as generating conditional loss of function tet2 and tet3 alleles such that their 
functions during later retinal development can be elucidated.  CRISPR/Cas9 technology 
now makes this possible in zebrafish (Albadri et al., 2017).   
It is known that CXXC4/IDAX, a protein with homology to the tet3 N-terminal 
domain, functions as a direct inhibitor of Wnt signaling by competitively binding with 
Axin to Dvl (Hino et al., 2001).  In tet2-/-;tet3-/- mutants, we detected no tet3 protein and 
5hmC was almost completely absent from the genome, supporting a catalytic role for tet2 
and tet3 during development. Significant changes in the expression of several Wnt 
ligands was detected in tet2-/-;tet3-/- mutants, and these changes could result from this lack 
of catalytic activity (i.e. directly, from the lack of 5hmC formation at the loci, or 
indirectly, from the lack of 5hmC at loci encoding modulators of expression the Wnt 
ligands). However, alternatively, changes in Wnt ligand expression could also result from 
loss of the tet3 N-terminal CXXC domain, which functions independently of tet3 
catalytic activity.  Our data cannot yet differentiate between these possibilities.  
Importantly, this highlights the need to better understand the catalytic vs non-catalytic 
functions of tet proteins in specific tissues and organs, where tet proteins could regulate 
gene expression in several different ways. 
Finally, in addition to DNA modifying enzymes like the Tets, chromatin 
regulators such as histone deacetylases and histone demethylases have also been shown 
to modulate cell extrinsic pathways during early retinal development (Lussi et al., 2016; 
Yamaguchi et al., 2005).  When combined with our work, these studies highlight that the 
epigenetic regulation of signaling events during development is likely to be a more 
significant and complex layer of regulation than previously realized.  Deciphering this 
complex epigenetic regulation will require a comprehensive, genome-wide approach 
encompassing multiple profiling strategies (e.g. bisulfite sequencing, oxidative bisulfite 
sequencing, RNA-seq, ChIP-seq, and ATAC-Seq) in pure, isolated RPCs and 
differentiated retinal cell types from both wild-type embryos, as well as embryos 
deficient in key enzymes operating in these epigenetic pathways, like tet2 and tet3.   
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Chapter 4:  Methylome and Hydroxymethylome Analysis of Retinal 
Progenitor Cells (RPCs)  
4.1 INTRODUCTION  
Genome-wide epigenetic profiling of combined DNA methylation and 
hydroxymethylation in various cell types has been a challenging goal since the discovery 
less than a decade ago of the conversion of 5mC to 5hmC and Tet protein function 
(Tahiliani et al., 2009).  The majority of earlier efforts in epigenomic profiling have been 
aimed at quantifying a combined (5mC+5hmC) mark using bisulfite conversion followed 
by sequencing (BS-seq) (Clark et al., 1994). These include approaches such as whole-
genome shotgun bisulfite (WGBS) and reduced representation bisulfite (RRBS) 
approaches (Meissner et al., 2005), which are typically done in conjunction with other 
relevant chromatin modification and transcriptome profiling to obtain a comprehensive 
view of the genomic distribution of epigenetic marks and gene expression.  For example, 
in human embryonic stem (ES) cells, a large scale profiling was done using WGBS, 
histone methylation ChIP-seq, and RNAseq (Gifford et al., 2013). This study identified 
epigenetic and gene expression changes in both pluripotent and developmental genes 
when human ES cells undergo lineage specification into germ layers. However, this was 
done using an in vitro directed differentiation paradigm and may not necessarily 
recapitulate the process in vivo.   
WGBS has been utilized in multiple in vivo models and a common theme emerges 
across studies where DNA methylation patterns often inversely correlate with gene 
expression, and each cell population exhibits a distinct methylation pattern and gene 
expression profile. For example, WGBS revealed unique DNA methylation profiles of 
human cells and tissues such as sperm, oocyte, blastocyst, ES cells and blood (Okae et 
al., 2014).  Additionally, subpopulations of cell types within the same tissue may also 
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exhibit distinct methylation patterns, which has been shown both in mammalian brain 
neuronal subtypes (Mo et al., 2015) and among rods and cone photoreceptor cells within 
the retina (Mo et al., 2016). Within the eye, genome-wide DNA methylation patterns 
have been profiled using WGBS from multiple time points during chicken retinal and 
corneal tissue development (Lee et al., 2017).  Furthermore, a recent study revealed 
distinct chromatin states during development of both mouse and human retina using 
comprehensive profiling of DNA methylation and numerous chromatin markers (Aldiri et 
al., 2017). It is important to note that these methylation profiling strategies relied on 
WGBS and RRBS, both of which do not distinguish between 5mC and 5hmC, instead, 
both marks are read as “methylated” during bisulfite sequencing (Huang et al., 2010). 
Given the antagonistic nature of these two opposing epigenetic marks, it is necessary to 
generate separate genome-wide profiles where each mark is quantified independently. 
Distinguishing 5mC from 5hmC during profiling is inherently challenging due to the fact 
that both marks are chemically nearly identical except for a single hydroxyl group.  
Several methods have been developed over the past decade that enable simultaneous 
profiling of 5mC and 5hmC at the genome-wide level. These methods can be categorized 
into two major approaches: (1) affinity-enrichment profiling and (2) bisulfite-based 
profiling.  
Affinity enrichment strategies rely on the ability of antibodies to bind uniquely to 
5mC and 5hmC. Then, they are pulled down with the fragmented DNA to be sequenced 
(MeDIP-seq and hMeDIP-seq). A weakness to this approach is the potential for antibody 
affinity bias towards certain repeat-rich regions of the genome (Wu and Zhang, 2011). 
Alternatively, 5hmC can be converted into a glycosylated form (g5hmC) using beta-
glucosyltransferase (bGT), which can be pulled down using a g5hmC-binding protein, 
JBP1, and sequenced (JBP1-seq).  However, the affinity of JBP1 for its target has been 
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shown to be inferior to that of a 5hmC-specific antibody (Robertson et al., 2011). 
Additionally, a major limitation of affinity-based profiling strategies is their resolution; 
the output reads only reveal 5mC/5hmC within ‘windows’ throughout the genome and 
the finest resolution of these windows is limited by the size of the DNA fragments after 
shearing and not at single-nucleotide level.   
 Bisulfite-based 5hmC profiling methods have built upon the original bisulfite 
sequencing strategy (Clark et al., 1994), and include a modification step prior to sodium 
bisulfite treatment. Tet-assisted bisulfite sequencing (TAB-seq) utilizes bGT to convert 
5hmC to g5hmC, which becomes “protected” and remains unconverted during bisulfite 
treatment, while 5mC is globally demethylated using a recombinant Tet1 enzyme and is 
fully converted to thymine (T) (Yu et al., 2012). This is often referred to as a direct 
profiling, because it reveals 5hmC levels directly. However, this strategy still relies on 
the enzymatic activity and accessibility of Tet1 to all 5mC marks throughout the entire 
genome. Alternatively, 5hmC can be indirectly identified using an oxidative bisulfite 
sequencing (OXBS-seq) approach where 5hmC is oxidized into 5-formyl-cytosine (5fC), 
which is then converted into T during bisulfite treatment (Booth et al., 2012). In other 
words, only 5mC remains unconverted (C), while 5hmC and C become converted into T 
(Fig 4.1). This is referred to as an indirect profiling of 5hmC, because it relies on a 
comparison with a parallel BS-seq where both 5mC and 5hmC are unconverted in order 
to accurately quantify 5hmC levels at single nucleotide resolution. By subtracting 
methylation levels of OXBS-seq from BS-seq, one can infer the starting level of 5hmC 
within the sample. Despite drawbacks, including the requirement of parallel and costly 
sequencing, OXBS is still the only available method that offers genome-wide, 
simultaneous profiling of both C, 5mC and 5hmC without relying on enzymatic activity 
or affinity of any recombinant proteins.  
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Since the recent invention of OXBS, the technology has been utilized in various 
mammalian contexts. In humans, during monocyte to macrophage differentiation, OXBS 
detected transient 5hmC levels during 5mC demethylation at loci specifically associated 
with genes unique to macrophages. These regions later become nucleosome-free and 
actively transcribed in macrophages (Wallner et al., 2016). Similarly, during 
spermatogonia stem cell differentiation, OXBS revealed partially and differentially 
methylated domains associated with spermatogenesis (Kubo et al., 2015). In a mouse 
model for aging, OXBS enabled the detection of small but significant differences in 
5hmC levels in age-related genes on the X-chromosome of young and old hippocampi 
(Hadad et al., 2016).  In cancer models, genome-wide BS/OXBS profiling revealed 
global hypermethylation and decreased 5hmC levels in human glioblastoma when 
compared to normal tissue (Raiber et al., 2017).   
While OXBS technology has been applied to 5hmC detection in several vertebrate 
systems, combined methylome and hydroxymethylome profiling in the retina has not 
been performed in any model organism. This is important because genes involved in 
retinal development such as specification TFs and genes encoding cell intrinsic and 
extrinsic signaling molecules are likely epigenetically regulated at the level of DNA 
methylation and hydroxymethylation. Changes in 5mC and/or 5hmC levels at or near 
these genes may correlate with changes in gene expression, and as shown in Chapter 3, 
misregulation of hydroxymethylation can lead to misexpression of critical genes, 
resulting in failure of cellular differentiation.  
To fully understand the role DNA hydroxymethylation plays a role in the 
epigenetic control of retinal development, it is necessary to generate comprehensive 
5mC/5hmC profiles of individual retinal cell types at relevant stages during retinogenesis. 
Here we present the first genome-wide map of DNA methylation (methylome) and 
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hydroxymethylation (hydroxymethylome) at single nucleotide resolution in the 
developing embryonic retina. Using zebrafish as a model, we isolated a pure population 
of retinal progenitors (RPCs) at specific time points before and during differentiation. 
Our analysis identifies numerous regions that display differential methylation and 
hydroxymethylation levels, many of which are overlapping. Some of these are associated 
with known eye genes while others are associated with potentially novel genes involved 
in retinal development.  
 
4.2 RESULTS  
4.2.1 Isolation of genomic DNA from a pure RPC population   
To obtain a pure population of RPCs, we utilized a transgenic reporter zebrafish 
carrying vsx2:GFP, which expresses a strong GFP signal starting at 20hpf in RPCs 
(Vitorino et al., 2009).  RPCs were collected via FACS from eyes dissected at two time 
points: early (22hpf), when most of the retina is composed of actively proliferating and 
undifferentiated RPCs; and late (27hpf), immediately before the onset of the first 
differentiation event, when RPCs exit the cell cycle and become RGCs (Hu and Easter, 
1999; Schmitt and Dowling, 1996). To ensure a viable and correctly identified 
population, cells were sorted based on size, GFP+ signal, and the absence of cell death 
signal (Live/Dead staining) (Fig 4.1A). To independently verify the collection of the 
appropriate cell population, sorted cells were visually inspected under a fluorescent 
microscope and a fraction of the cells were processed for semi-quantitative RT-PCR. 
RPC populations were found to retain expression of GFP and vsx2 for at least 2 hours 
post-sorting, while GFP- non-RPC populations, likely extra-ocular tissue, did not possess 
GFP or vsx2 transcripts at a detectable level (data not shown).  In this pilot study, we also 
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collected cells from whole embryos as a reference sample. Altogether, two comparisons 
were done: 22hpf RPC vs whole embryo, and 22hpf RPC vs 27hpf RPC.  
Genomic DNA was extracted, quantified, and processed through OXBS and BS 
reactions in parallel (Fig 4.1B and Appendix A). Before processing, genomic DNA was 
spiked with two sets of quality control spike-in DNA duplexes containing 5mC and 
5hmC at known locations: digestion control (DC) for interrogation of the OXBS reaction 
before sequencing, and sequencing control (SQ) for post-sequencing assessment of 
conversion levels. For the OXBS reaction, DNA was treated with an oxidizing agent 
followed by a bisulfite conversion treatment. For the BS reaction, DNA was mock-treated 
with water then bisulfite converted. Treated DNA was sub-sampled to assess the 
completion of the OXBS reaction by amplification of the DC spike-in followed by 
digestion with the restriction enzyme TaqaI, which cuts at the TCGA sequence (also 
present in the cutting control: CC). The DC duplex contains T5hmCGA which is fully 
converted into TTGA (non-digestible) after OXBS treatment, while in BS treatment it 
remains as TCGA and will thus be fully digested (Fig 4.2A). This amplification-digestion 
assay provided a semi-quantitative assessment of the BS/OXBS reaction efficiency pre-
sequencing and allowed us to decide whether to proceed with next-generation sequencing 
based on conversion efficiency.  Because we observed a distinct size difference between 
fully digested and undigested fragments post-treatment (Fig 4.2A, arrows), the libraries 




4.2.2 Methylome and Hydroxymethylome profiling approach  
Once the samples passed the DC amplification-digestion checkpoint, genomic 
DNA samples post-BS and post-OXBS treatment were processed through adapter ligation 
and indexing, then sequenced on an Illumina NextSeq using paired-end 150 cycles.  
Using FastQC for an initial quality check, we observed a good sequence quality 
throughout the entire length of the reads. In addition, overall sequences exhibited a low 
level (<2%) of C/G nucleotides and a high level of A/T nucleotides, typical of a bisulfite 
converted libraries (Fig 4.2B-C).   
 
To quantitatively determine the level of base conversion after BS and OXBS 
treatment, sequences were aligned to the SQ spike-in control duplexes and the levels of 
C, 5mC, and 5hmC were quantified. Overall, we observed a complete conversion ratio, 
where all unmethylated Cs were converted to Ts, and 5mCs + 5hmCs remained 
unconverted after BS treatment. In contrast, after OXBS treatment, only 5mCs remained 
unconverted, and all Cs+5hmCs were all converted to Ts (Fig 4.2D-E).  
 
Raw sequences (fastq.gz), excluding the spike-in sequences, were aligned to the 
fully converted and indexed zebrafish genome (GRCz10) using a bisulfite compatible 
aligner (Pedersen et al., 2014). After alignment, the individual methylation score at each 
cytosine base was extracted using Bismark Methylation Extractor (Krueger and Andrews, 
2011) at a mean depth of 1.9 fold coverage per cytosine. It is important to note that the 
methylation call files generated here contain combined 5mC+5hmC scores for BS-seq 
and only 5mC scores for OXBS-seq. To generate an estimated level of individual C, 
5mC, and 5hmC at every nucleotide position, we relied on a maximum likelihood 
estimation approach (Qu et al., 2013), utilizing MLML (Maximum-Likelihood 
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Methylation Level) software, which takes into account methylation counts from both 
BS/OXBS and the depth of read coverage; MLML-based estimation improves in 
accuracy as the read coverage increases. Once the estimation was performed for each 
sample, three methylation call files were generated. Each C was assigned a percentage (0-
100%) for each possible modification: 5mC, 5hmC, and unmethylated C.  Overall, we 
observed an average of 82.79% combined methylation level across all CpGs in the 
genome. Of these, 74.98% are 5mC and 7.81% are 5hmC.  
 
 From this step forward, the individual 5mC/5hmC percentage files can be treated 
as a regular methylation score file and are thus compatible with a wide range of 
downstream methylation analysis pipelines. Here we use the MethPipe software suite 
(Song et al., 2014) to identify regions of hypo-methylation and hyper-methylation 
(HMRs), differentially methylated regions (DMRs), and differentially hydroxymethylated 
regions (DhMRs).  Identified regions were exported as scored genomic coordinates (.bed 
files) similar to an output from a ChIP-seq experiment, then annotated and motif analyzed 




Figure 4.1: Workflow of methylome and hydroxymethylome profiling in the retina. 
Zebrafish vsx2:GFP embryos at 22hpf were dissected to obtain a minimum 
of 200 eyes, which were dissociated and cell sorted for GFP+ RPC 
population (A). Genomic DNA was extracted, divided in half, and processed 
through a parallel BS/OXBS library preparation protocol, where 5hmC is 
either remaining as C in the BS half or converted to 5fC and then T in the 
OXBS half. All reads were mapped, 5mC/5hmC levels calculated, and 
genome-wide maps generated (B).    
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Figure 4.2: Digestion control (DC) and sequencing control (SQ) interrogation show 
complete C and 5hmC conversion after OXBS treatment.  
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 (Figure 4.2 – continued). Genomic DNA samples were spiked with DC and 
SQ duplexes before BS/OXBS parallel reactions and library preparation. 
Amplification-digestion followed by gel electrophoresis semi-quantitatively 
show complete digestion by TaqaI after OXBS treatment, indicating that 
5hmC is fully converted to T (A). CC: cutting control. SQ6hmC: sequencing 
control containing six 5hmC nucleotides. Sequences generated by Illumina 
NextSeq revealed high quality reads (B) and low GC content (C). Post-
sequencing alignment quantitatively showed a complete C and 5hmC 
conversion after OXBS and only CàT conversion after BS reaction. (D) 
Sequencing control SQ6hmC spike-in duplex. (E) Quantitative measurement 
of 5mC/5hmC levels on SQ6hmC post-sequencing. Red bars: 5hmC; Green 
bar: 5hmC. 
4.2.3 Early RPCs (22hpf) to whole embryo comparison  
We sought to perform the first methylome and hydroxymethylome comparison 
between 22hpf RPCs and whole embryos 1) because these cell/tissue types are among the 
most abundant and 2) to test whether we can detect changes in 5mC and 5hmC between 
groups of cells that are biologically vastly different.  Using the extracted methylation 
scores, we observed a high average genome-wide methylation level of 82% 
(5mC+5hmC) which is consistent with studies using other vertebrate model systems (e.g. 
(Mo et al., 2016; Okae et al., 2014; Ziller et al., 2013)).   
To spot-check the data, individual 5mC, 5hmC, and unmethylated C tracks were 
visualized at candidate loci where methylation statuses are already known using 
Integrative Genome Viewer (IGV, Broad Institute). These tracks were then compared to 
published WGBS data (which does not distinguish between 5mC and 5hmC) from 
embryonic mouse and human whole retinal tissues (Pecan database (Aldiri et al., 2017), 
https://pecan.stjude.cloud/proteinpaint/study/retina2017). We observed a large (80kb) 
domain covering nine hox genes where 5mC and 5hmC are nearly absent in both 22hpf 
RPCs and whole embryos (Fig 4.3A). Notably, the hox gene cluster also possesses a 
similarly large and hypomethylated domain in both mouse and human embryonic retinae.  
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Figure 4.3: Methylome and hydroxymethylome profiles show expected 5mC and 5hmC 
distribution patterns at known genomic regions. Windows encompassing 
vsx2, atoh7, and hox cluster were captured using IGV. Methylation scores 
are displayed as a percentage (0-100%) for each cytosine modification 
(5mC, 5hmC, unmethylated C) in each track. Green: 22hpf RPC; Blue: 




To locate regions where 5mC and 5hmC levels significantly vary between 22hpf 
RPCs and whole embryos, 56,524 DMRs and 4,958 DhMRs were identified using 
MethDiff (Song et al., 2014). Of these, 4,285 DMRs and 724 DhMRs possess at least 5 
CpGs and 3 significantly differentially methylated CpGs (p<0.05).  To test the biological 
relevance of these regions, we spot-checked these data using loci at/near retinal 
developmental genes. First we analyzed vsx2, a gene highly expressed in RPCs, and 
found a 5mC methylation valley approximately 10kb upstream and downstream of the 
transcription start site (TSS), a feature commonly observed in actively transcribed genes 
in human and mouse (Aldiri et al., 2017). This hypomethylated vsx2 region is present in 
both 22hpf RPCs and whole embryos, likely because vsx2 is also expressed at a lower 
level in the brain and spinal cord, in addition to the strong expression in RPCs (Vitorino 
et al., 2009). Interestingly, there are four DMRs surrounding the vsx2 TSS where 5mC 
levels are lower in 22hpf RPCs than whole embryos, correlating with higher vsx2 
expression in RPCs (Fig 4.3B).  Second, atoh7, a specification factor for RGCs, the 
earliest-born retinal cell type, shows 1) a significant DMR within 5kb of the gene where 
5mC levels are lower in 22hpf RPCs than in whole embryos, and 2) a few sparse 
positions where 5hmC levels are higher in 22hpf RPCs than in the whole embryos (Fig 
4.3C). Collectively, these positions of lower 5mC and higher 5hmC may indicate pre-
activation of atoh7 prior to active transcription later in development when RPCs begin to 
differentiate into RGCs starting at 28hpf (Hu and Easter, 1999).  
Next, to take an unbiased approach and identify novel genes that may be involved 
in retinal development, 204 DMR/DhMR overlapping regions were identified where 5mC 
is lower and 5hmC is higher in RPCs than in the whole embryos (Fig 4.4A and Table 
4.1).  We reasoned that regions where 5mC is lower and 5hmC is higher in RPCs than in 
whole embryos are likely located near genes that are or about to be more actively 
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transcribed in RPCs than in the embryo as a whole.  Interestingly, many of these 
DMR/DhMR intersecting regions (“peaks”) are located within transposable elements 
(TE) and long terminal repeat (LTR) regions. To specifically test whether these peaks are 
indeed enriched for TE and LTR, we ‘shuffled’ the genomic coordinates of the peaks so 
that they are randomly distributed throughout the genome and compared their enrichment 
on known genomic features.  Indeed, DMR/DhMR intersecting peaks show higher 
enrichment with LTR and TE than the shuffled regions (Fig 4.4B-C), indicating that these 
elements may be epigenetically regulated, a known phenomenon that has been 
extensively described in the context of DNA methylation in other model organisms 
(Daron and Slotkin, 2017; Slotkin and Martienssen, 2007).     
Many of these 204 DMR/DhMR intersecting regions are located near known eye 
genes while some are near unknown or uncharacterized genes (Table 4.1). For example, 
the top candidate is located upstream of microRNA-181a (Fig 4.4D), which is one of the 
most biologically interesting candidates because mir181a is not expressed in RPCs at 
22hpf as shown by our RNA-seq data (Table 4.1); however, it is highly and specifically 
expressed later at 4dpf in zebrafish RGCs (Wienholds, 2005) (Fig 4.4E).  In mouse, 
miR181a has been shown to promote de-differentiation of fibroblast to pluripotent stem 
cell,  in conjunction with other pluripotency factors (Judson et al., 2013). This suggests 
that miR181a may play a role in cellular differentiation during development, but its role 
has not yet been functionally tested in the retina.  Similar to miR181a, other genes near 
DMR/DhMR intersecting regions are also expressed at low levels (Table 4.1), indicating 
that they may be undergoing pre-activation, although expression profiling at a later time 
point and in differentiated cells is  necessary to support this hypothesis.    
To identify potential roles of the 204 DMR/DhMR intersecting regions, we 
performed motif analysis using Homer and gene ontology analysis using DAVID, which 
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revealed that genes located near DMR/DhMR peaks are likely transcription factors (TFs), 
with potential roles in development and cell differentiation. Additionally, the top 
candidate motifs correspond to binding sites for TFs with well-established roles in eye 
development, such as Pou4f3 and Six6 (Fig 4.4F-G).  
It is important to note that these analyses were generated from one BS/OXBS 
sequencing run, and additional replicates are required in order for these results to be more 
reliable and conclusive.  Additional rounds of sequencing at higher depth, although costly 
to run, will allow statistical analyses such as false discovery rate (FDR) that cannot be 





Figure 4.4: DMR/DhMR intersecting regions are overlapping transposons and located 
near novel retinal genes. DMR/DhMR intersecting regions (peaks) were 
located and nearest genes identified (A). Intersecting peaks show higher 
enrichment score for LTR and transposons, compared to randomly 
distributed peaks (B-C). The top candidate peak is located upstream of 
miR181a, which is expressed specifically in RGCs (D-E). GO and Motif 
analyses show that intersecting peaks are enriched for transcription factors 













mir181a-1 microRNA 181a-1 0.50 eye, GC, BP 0.00 
fars2 phenylalanyl-tRNA synthetase 2, mitochondrial 0.38 RPE 4.37 
zgc:174354 zgc:174354 0.32 no data  - 
si:rp71-1h3.1 si:rp71-1h3.1 0.29 no data  - 
znf1070 zinc finger protein 1070 0.28 no data  3.67 
nppa natriuretic peptide A 0.25 heart 0.32 
cryba1l1 crystallin, beta A1, like 1 0.23 lens 8.70 
p2ry10 purinergic receptor P2Y, G-protein coupled, 10 0.22 no data  0.00 
zgc:172282 zgc:172282 0.21 no data  0.00 
cfap58 cilia and flagella associated protein 58 0.20 no data  0.54 
tbxa2r thromboxane A2 receptor 0.19 eye, brain  0.00 
igfbp2b insulin-like growth factor binding protein 2b 0.19 eye 2.42 
si:dkey-27n6.1 si:dkey-27n6.1 0.19 no data  0.32 
fgfrl1b fibroblast growth factor receptor-like 1b 0.18 eye, lens 2.88 
prkag3b 
protein kinase, AMP-activated, gamma 3b non-
catalytic subunit 0.18 no data  0.38 
otx1b orthodenticle homeobox 1b 0.17 retina       6.19 
sgut1 
SGT1 homolog, MIS12 kinetochore complex 
assembly cochaperone 0.17 eye, brain  14.89 
xylb xylulokinase homolog (H. influenzae) 0.17 liver 7.59 
cnot6b CCR4-NOT transcription complex, subunit 6b 0.17 no data  5.26 
Table 4.1: List of the top 20 genes containing nearby differentially methylated regions 
(DMRs) overlapping with differentially hydroxymethylated regions 
(DhMRs) between 22hpf RPCs and whole embryos, ranked by normalized 
score (number of significantly differentially methylated CpGs divided by the 
region size). Expression domains are summarized from the Zebrafish 
Information Network (zfin.org) either from direct submissions or curated 
publications. Gene expression levels were calculated from 22hpf RPC RNA-
seq and reported in transcripts per kilobase million (TPM).   
 100 
4.2.4 Comparison between early RPCs (22hpf) and late RPCs (27hpf) 
To further investigate methylome and hydroxymethylome dynamics at a pivotal 
time window of retinal development, we performed BS/OXBS-seq in early RPCs (22hpf) 
and compared 5mC/5hmC levels to late RPCs (27hpf), immediately before the onset of 
neurogenesis events when the first RGCs exit the cell cycle and begin to differentiate (Hu 
and Easter, 1999). Genomic DNA from FAC-sorted cells were BS/OXBS-treated, 
libraries generated and sequenced at an average coverage depth of 2.12 fold.   Initial 
analysis based on gene-by-gene observation of 5mC/5hmC profiles at known retinal 
genes and hox clusters showed no noticeable differences between the profiles at any of 
the candidate regions. Entire hox clusters were found to be largely hypomethylated in 
both 22hpf and 27hpf RPCs (Fig 4.5A).  Similarly, 5mC/5hmC profiles appear identical 
at candidate retinal neurogenesis genes in both 22hpf and 27hpf RPCs: vsx2 and ptf1a 
both show hypomethylated 5mC regions throughout the entire gene body, while crx is 
hypomethylated at the TSS, and atoh7 remains methylated (Fig 4.5B). Importantly, no 
significant DMRs or DhMRs were present in or near these five genomic windows, 
indicating that the methylome and hydroxymethylome profiles of these regions are 
virtually identical.   
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Figure 4.5: Methylome profiles appear similar between hox cluster and candidate retinal 
neurogenesis genes of 22hpf and 27hpf RPC. Methylation scores are 
displayed in percentage (0-100%) for each cytosine modification (5mC, 







Despite having overall similar epigenomic profiles at candidate retinal genes, 
differential methylation analysis identified 3,836 DhMRs and 53,938 DMRs between 
22hpf and 27hpf RPC populations throughout the genome. Of these, 868 DhMRs and 
1,521 DMRs possess at least 5 CpGs and 3 significantly differentially methylated CpGs 
(p<0.05). These regions are categorized, based on the changes in 5mC and 5hmC levels 
between 22hpf and 27hpf, into four categories: 5mC-losing (n=1,100), 5mC-gaining 
(n=421), 5hmC-gaining (n=449), and 5hmC-losing (n=419).  To determine the biological 
relevance of these regions, we performed annotation based on the location of closest 
genes and performed motif and GO analyses (Fig 4.6A-C).   
 
We first investigated genes located near 5hmC-gaining regions because these are 
likely to become actively transcribed at or soon after 27hpf (Table 4.2). Genes in this 
group are composed of developmental transcription factors and signaling molecules with 
known roles in development (e.g. pou3f1, rbp2a, crabp2a, smad7).  Closer inspection of 
the methylation score tracks showed that these regions indeed gained 5hmC levels in 
RPCs over time from 22hpf to 27hpf (Fig 4.6A).  Interestingly, based on the publicly 
available expression data (zfin.org), five of the top 20 genes are expressed within the eye 
between 32-42hpf, and one, rbp2a, is expressed specifically within differentiated 
neurons, presumably early-born photoreceptor cells in the ventral retina later in 
development (Fig 4.7A).  
 
To identify genes undergoing activation and becoming transcribed, which often 
contain regions of low 5mC and elevated 5hmC as shown in the case of miR181 above, 
we intersected the 5mC-losing regions with 5hmC-gaining regions, and again performed 
annotation, motif analysis, and GO analysis (Fig 4.6D-F).  While there are overlapping 
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genes between this list and the 5hmC-gaining list (e.g. smad7, crabp1a, pth1b), many of 
the identified genes possess unique characteristics (Table 4.3). First, their closest 
DMR/DhMR peaks are enriched for vsx2 binding motifs, suggesting that they may be 
regulated by vsx2 (Fig 4.6E). Second, GO analysis showed enrichment for eye, retina, 
and optic nerve developmental terms, which implies that genes containing these peaks 
may be involved in RGC differentiation (Fig 4.6F). Third, in situ expression of at least 3 
of the top 20 genes (slc17a6b, glra4b, pcbp4) is detected in the eye, with slc17a6b being 
expressed specifically in RGCs (Fig 4.7B).  
 
Next, we hypothesized that genes that are no longer required once RPCs 
differentiate into neurons would undergo inactivation and begin to gain 5mC over the 
course of 22-27hpf. These genes may be expressed in non-RPC cells/tissues later in 
development, but their expression should be absent in RPC-derived retinal cells. To 
identify these genes, we annotated and performed GO and motif analyses for DMRs 
where 5mC levels are higher in 27hpf than 22hpf RPC (5mC-gaining) (Fig 4.6G-I). 
Indeed, several genes in this category are expressed in non-ocular tissues, such as head 
mesoderm, somites, cranial muscle, cartilage, and olfactory receptors at post-27hpf time 
points (Table 4.4).  Interestingly, GO terms for genes in this group contain a diverse mix 
of biological processes such as homophilic cell adhesion, chromatin modification, and 
epithelial cell apical/basal polarity, which may coincide with the loss of RPC identity as a 
pseudostratified epithelium to become differentiated neurons after 27hpf.   
 
It is important to note that because the expression data of the remaining genes on 
these lists are not yet available on the public database or are available at 
resolutions/regions that are uninformative, we cannot conclude that they are not 
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expressed in the cells/tissues of interest. Additional factors should be taken into 
consideration when interpreting this dataset: 1) these results are still preliminary and 
additional sequencing at higher depth in biological replicates should improve the data 
quality 2) DMRs and DhMRs will be intersected with lists of differentially expressed 
genes in 27hpf RPCs from RNAseq, which will be performed in the near future 3) 
candidate DMRs and DhMRs can be independently validated by traditional gene-by-gene 
bisulfite sequencing for combined 5mC+5hmC and glucosylation-digestion (Quest assay 






Figure 4.6: Regions of differential methylation and hydroxymethylation are located near 
genes with known and unknown roles during retinal development and are 
potential binding sites for retinal developmental transcription factors. 
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Gene Name Gene Description Normalized score Expression  
rbp2a retinol binding protein 2a, cellular 0.44 PR, ventral patch  
hdac3 histone deacetylase 3 0.43 head, ubiquitous 
sdc4 syndecan 4 0.38 NCC, melanocyte 
htra3a HtrA serine peptidase 3a 0.36 head, ubiquitous 
nanos3 nanos homolog 3 0.31 PGCs 
pth1b parathyroid hormone 1b 0.31 eye, forebrain, heart  
znf236 zinc finger protein 236 0.30 ubiquitous 
crabp1a cellular retinoic acid binding protein 1a 0.30 GC, PR 
scn12aa sodium channel, voltage gated, type XII, alpha a 0.30 eye, brain spinal cord 
txnl1 thioredoxin-like 1 0.29 ubiquitous 
smad7 SMAD family member 7 0.29 eye, RPC 
pou3f1 POU class 3 homeobox 1 0.29 eye, brain  
plcxd3 
phosphatidylinositol-specific phospholipase C, X domain 
containing 3 0.28 brain, branchial arch 
park2 parkin RBR E3 ubiquitin protein ligase 0.25 ubiquitous 
otud6b OTU domain containing 6B 0.25 ubiquitous 
si:ch211-262n1.4 si:ch211-262n1.4 0.25 no data 
grm1b glutamate receptor, metabotropic 1b 0.24 RGC, optic tectum 
zgc:103482 zgc:103482 0.23 no data 
zgc:174710 zgc:174710 0.23 no data 
adck1 aarF domain containing kinase 1 0.22 no data 
Table 4.2: List of the top 20 genes containing a nearby regions where 5hmC levels are 
significantly higher in 27hpf than 22hpf RPCs (5hmC-gaining) ranked by 
normalized score (number of significantly differentially hydroxymethylated 
CpGs divided by the region size). Expression domains are summarized from 
the Zebrafish Information Network (zfin.org) either from direct submissions 




Gene Name Gene Description Normalized score Expression 
crabp1a cellular retinoic acid binding protein 1a 0.45 eye, optic tectum 
sdc4 syndecan 4 0.38 crest, melanocyte 
pth1b parathyroid hormone 1b 0.31 eye, forebrain 
nol4lb nucleolar protein 4-like b 0.26 ubiquitous 
slc17a6b 
solute carrier family 17 (vesicular glutamate transporter), 
member 6b 0.25 RGC, brain 
smad7 SMAD family member 7 0.25 eye (RPC?), brain 
egln3 egl-9 family hypoxia-inducible factor 3 0.24 ubiquitous 
zgc:174710 zgc:174710 0.23 no data 
eif3ja eukaryotic translation initiation factor 3, subunit Ja 0.21 eye and tectum 
chchd6a coiled-coil-helix-coiled-coil-helix domain containing 6a 0.19 eye and brain 
tubb2 tubulin, beta 2A class IIa 0.19 eye, CMZ, brain 
si:ch211-262n1.4 si:ch211-262n1.4 0.19 no data 
gbx1 gastrulation brain homeobox 1 0.16 mibrain, hindbrain 
prkrip1 PRKR interacting protein 1 (IL11 inducible) 0.14 no data 
tmem129 transmembrane protein 129, E3 ubiquitin protein ligase 0.13 eye, brain, pectoral fin 
vax2 ventral anterior homeobox 2 0.13 ventral retina 
gsdf gonadal somatic cell derived factor 0.13 testis, ovray 
glra4b glycine receptor, alpha 4b 0.12 retina (RGC, INL) 
wbp1 WW domain binding protein 1 0.11 ubiquitous 
pcbp4 poly(rC) binding protein 4 0.11 cranial ganglion 
Table 4.3: List of the top 20 genes containing nearby differentially methylated regions 
(DMRs) overlapping with differentially hydroxymethylated regions 
(DhMRs) between 22hpf and 27hpf RPCs, ranked by normalized score 
(number of significantly differentially methylated CpGs divided by the 
region size). Expression domains are summarized from the Zebrafish 





Gene Name Gene Description Normalized score Expression 
si:dkey-61p9.11 si:dkey-61p9.11 0.30 no data 
lhx2a LIM homeobox 2a 0.23 neural tube, olfactory organ 
murcb muscle-related coiled-coil protein b 0.22 muscle, bone 
lgi3 leucine-rich repeat LGI family, member 3 0.21 no data 
znf1068 zinc finger protein 1068 0.20 no data  
ntn1a netrin 1a 0.18 CNS, optic stalk 
colec11 collectin sub-family member 11 0.18 head mesoderm, liver  
rpl27a ribosomal protein L27a 0.17 ubiquitous 
them4 thioesterase superfamily member 4 0.15 no data 
stoml2 stomatin (EPB72)-like 2 0.14 no data 
ints2 integrator complex subunit 2 0.14 ubiquitous 
si:dkey-169i5.4 si:dkey-169i5.4 0.14 no data 
hrasb Harvey rat sarcoma viral oncogene homolog b 0.13 no data 
ing4 inhibitor of growth family, member 4 0.12 ubiquitous 
fgf7 fibroblast growth factor 7 0.11 no data 
slc39a4 solute carrier family 39 (zinc transporter), member 4 0.11 ubiquitous 
LOC100149406 odorant receptor 0.10 olfactory organ 
tox2 TOX high mobility group box family member 2 0.10 no data 
crb2b crumbs family member 2b 0.10 rod, cone, pineal gland 
znf609a zinc finger protein 609a 0.10 no data 
Table 4.4: List of the top 20 genes containing nearby regions where 5mC levels are 
significantly higher in 27hpf than 22hpf RPCs (5mC-gaining), ranked by 
normalized score (number of significantly differentially methylated CpGs 
divided by the region size). Expression domains are summarized from the 





Figure 4.7: Methylome and hydroxymethylome analysis of 22hpf vs 27hpf RPCs 
reveals candidate retinal developmental genes with expression in relevant 
domains. For 5hmC-gaining genes, crabp1a, pou3f1, and smad7 are 
expressed in the RPCs and brain, while rbp2a is expressed in the PR ventral 
patch (A). For 5mC-losing/5hmC-gaining genes, eif3ja is expressed in the 
eye and brain; slc17a6b is expressed in the RGCs, and chchd6a is 
ubiquitously expressed (B). For 5mC-gaining genes, murcb is expressed in 
the muscle and cartilage, and ing4 is expressed ubiquitously (C). All images 
are from the publicly available database, Zebrafish Information Network 





Simultaneous profiling of methylation and hydroxymethylation marks in a pure 
cell population has long been a challenge in developmental epigenetics. Traditional 
WGBS-seq offers a massive amount of mixed methylation data points where 5mC and 
5hmC cannot be distinguished, while affinity-based sequencing offers specific 
5mC/5hmC in a regional but not a base-resolution view of the epigenome. Capitalizing 
on the recent development of BS/OXBS chemistry, coupled with next-generation DNA 
sequencing, we show here for the first time a complete methylome/hydroxymethylome 
map of isolated RPCs during retinal development at nucleotide-resolution. While our 
overarching goal is to profile 5mC/5hmC of RPCs and all differentiated retinal cell types 
over the course of development, we present here the data generated from early RPCs, late 
RPCs, and whole embryos, representing the first phase of this endeavor.  
By comparing the methylome and hydroxymethylome of early (22hpf) RPCs to 
whole embryos at the matched time point, we verified that the 5mC/5hmC profiles of 
candidate retinal genes (e.g. vsx2, atoh7) follow the expected trajectories according to 
their known expression patterns and timing in RPCs and differentiated neurons. Using an 
unbiased approach, we identified several regions of differential methylation and 
hydroxymethylation (DMR, DhMRs) that are located near genes that are expressed in the 
eye and brain. These genes include both well-studied and uncharacterized genes. For 
example, miR181a is expressed specifically in zebrafish RGCs later in development 
(Wienholds, 2005) and has a role in mammalian cellular differentiation (Judson et al., 
2013), but its role is unknown within the context of eye development.  Also near the top 
of the list (Table 4.1) is an equally intriguing but less mysterious gene, nppa. We found 
this gene interesting because it is a heart-specific gene whose expression is nearly 
undetectable in the RPCs (TPM=0.32) and in whole embryonic eyes, but it was identified 
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as a top candidate gene with ectopic expression in the retina when tet enzymatic activity 
is absent in tet2-/-;tet3-/- mutant embryos as shown in our previous work (Chapter 3) 
(Seritrakul and Gross, 2017). This suggests that nppa is perhaps among the top 
epigenetically-regulated genes whose expression is the most sensitive to changes in 
5mC/5hmC levels.  
In the comparison between 22hpf and 27hpf RPCs, we found that 5mC/5hmC 
profiles are essentially identical at candidate retinal genes (vsx2, atoh7, crx, ptf1a). This 
is a surprising finding given that 22-27hpf is a critical time window leading up to the first 
wave of differentiation events when RPCs give rise to RGCs and other early-born retinal 
neurons (Almeida et al., 2014; Hu and Easter, 1999; Schmitt and Dowling, 1996), and 
one would expect to see evidence of epigenomic modification when RPCs are undergoing 
reprogramming. Three plausible and not mutually exclusive scenarios may explain these 
results.  
First, based on a close gene-by-gene inspection of epigenomic profiles in human 
and mouse whole embryonic retinae from the Pecan database (Aldiri et al., 2017), there 
appear to be similar DNA methylation profiles (WGBS tracks) at these same retinal 
specification genes, and the profiles do not change over the course of early retinal 
neurogenesis. Additionally, by layering on the chromatin marks from the same group of 
samples, it becomes clear that the TSS of these genes also possess consistent chromatin 
states for a bivalent domain (H3K4me1-3, H3K27me3, H3K9Ac), suggesting that DNA 
methylation and hydroxymethylation act cooperatively with other epigenetic 
mechanisms, namely histone methylation and acetylation, to turn the genes on during 
neurogenesis. This is consistent with recent findings that 5mC/5hmC profiles benefit 
from being analyzed in conjunction with other epigenomic marks that influence the 
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chromatin state in order to make meaningful interpretation possible (Mo et al., 2016; 
Ueno et al., 2016; Wang et al., 2018).  
Second, our candidate gene analysis centers around the profile of known 
candidate retinal developmental genes and expands to surrounding regions. However, 
these may or may not be the true regulatory regions driving the expression of these genes. 
It is known that enhancers can reside far away from the genes that they are driving, and 
their locations may not be immediately identifiable (Bulger and Groudine, 2011; Zentner 
and Scacheri, 2012). Although many putative enhancers have been identified across 
many mammalian cell types (Lizio et al., 2015), their genomic coordinates in zebrafish 
are less known. Therefore, the locations of differential methylation and 
hydroxymethylation important for driving the expression of retinal neurogenesis genes 
may be outside of the windows we examined, and to identify them, additional 
information from other chromatin marks is required.  
Third, it is possible that the pools of vsx2+ RPCs we isolated from the retinae 
contain a heterogeneous mix of RPC subpopulations with various epigenomic profiles, 
rather than a homogeneous pool of identical RPCs, and the signals are averaged out from 
bulk BS/OXBS profiling. This is more likely to be true especially for the later RPCs 
isolated at 27hpf shortly before the onset of differentiation.  Recent findings suggest that 
what we thought of as a uniform, seemingly indistinguishable population of progenitor 
cells may in fact be composed of distinct subpopulations, each one with a unique 
potential for subsequent differentiation (Cepko, 2014; Johnson et al., 2015), and these 
progenitors could undergo a series of transformations through “transitional progenitor” 
steps (Jin, 2016).  In this scenario, one could imagine an immature retina composed of a 
progenitor pool for early-born RGCs and a larger, co-existing pool for later-born cell 
types (MG, BP, rods). At 27hpf, the RGC progenitors begin to modify their epigenomic 
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and transcriptional profiles to differentiate into mature RGCs, and at the same time the 
late-born progenitors undergo epigenomic changes in a different direction. Because there 
are only a few RGCs born at 28hpf, their unique epigenetic signal is drowned out by the 
undifferentiated RPCs and/or the late-born progenitor pool.  To directly answer this, we 
need to employ a modified strategy where each RPC is profiled uniquely for the 
epigenome and transcriptome. Recent development in the field of genome editing and 
single-cell sequencing now make this a more feasible approach, as outlined in Future 
Directions (Chapter 5).  
Although we present here the first successful combined BS/OXBS analysis in the 
developing retina, several technical improvements could be made. First, increasing 
sequencing depth would greatly improve the data quality, as sequencing depth directly 
influences the confidence of 5mC/5hmC methylation levels, both at the initial 
methylation calls and later during the maximum-likelihood 5hmC estimation. In the case 
of a limited budget, enhanced reduced-representation methods (eRRBS and RR-OXBS) 
could be utilized to allow higher coverage on a subset of CpG islands around MspI (or 
another restriction enzyme of choice), although this will reduce the coverage in other 
parts of the genome (Garrett-Bakelman et al., 2015).  Second, an independent, direct 
5hmC profiling technique could be employed in conjunction with the indirect OXBS-
based profiling when maximum confidence in 5mC/5hmC levels is required. The raw 
data from all three libraries (BS, OXBS, TAB-seq) can be combined and processed, again 
using the compatible maximum-likelihood program such as MLML (Qu et al., 2013). 
Finally, to generate a biologically meaningful set of methylome and hydroxymethylome 
profiles, many more samples need to be purified and sequenced. The technical limitation 
here is the limited availability of transgenic lines that express fluorescent reporter in only 
one cell type (vsx2 in RPCs, atoh7 in RGCs, for example).  Fortunately, efforts in 
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enhancer trapping have made available many more transgenic lines with unique 
expression in various cell types, several of which are within the retina (Kawakami et al., 
2010). Additionally, Crispr-Cas9 editing strategy now allows insertion of a Gal4 
sequence directly into a GFP or mCherry line, allowing conversion of existing lines to be 
utilized in cell sorting.  These recent developments will allow us to generate epigenomic 





















Chapter 5:  Summary and Future Directions 
 
5.1 SUMMARY OF WORK  
DNA methylation (5mC) and hydroxymethylation (5hmC) have been subjects of 
investigation over the past decade in both developmental and disease contexts, due to 
their regulatory roles in modulating the expression of diverse sets of genes in conjunction 
with other chromatin modifications. However, little is known regarding the genomic 
distribution of these epigenetic marks and the roles they play during eye development. 
My dissertation work directly aimed at profiling the genome-wide distribution of 
5mC/5hmC and investigating the expression and function of both families of DNA 
methylation machinery: de novo DNA methyltransferases (dnmt3 family, which add 5mC 
to unmethylated C) and cytosine dioxygenases (tet family, which convert 5mC to 5hmC).  
In Chapter 2, I showed that all members of the dnmt3 family are expressed in 
distinct and overlapping domains of the developing eye. However, when these genes are 
mutated, either individually or in pairs, the resulting embryos still develop normally 
without any overt phenotypes, suggesting a high level of functional redundancy 
(Seritrakul and Gross, 2014).  In Chapter 3, I generated mutants for tet2 and tet3, which 
are both expressed during retinal neurogenesis, and identified cell type-specific neuronal 
defects in the tet2-/-;tet3-/- double mutant embryos (Seritrakul and Gross, 2017). I found 
that the mutant retinal cells are specified but most failed to terminally differentiate, due to 
altered expression of genes involved in extrinsic signaling pathways.  In Chapter 4, I 
generated the first genome-wide nucleotide-resolution maps of 5mC/5hmC distribution of 
retinal progenitor cells during neurogenesis, which show expected methylation patterns at 
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candidate retinal genes and enabled discovery of several novel genes and pathways 
potentially involved in retinal neuron differentiation.  
These results lay the foundation for future investigation into more mechanistic 
details of DNA methylation and hydroxymethylation during retinal neurogenesis, using 
recently developed genome engineering and single-cell epigenomic profiling, as 
described below:  
 
5.2 FUTURE DIRECTIONS   
5.2.1 Functional test of dnmt3 tissue-specific requirements 
In zebrafish, six members of the dnmt3 family exists, all with predicted de novo 
methyltransferase domains (Goll and Halpern, 2011). Results from Chapter 3 suggest that 
several of these enzymes function redundantly (dnmt4/dnmt7 and dnmt6/dnmt8, at the 
very minimum), and this resulted in the lack of phenotype at both the whole embryo level 
and eye-specific level.  While it is feasible to generate combinatorial mutant lines that 
lack all genes in the dnmt3 family, this process is time-consuming, laborious and may or 
may not yield interpretable phenotypic results. Nevertheless our lab has generated a 
compound mutant for dnmt3,4,5,6,8, which still showed normal development and no eye 
phenotype (Angileri et al., unpublished observations).    
As an alternative, a cell-specific targeted inactivation of de novo methylation is a 
more viable option. Over the course of time between the generation of my double 
mutants and the conclusion of this Dissertation, a mutation (R882H) in Dnmt3A has been 
identified in human patients and functionally validated in a mouse model for acute 
myeloid leukemia (AML). This R882H substitution is within the catalytic domain and 
causes the mutant protein to act in a dominant-negative manner, inhibiting the formation 
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of the Dnmt3A and Dnmt3B tetramers required for methyltransferase activity, and thus 
inhibiting the endogenous wildtype proteins’ function (Kim et al., 2013a; Russler-
Germain et al., 2014). This mutation will be useful in enabling functional testing of 
dnmt3-family genes without having to generate a compound mutant. This can be 
achieved using three approaches:  
First, for investigating global effects, one would simply overexpress the mutated 
dominant-negative Dnmt3aR882H in zebrafish, either by mRNA injection or transgenically 
under control of a global or heat-inducible promoter (e.g. Hsp70l:gal4; 10xUAS: GFP-
Dnmt3a-DN). Second, to achieve more precise control, several existing driver lines could 
be used to activate Gal4 in specific cell types of interest, such as vsx2:gal4 (for RPC), 
atoh7:gal4 and isl2b:gal4 (for early and late RGC, respectively), and opn1sw1:gal4 (for 
PR). Third, using information from the methylome map generated in Chapter 5, one 
could target the engineered mutant protein to genomic loci that normally gain 5mC (and 
presumably lose transcriptional activity) during differentiation and assess the resulting 
phenotype when de novo methylation is inhibited. This is now feasible using the Crispr-
Cas SunTag-directed targeting strategy, which has already been validated to function 
with the wildtype Dnmt3A (Huang et al., 2017). Using sgRNAs targeted to 5mC-gaining 
sites, the SunTag on the deactivated Cas9 can ‘tow’ and concentrate Dnmt3 (mutant or 
wildtype) protein to virtually anywhere in the genome. The resulting cells can then be 
sorted and analyzed for methylation and gene expression changes.  
 
5.2.2 Tissue-specific analysis of Tet function  
Results from gene expression and pharmacological rescue experiments in tet2-/-
;tet3-/- embryos indicate that tet enzymes functions are mediated non-autonomously via 
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cell-extrinsic pathways during retinal neuron differentiation (Chapter 3). An obvious 
question remains to be answered: what cells or tissues are the source of these extrinsic 
molecules?  While mosaic analysis using shield-stage transplantation offers one way to 
address this, it is a relatively invasive, laborious process and does not allow much control 
of the specific number and location of the resulting clones. To avoid this, or as an 
alternative approach, I outline below two options that are available and offer more spatio-
temporal control. 
First, to generate tet2/3 null clones and simultaneously lineage-trace them in the 
retina, one could utilize the 2C-Cas9 strategy (Donato et al., 2016) where tet3 mutation is 
induced mosaically on a tet2-/- background (phenotypically wildtype) by injecting a 
construct containing UAS:Cas9-Cre and sgRNAs targeting tet3 under control of retina-
specific Gal4 driver (e.g. vsx2:gal4) (Fig 5.1). This will result in a variable number of 
tet2-/-;tet3-/- mutant clones among phenotypically wildtype tet2-/-;tet3+/? neighbors and allow 
analysis of retinal neuron type-specific differentiation using conventional immuno-
histological staining. Additionally, labeled (i.e. double mutant) cells can then be FAC-
sorted for transcriptome and methylome analysis and mutation validation by PCR, in 
comparison to the neighboring non-GFP, phenotypically wildtype cells.    
Second, to pinpoint potential sources and timing of the extrinsic signals required 
for neuronal differentiation, Tet2 or Tet3 overexpression constructs utilized in Chapter 3 
can be driven using a cell-specific UAS driver in the tet2-/-;tet3-/- background. Several UAS 
lines exist that will allow expression of the construct in both early in development 
(vsx2:gal4 for RPCs, tfec:gal4 for RPE; cryaa:gal4 for lens) and later in development 
(isl2b:gal4 for RGCs, gfap:gal4 for MG, opn1sw1:gal4 for cones, for example) in a cell 
type-specific manner.  Any domains where Tet2 or Tet3 wildtype expression ‘rescues’ 
retinal neuron differentiation in the tet2-/-;tet3-/- background is a candidate source of the 
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extrinsic signals mediated by tet enzymes. Tet2 and Tet3 catalytically in active constructs 
can be used as a control, which would result in a lack of rescued phenotype, and the 
embryos would look identical to those with the tet2-/-;tet3-/- background. 
 
 
Figure 5.1: Schematic for clonal analysis of Tet loss-of-function experiments. See text 
for details. 2C-Cas9 construct adapted from (Donato et al., 2016). 
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5.2.3 Methylome and hydroxymethylome data mining  
My analyses in Chapter 4 represent the tip of the iceberg in terms of the amount 
of information we can potentially learn from the BS and OXBS data generated, the 
additional data currently being generated (27hpf RPC RNAseq and replicates of 
BS/OXBS) and soon to be generated in the near future (BS/OXBS and RNAseq for 
RGCs and later born retinal neurons). As more bioinformatic tools and approaches 
become available, additional data mining is possible. For example, to streamline the 
analysis and reduce computational time, all of the methylation (5mC, 5hmC, C) levels 
were calculated from cytosines located within the CpG context, which is the most 
prominent form of methylation in vertebrate genomes (Smith and Meissner, 2013). 
However, DNA methylation is known to occur in a non-CpG context (CH = CA, CT, 
CC) at minimal levels in vertebrates, and at higher levels in plants (Zemach et al., 2010). 
A recent study reported that in postmitotic neurons, the combined CH level is typically 
less than 2%, and 5hmC occurs mostly in the CA context (5hmCA) near enhancer shores 
(Mellén et al., 2017). An advantage of the OXBS strategy we used is that methylation 
marks in all contexts are processed and sequenced at the same time. Therefore, additional 
methylation extraction rounds can be done on our existing OXBS reads, using Bismark or 
MethPipe, with modification to extract methylation score in a non-CG context, and 
subsequent downstream analysis can be performed as we did for CpG. This will yield the 
first non-CG methylome and hydroxymethylome maps in developing RPCs.  
Additionally, regions of the vertebrate genome can be classified as partially 
methylated domains (PMDs), continuous regions where methylation levels are lower than 
genome average but not as low as those located within the hypomethylated regions 
(HMRs). These PMDs are often associated with gene repression and inactive chromatin 
marks, and genes located within PMDs show tissue-specific expression and are subjected 
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to the gain/loss of 5mC over the course of development (Gaidatzis et al., 2014; Schroeder 
et al., 2013). In practice, we can identify these PMDs in BS/OXBS data, compare 
methylation levels between 22hpf and 27hpf RPCs, and generate a list of differentially 
partially methylated domains (DPMDs). To identify biologically relevant genes within 
these domains, additional chromatin state data are likely required. This can be obtained 
by performing additional ChIP-seq for active/inactive histone mark and/or ATAC-seq. 
Alternatively, existing chromatin state data can be compared between mouse and human 
at an equivalent developmental time points (Aldiri et al., 2017). Although these data were 
generated from whole dissected retina, and not FAC-sorted RPCs, they should be 
comparable at an early developmental time because most of the retina is composed of 
RPCs.   
 
5.2.4 Functional analysis of novel retina neurogenesis genes  
The combined methylome and hydroxymethylome analysis in Chapter 4 
identified a number of genes located near regions of differential methylation and 
hydroxymethylation (DMRs/DhMRs), some of which are known eye genes while several 
others are uncharacterized, potentially novel neurogenesis genes. The next step in 
validating these candidates is to perform a series of expression analyses by in situ 
hybridization at early (22hpf) and late (27hpf) time points. Utilizing the wildtype, tet 
double mutant line (tet2-/-;tet3-/-), and dnmt3 loss-of-function line (either a combinatorial 
knockout or the overexpressed dnmt3-DN as described above), one can begin to 
distinguish whether the transcription of these genes is indeed regulated by DNA 
methylation and/or hydroxymethylation.  
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According to the model presented in Chapter 3, one would expect to see cell type-
specific expression patterns for 5mC-losing and/or 5hmC-gaining genes. For example, 
slc17a6b is not expressed in RPCs at 22hpf but strongly expressed in the inner retina, 
presumably RGCs, by the end of neurogenesis (Thisse and Thisse, 2004). In tet2-/-;tet3-/-, 
the expression would likely be absent because the gene stays silenced due to the lack of 
5mC à 5hmC conversion (Fig 5.2A). Conversely, genes that gain 5mC likely turn from 
active in early RPCs to become repressed as RPCs differentiate into neurons, and 
eventually only maintain the expression in the CMZ where cells stay proliferative. In 
dnmt3 LOF embryos, this expression is likely expanded because 5mC could not be added 
de novo to silence the gene, and expression would be maintained in the specified and/or 
differentiated neurons (Fig 5.2B). This may also indicate that the cells, though specified, 
are not differentiated and remain ectopically proliferative, similar to the phenotype 
characterized in tet2-/-;tet3-/-. Lastly, for novel genes that show promising expression 
patterns, knockout lines can be easily and quickly generated using Crispr-cas9 to further 
functionally test their roles during retinal development in vivo.  
 123 
 
Figure 5.2: Expected expression patterns of candidate genes identified from OXBS 
analysis in embryonic retina. 5mC-losing and/or 5hmC-gaining genes likely 
become expressed in differentiated neurons, and this expression is abolished 
in tet2-/-;tet3-/-(A). 5mC-gaining genes likely lose expression upon 
differentiation, only staying on in the CMZ, and this domain is expanded in 
dnmt3 loss-of-function embryos.  
 124 
5.2.5 Simultaneous lineage tracing and profiling of developing RPCs 
The exact trajectory of retinal cell differentiation from RPCs to neurons and MG 
is still unclear. This is in contrast to the resolved cellular lineage in other systems such as 
hematopoiesis where multipotent hematopoietic stem cells give rise to various blood cell 
types in a clearly defined differentiation hierarchy (Rieger and Schroeder, 2012). Studies 
using long-term live imaging are beginning to document the stochastic behavior of 
differentiating RPCs both in vivo (He et al., 2012) and in vitro (Gomes et al., 2011), 
while functional experiments combined with mathematical modeling have elucidated the 
probabilistic and independent activity of core TFs in determining the fate of 
differentiating RPCs (Boije et al., 2015). These data support the stochastic model and 
imply that such a clearly defined lineage tree may not be necessary.  
In contrast, experimental data show that RPCs undergo transitions from being 
multipotent to being restricted in differentiation potential as they turn on/off lineage-
specific genes. For example, all early RPCs express vsx2, which acts to repress 
differentiation genes, and this expression decreases in most differentiating RPCs 
(Vitorino et al., 2009). During neurogenesis some RPCs turn on atoh7 to become RGCs 
or PRs (Poggi et al., 2005), others turn on vsx1 to become BPs or ACs (Jusuf et al., 
2011), and those that retain vsx2 expression are destined to become MGs and BPs 
(Vitorino et al., 2009). These data support the competency model and, at least to some 
degree, imply the existence of a lineage tree.  
The seemingly indistinguishable RPCs are thought to be intrinsically unique  
(Cepko, 2014; Dyer and Cepko, 2001; Trimarchi et al., 2008) and there may exist 
“transitional” progenitors with dynamic epigenome and transcription profiles (Jin, 2016). 
In addition, single-cell RNAseq suggests that neural progenitors in the human cortex are 
indeed transcriptionally heterogeneous (Johnson et al., 2015).  In Chapter 4, we observed 
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that the methylome and hydroxymethylome profiles are overall quite similar between 
22hpf and 27hpf RPCs with only a few hundred DMRs and DhMRs across the genome, 
which may reflect, at least in part, the inherently heterogeneous nature of the RPC pools.  
To resolve the retinal cell differentiation lineage and simultaneously profile the 
epigenome and transcriptome of individually developing RPCs and differentiated retinal 
cells, one could utilize the recently developed single-cell combined barcoding and 
epigenomic profiling approach. This can be done using the genome editing of synthetic 
target arrays for lineage tracing (GESTALT) (McKenna et al., 2016) by “barcoding” the 
early RPCs (22hpf) before differentiation and reconstructing the lineage relationship 
between differentiated cells at the end of neurogenesis (72hpf) based on the mutations 
accumulated within the barcodes. The cells carrying the barcodes can then be 
simultaneously profiled for DNA methylation and transcription using scNMT (Clark et 
al., 2018; Ren and Pott, 2017).  
In practice, this would require generating a zebrafish line carrying a Cas9 
construct under a heat shock promoter, a constitutive expression cassette with sgRNAs 
targeting the sequences on the barcodes, and a heatshock-inducible barcode array tagged 
with mCherry to allow for transcription (for RNAseq) and isolation of the labeled cells by 
FAC-sorting (Fig 5.3). The early RPCs will be heat shocked, and this triggers the Crispr-
mediated mutation accumulation on the barcode over time. At the completion of 
neurogenesis, labeled cells will be isolated, and mRNA and genomic DNA extracted. The 
barcodes embedded within the mCherry mRNA will be sequenced along with the rest of 
the transcriptome, and a lineage tree will be constructed based on the “evolutionary” 
history of each cell.  Meanwhile, the genomic DNA of each cell will be bisulfite treated 
and sequenced to obtain single-cell methylome profile.  
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It is important to note that this single-cell technology does not allow simultaneous 
profiling of 5hmC, as each strand of DNA can physically only be probed once for either 
5mC or 5hmC, and not both. Additionally, although single-cell profiling is possible for 
5hmC, it still relies on the enzymatic activity of BGT, and not an OXBS-based approach, 
thus will be limited in resolution (Mooijman et al., 2016). Regardless of the limitation, 
this combined approach (scGESTALT + scNMT) would allow tracing of the 
developmental trajectory of each retinal cell during neurogenesis and offer 
comprehensive methylome and transcriptome profile of those same cells. Additionally, 
depending on the topology of the tree, this approach may also lead to the discovery of 
new intermediate RPC types, and the transcriptome profiles may uncover novel genes 











Figure 5.3: Schematic diagram of the combined scGESTALT + scNMT profiling 









Appendix A: Material and Methods 
A1: ANIMAL LINES AND HUSBANDRY 
Zebrafish were maintained at 28.5°C on a 14/10 light/dark cycle and treated in 
accordance with the University of Texas at Austin and University of Pittsburgh IACUC 
regulations governing animal research. Euthanasia utilized tricaine, following procedures 
standard in the field and as approved by the IACUC. Embryos were incubated in the dark 
at 28.5°C and staged according to (Kimmel et al., 1995). Lines utilized in this study are: 
tet2au59, tet3au60, 10xUAS-nls-mCherry-t2a-myc-flag-TET2wtau50, 10xUAS-nls-mCherry-t2a-
myc-flag-TET2mutau51, Tg(isl2b:GFP) (Pittman et al., 2008) and Tg(vsx2:GFP) (Vitorino 
et al., 2009). 
A2: PHYLOGENETIC ANALYSIS OF PROTEINS WITHIN DNMT3 AND TET FAMILY  
For dnmt3-family proteins, All amino acid sequences were obtained from NCBI 
with the following accession numbers: AAI63893.1 (zebrafish dnmt1); NP_001018153.1 
(zebrafish dnmt2); NP_571461.1 (zebrafish dnmt3); AAI24099.1 (zebrafish dnmt4); 
NP_001018315.1 (zebrafish dnmt5); AAI62582.1 (zebrafish dnmt6); AAI63546.1 
(zebrafish dnmt7); NP_001018144.1 (zebrafish dnmt8); AAH53047.1 (mouse Dnmt1); 
NP_001258682.1 (mouse Dnmt3A); NP_001258673.1 (mouse Dnmt3B); AAI26228.1 
(human DNMT1); AAH 23612.1 (human DNMT3A); NP_ 008823.1 (human DNMT3B).  
For tet-family proteins, Amino acid sequences were downloaded from NCBI, 
using the following accession numbers: NP_085128.2 (human TET1), NP_001240786.1 
(mouse Tet1), AHE93329.1 (zebrafish tet1), NP_001120680.1 (human TET2), 
NP_001035490.2 (mouse Tet2), AHE93330.1 (zebrafish tet2), NP_001274420.1 (human 
TET3), NP_898961.2 (mouse Tet3), AHE93331.1 (zebrafish tet3).  Alignments and 
phylogenetic trees were constructed using Geneious Tree Builder software with standard 
neighbor-joining method (Biomatters).  
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A3: IN SITU HYBRIDIZATION  
Whole-mount in situ hybridization was performed essentially as described (Jowett 
and Lettice, 1994) with the following modification to allow probes to access the lens: (1) 
Full-length RNA probes were hydrolyzed with a mixture of 0.6 M sodium carbonate and 
0.4 M sodium bicarbonate for 20 min. (2) Embryos older than 72 hpf were pretreated 
with 1 mg/ml Collagenase type IA before proteinase treatment step. DIG-labeled RNA 
probes for notch1a, deltaA, ascl1a, vsx2, pax6a, neurod4 and atoh7 were described 
previously (Uribe and Gross, 2010). Probes for dnmt3-8, tet1, tet2, tet3, lef1, wnt1, 
wnt9B, opn1sw1, opn1mw1, and nppa were cloned from zebrafish cDNA using primers 
listed in (Table A1) .  PCR fragments were cloned into pGEM-T-Easy vector (Promega), 
sequence verified, linearized, and transcribed using SP6 and T7 polymerases with DIG 
RNA labeling mix (Roche). Synthesized RNA probes were purified using RNeasy kit 
(Qiagen), mixed 1:200 with hybridization buffer (50% formamide, 5xSSC, 0.1%tween, 
5mg/ml yeast tRNA, 50µg/ml heparin), and heated to 68°C before use. Once the 
appropriate level of staining is achieved, embryos were re-fixed and embedded in tissue- 










primer name locus sequence 
dnmt3 F dnmt3 TGAATCAACACCATTTCCACGG 
dnmt3 R dnmt3 AAAGCCCAACAAGAGCACACTG 
dnmt4 F dnmt4 CGGCACCTTCAATCTCTGCTAT 
dnmt4 R dnmt4 GCCAGGGGGAAAACACAATACTC 
dnmt5 F dnmt5 TCCCACTGTTATGGAGAATGGTTG 
dnmt5 R dnmt5 TCCTGAAAATCACAAAGCGGC 
dnmt6 F dnmt6 TGGGGCAGGAAAAAAAAGTGAC 
dnmt6 R dnmt6 TCTCATAGGGCTCCGATTCAGG 
dnmt7 F dnmt7 AATCCTGATGACAAGTGCAGTCG 
dnmt7 R dnmt7 CAGCAAGTACCACATGACAGTTGG 
dnmt8 F dnmt8 ACACACACACAGCGACCTAAGAGG 
dnmt8 R dnmt8 CACAGTGAGGGAACGGTTTACCTG 
opn1mw1_F1 opn1mw1 TGAACGGGACAGAAGGGAGC 
opn1mw1_R1 opn1mw1 AAGTCTTGGAGAAGAAGGCTGGAA 
opn1sw1_F1 opn1sw1 ACGTTGTGTGCGATGGAAGCG 
opn1sw1_R1 opn1sw1 GACATAGGTGTACCAGTTCTGCACA 
nppa_F1 nppa CAGAGACACTCAGAGATGGCCG 
nppa_R1 nppa CCATTTAATGTTACTTACTGAAGGCAAAGGTC 
tet1_F1 tet1 CTCAGGTATCAAAAACCTACGATGTGC 
tet1_R1 tet1 TCCAGCCTCCTCTTGTGTGC 
tet2_F1 tet2 CTTGAAACAAGGGCAGCCTTGT 
tet2_R1 tet2 CTCATGAGTCTGTTGCTGAAGCAAG 
tet3_F1 tet3 CAACCACCAACCTTCACCTT 
tet3_R1 tet3 ATGCATGCAGTGATTCCTGA 
wnt1 F wnt1 ACTGTCGCATCAGAGATGCAGC 
wnt1 R wnt1 TATTTACCACCCCGGATTCAGAACA 
wnt9B F wnt9B GTTTTAAAGAGACGGCCTTCCTGC 
wnt9B R wnt9B CCCACTCATTTGCCTCTGTTTACTTC 
lef1 F lef1 ACACCACCCACAAGATGTCA 
lef1 R lef1 TGAACACACAGGTGCCAAAT 
 




A4: TALEN-MEDIATED GENOME EDITING  
TALEN site were selected using a target selection tool, Mojo Hand, to identify 
suitable DNA binding sites (Neff et al., 2013). To facilitate identification and genotyping, 
TALENs were designed to cut at restriction endonuclease recognition sites. Plasmids 
encoding the repeat variable domain (RVDs), FokI nuclease domain, and other accessory 
sequences were assembled using the Golden Gate platform (Bedell et al., 2012b; Cermak 
et al., 2011; Dahlem et al., 2012). Completed constructs were in vitro transcribed and 
injected into 1-cell stage embryos. Resulting embryos were analyzed for mutations at the 
target site by restriction fragment length polymorphism (RFLP) and raised to adulthood. 
Potential founders were then analyzed for germline transmission of desirable loss-of-
function mutations and outcrossed to wildtype fish in order to establish mutant lines. All 
TALEN-induced stable mutant lines currently maintained in the lab carry validated 
mutations that disrupt reading frames and are predicted to cause premature stop codons. 
Heterozygous adults of each line were identified by fin-biopsy and incrossed to generate 
homozygous mutant embryos. RFLP genotyping primers and restriction enzymes for 
dnmt-3 family genes are listed in Table A2. 
To generate the tet2-/- and tet3-/- mutant lines, TALEN constructs were generated 
using Golden Gate assembly (Bedell et al., 2012b; Cermak et al., 2011) targeting the 
following sequences (spacer in bold and restriction endonuclease recognition sites 
underlined): 
CATCCCAGATGGAATGGATAGATTTAAACTCAACTTCTGCTTCAAC for tet2au59; 
GCTCTGGGAGATAAACTGTACAGAGAAGTCACAGAAACCATCACCAAAT for 
tet3au60.   
Embryos at the 1-cell stage were injected with in vitro synthesized (Ambion) 
mRNA encoding the TALEN constructs (left and right arms) targeting tet2 and tet3, 
separately, and raised to adulthood. At breeding age, potential founders were screened for 
germline transmission of mutations by sperm genomic PCR, followed by whole amplicon 
Sanger sequencing. Genotyping primers are listed in Table A2).  Founders with deletions 
that resulted in frameshifts and premature stop codons were outcrossed to wildtype 
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females and embryos reared to adult. Potential heterozygotes were then screened for the 
desired mutation by restriction fragment length polymorphism (RFLP) using DraI for tet2 
and RsaI for tet3. RFLP fragments were resolved on a 1% agarose gel and mutant 
fragments were detected by the resistance to DraI and/or RsaI digestion (Fig. S2). To 
generate the double mutant line, heterozygotes carrying tet2 or tet3 mutations were 
crossed, and offspring were screened for the presence of both mutations by RFLP. tet2+/-
;tet3+/- fish were then incrossed to obtain tet2-/-;tet3-/- embryos.  Because homozygous 
mutation in either tet2 or tet3 alone does not affect viability, the remaining embryos 
survived to adult and a normal Mendelian distribution was obtained (Fig. S2).  
 
Gene restriction enzyme primer sequence 
dnmt4 MboII F ACGTAATCTCGACCGCAAGGGA 
R AAGGCCAAGCCATGTTGAAGC 
dnmt6 AluI F GGGCCGAACTGTGTAATATTCTTAGGA 
R TCAGGCTGGAACGAACCACTC 
dnmt7 AluI F CTCTGGGTATTGCTGACATGCATTATTC 
R ACTACGCATAGAACTTAGTGTGCAAGG 
dnmt8 EcoRV F GAAAATGGATCTAATGGCGTGTGTGATAT 
R AGGAGGTCATCAGTTTTCAGGATTAAAAG 
tet2 DraI F CACAAACCTCTCAGACAGGTCAGT 
R TCTCTGTTGACTTTCAGGGGCAG 
tet3 RsaI F CAATGCCTAGATCAACCACTTAGTGTC 
R GTATCAGGAATGTGCAAACATCTCATTTG 
Table A2: List of primers and restriction enzymes used for genotyping of the mutant 







A5: CRISPR-MEDIATED GENOME EDITING  
CRISPR line for dnmt4 deletion was generated following the protocol as 
described (Auer et al., 2014). Oligo sequences for the construction of sgRNAs were 
GCAGCTAATACGACTCACTATAGGTGAGTGTACCTGCGGGTGGTTTTAGAG
CTAGAAATAGCAAG (for targeting exon3) and 
GCAGCTAATACGACTCACTATAGGCGCCAGACAGAAGCTGCTGTTTTAGAG
CTAGAAATAGCAAG (for targeting exon 22). Targeting sequences are in bold. 
Deletions were detected by PCR using primers E3_GTF1: 
CTGTCACACATCTTTCCCAGATGAC, E3_GTR1: 
CCATTGACTGAAAGCTTCTTCAGGGC for exon3 and E22_GTR2: 
TTGAGTTTGGCCTGTTGCTCAA. If the deletion is present, the genomic DNA is 
amplified with E3_GTF1 and E22_GTR2. However, if the deletion is absent, the PCR for 
E3-E22 fails, and genomic DNA is instead amplified with E3_GTF1 and E3_GTR1.  
 
A6: GENERATION OF TET OVEREXPRESSION TRANSGENICS  
10xUAS:mCherry-Tet2WTau50 and 10xUAS:mCherry-Tet2mutau51 were generated 
using mouse Tet2 wild-type and catalytically inactive constructs (Ito et al., 2010). These 
domains were reconfigured into zebrafish inducible overexpression constructs using the 
Tol2 Kit (Kwan et al., 2007). Briefly, the entire coding sequences were amplified and 
ligated, along with a mCherry-T2A-myc coding fragment, into Gateway-compatible 
pME-MCS using Gibson assembly system (NEB). These intermediate fragments were 
then assembled into expression constructs consisting of p5E-10XUAS, pME-mCherry-
T2A-Myc-Flag-Tet, p3E-poly-A-tail, and the pDestCG2 backbone carrying cmlc2:GFP. 
The final DNA constructs were injected into 1-cell stage zebrafish embryos along with 
Tol2 mRNA for stable genomic integration (Kwan et al., 2007). Embryos were screened 
for the heart GFP expression at 3-4dpf and raised to adult. Multiple founders were 
screened for germline transmission and the strongest expressing lines were kept for 
experiments.  
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A7: RT-PCR AND WESTERN BLOT ANALYSIS  
RT-PCR for tet2 and tet3 was performed using exon-spanning primers listed in 
Supplementary Table 3. Embryos at 2dpf and 5dpf (n=20 per genotype per condition) 
were euthanized and RNA extracted using RNeasy kit (Qiagen). cDNA libraries were 
generated using iScript cDNA synthesis kit (BioRad).  
Western blot analyses was performed essentially as described (Tittle et al., 2011) 
with slight modifications. At 3dpf, 40 embryos per condition were euthanized, de-yolked, 
and protein extracted.  Samples were separated by electrophoresis on 4-12% bis-tris gel 
with NuPage MOPS SDS running buffer (Invitrogen) and transferred to PVDF membrane 
at 30V for 2 hours, then at 12V overnight at 4°C. Membranes were blocked in 1%BSA, 
5% non-fat milk in TBST for 2 hours at RT and incubated in anti-TET3 rabbit polyclonal 
antibody (ab139311, Abcam) overnight at 4°C, then washed, incubated with HRP-
conjugated donkey-anti-rabbit antibody (711-035-152, Jackson Immuno Research), 
rinsed, and incubated with substrate solution (Super Signal West Femto, Thermo Fisher).   
Images were acquired and band intensity quantified using ChemiDoc XRS+ system 
(BioRad). For normalization, membranes were stripped for 12 minutes in Restore 
Western Blot stripping buffer (Thermo Fisher), rinsed, re-blocked, probed with anti-actin 
mouse monoclonal antibody (CP01, Millipore) followed by HRP horse-anti-mouse 
secondary (7076, Cell Signaling) and imaged as above.  
A8: BRDU INCORPORATION, PLM ASSAYS, AND TUNEL ASSAY 
5-bromo-2-deoxyuridine (BrdU) incorporation was performed using a 15-minute 
pulse for PLM assays, and a 2-hour time window for 48hpf-5dpf assays. Embryos were 
treated in 0.3% BrdU, fixed in 4% PFA in PBS, embedded, and cryosectioned at 12µm. 
Sections were treated with 4M HCl at 37°C for 10min, blocked in block solution (5% 
normal goat serum, 0.1% tween, 1% DMSO, in PBS), incubated with anti-BrdU (1:250; 
Abcam) in block overnight at 4°C, stained with anti-rat Cy3 secondary (1:250) and 
counterstained with Sytox green at 1:10,000 (Molecular Probes). Cells undergoing 
mitosis were detected using anti-phospho histone H3 (ser10) (1:250) (Millipore 06-570), 
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stained with anti-rabbit Cy2 secondary (1:250), and counterstained with DAPI (1:500). 
For TUNEL analysis, embryos at 36hpf, 3dpf, 4dpf, and 5dpf were fixed in 4% PFA 
1xPBS at 4°C overnight, cryosectioned at 12µm, and processed for TUNEL using TMR 
Red in situ cell death detection kit (Roche) per manufacturer’s protocol.  
 
A9: IMMUNOHISTOLOGICAL ANALYSIS 
Immunohistochemistry was perform as described (Uribe and Gross, 2007), with 
the following antibodies: zpr-1 (cones; ZIRC), zpr-3 (rods; ZIRC), zrf-1/gfap (Muller glia 
cells; ZIRC), Zn8 (ganglion cells; ZIRC), and HuC/D (ganglion and amacrine cells; 
Molecular Probes). Embryos were cryosectioned at 12µm and incubated with primary 
antibodies diluted at 1:200 in block overnight at 4°C, then incubated with secondary 
antibody (anti-mouse Cy3) for 2hrs. Sections were counterstained with Alexa Fluor-633 
Phalloidin at 1:100 and Sytox green at 1:10,000 (Molecular Probes) or mounted using 
Vectashield with DAPI (Vector Labs).   
 
A10: WHOLE-MOUNT CHROMOGENIC IMMUNOSTAINING  
Embryos were fixed in 4% PFA 1x PBS at 4°C overnight, rinsed once in PBST 
(0.1% tween-20, 1xPBS), once in water, and treated with 100% acetone for 7min at -20 
°C to permeabilize the tissue, then rinsed one time each in water, PBST and PBDTX 
(1%BSA, 1%DMSO, 0.1% TritonX, 1xPBS, pH=7.3). Embryos were blocked for 1hr 
(2%NGS in PBDTX), incubated in Zn8 primary antibody (ZIRC) at 1:200 dilution 4°C 
overnight, washed 4 x 20min in PBDTX, and incubated in secondary horse anti-mouse 
HRP-tagged secondary (Cell Signaling) at 1:1,000 dilution for 2hrs. Embryos were then 
washed in PBSTX (0.5% Triton-X, 1xPBS) 4 x 20min, incubated in DAB working 
solution (Vector Labs) for 2-10min until staining was visible, rinsed in water, and stored 
in PBS before imaging.  
 136 
A11: RNA EXTRACTION AND TRANSCRIPTOME ANALYSIS 
One hundred zebrafish eyes were dissected at either 36hpf or 72hpf using a flame-
sharped tungsten wire, and RNA extracted using Qiagen RNeasy kit as described (Uribe 
et al., 2012).  For 36hpf, library preparation with polyA mRNA capture and sequencing 
was performed using Illumina NextSeq 500 paired-end 75bp reads. 450 million reads 
were generated. Raw FASTQ sequences were quality checked, trimmed, and mapped 
using CLC Genomic Workbench 9.0.1 to zebrafish reference genome GRCz10 at 85% 
mapping efficiency. Transcript abundances were calculated and differentially expressed 
genes (DEGs) were identified using CLC Genomic Workbench 9.0.1. For 72hpf, library 
was prepared as above and sequenced on an Illumina HiSeq 2500 PE2x125. 66 million 
reads were generated. FASTQ sequences were quality checked using FastQC (Babraham 
Bioinformatics), mapped to GRCz10 using TopHat, and DEGs were identified using 
Cufflinks package from Tuxedo suite (Trapnell et al., 2012). Genes with expression 
values above log2 fold-change of 2 are considered differentially expressed. All 
computational analyses utilized the Texas Advanced Computing Center and University of 
Pittsburgh Center for Simulation and Modeling. Raw and processed data are publicly 
available through NCBI Gene Expression Omnibus (accession number GSE80134).  
Functional annotation was done using DAVID Bioinformatics 6.8 
(https://david.ncifcrf.gov). Differentially expressed gene lists from RNAseq were filtered 
for log2 fold-change of 2 or higher and submitted to DAVID Gene Ontology for 
biological pathways (GOTERM_BP_DIRECT). 
A12: MOSAIC RETINAL ANALYSIS 
Shield-stage transplantation experiments were performed essentially as described 
(Carmany-Rampey and Moens, 2006). Embryos were injected with Alexa Fluor 488 
dextran (10,000 MW, anionic, fixable) diluted at 1% in 0.2M KCl. Cells were 
transplanted from labeled donor embryos into unlabeled host embryos at the shield stage, 
targeting the presumptive retinal field (Woo and Fraser, 1995). Approximately 10 cells 
were transplanted per host embryo to minimize the ‘community’ effect resulting from 
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clones that are too large. Embryos were sorted at 24hpf for donor clone contribution and 
fixed at 72hpf for sectioning and immunohistochemistry.  
A13: IMAGING 
Confocal imaging of cryosectioned and immuostained embryos was done using 
Zeiss LSM5 and Olympus FV1200 confocal microscopes. Whole-mount images were 
taken using Leica MZ16F stereomicroscope. Sectioned in situ hybridization images were 
captured using Leica DM2500. All images were analyzed using ImageJ (imagej.nih.gov). 
Cell counting was done using ImageJ Cell Counter plug-in. 
A14: SITE-SPECIFIC 5MC AND 5HMC QUANTIFICATION 
Bisulfite sequencing was performed using EZ DNA Methylation-Direct kit (Zymo 
Research) using primers listed in Table A3. Eye tissues at 72hpf were dissected (n=7 per 
condition) and immediately processed through proteinase K digestion and bisulfite 
conversion. Converted DNA was purified and amplified using hot-start ZymoTaq and 
bisulfite-specific primer pairs (Supplementary Table 3). PCR amplicons (~300bp) were 
either directly sequenced or sub-cloned for sequencing. Sequencing traces were analyzed 
using QUMA (RIKEN, Japan). Our bisulfite treatment procedure generally yielded ~98% 
conversion.  Clones that contained low quality sequences were manually excluded from 
the analysis.  
Locus-specific 5hmC quantification was performed using the Quest 5hmC 
Detection kit (Zymo Research) using primers listed in Table A3. Briefly, genomic DNA 
was extracted at 72hpf using Purelink Genomic DNA purification kit (Invitrogen). 
Genomic DNA was divided into three groups: 1) Glycosylated and digested with a 
glucosyl-5hmC sensitive endonuclease, MspI [+GT]; 2) Unglucosylated and digested 
with MspI [-GT] (negative control); 3) unprocessed genomic DNA [untreated] (positive 
control). All DNA samples were purified, and equal amounts used as templates for 
quantitative real-time PCR. Quantitative real-time PCR was done using SYBR green 
master mix in 10ul volume, and reactions run in a CFX384 detection system (BioRad). 
Cq values were first evaluated by comparing the difference between the +GT and -GT, 
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and between +GT and untreated. If Cq+GT is close to (<1 Cq difference) Cquntreated, the locus is 
considered fully hydroxymethylated. Conversely, if Cq+GT is close to Cq-GT, the locus is 
considered non-hydroxymethylated. For each locus with Cq values that pass these 
criteria, they are considered partially hydroxymethylated, and percent 5hmC was 
calculated as follows: %5hmC = {[Cq-GT – Cq+GT] / [Cq-GT – Cquntreated]} *100.  
 
Name Purpose Region Sequence 
sw_TSS_bsF1  bisulfite sequencing opn1sw1 TSS TAGGGAGATGTTTATTAAGATGTAGTTGAGAGG 
sw_TSS_bsR1  bisulfite sequencing opn1sw1 TSS ATCCCCRCCTTTTCACACCAAACAAAAC 
sw_TSS_bsF2  bisulfite sequencing opn1sw1 TSS GGTGGTTTTTTATAAAATTTTTAAAGTTTTGTTTGGTG 
sw_TSS_bsR2  bisulfite sequencing opn1sw1 TSS CTTTAAAAAATCTTCTCCTATATTCAACAAAAACTC 
sw_TSS_quF1  Quest-5hmC detection opn1sw1 TSS TGAAAAGGCGGGGATGAAAAGG 
sw_TSS_quR1  Quest-5hmC detection opn1sw1 TSS CGACACGTGTGGCCTAATCAA 
sw_TSS_quF2  Quest-5hmC detection opn1sw1 TSS AGTCAACAAGGAGCCTGACTGAA 
sw_TSS_quR2  Quest-5hmC detection opn1sw1 TSS TCACATGGACAGGGCGGATTAT 
mw_TSS_bsF1 bisulfite sequencing opn1mw1 TSS ATATAGGYGGTTTTAATTTAGGTTTTAGTAAAAATG 
mw_TSS_bsR1 bisulfite sequencing opn1mw1 TSS CCAAAAACCATATAACCCACAAATAAAC 
mw_TSS_bsF2 bisulfite sequencing opn1mw1 TSS ATTAATTYGTGTTGGAAGAAATGGATATTATGTTG 
mw_TSS_bsR2 bisulfite sequencing opn1mw1 TSS AAACTTCRCACAAACCCAATCCTATTTAAC 
mw_CCGG_bsF1  bisulfite sequencing opn1mw1 MspI site TAAAGTTGATATGTTAGTTTTTGTTATGTGAGTTGTAG 
mw_CCGG_bsR1  bisulfite sequencing opn1mw1 MspI site TAAAAAATTACAATAAAAAAAAAACCCAATAAAAAACC 
mw_CCGG_quF1  Quest-5hmC detection opn1mw1 MspI site CATGTGAGTTGCAGCGTACTTTCAG 
mw_CCGG_quR1  Quest-5hmC detection opn1mw1 MspI site CGCAAATGACAGCAGCCTTTAGG 
OpCGI_bsF1 bisulfite sequencing opsin CpG island TTTTTTTGGAYGTTTGAAGAGATTGTAGTGTTTG 
OpCGI_bsR1  bisulfite sequencing opsin CpG island AAACCTCRACTAAAAAACTAAAACCTATC 
OpCGI_bsF2  bisulfite sequencing opsin CpG island GTAAAGYGAGGGGGTATTAGTTGAAAAG 
OpCGI_bsR2 bisulfite sequencing opsin CpG island ATAACRCAAACTAAACATCCTATAACC 
OpCGI_quF1  Quest-5hmC detection opsin CpG island ATAGTGGAGGAAGAAAGCCGAGAG 
OpCGI_quR1  Quest-5hmC detection opsin CpG island TCTCCACGTCCTCCTTCTCCT 
OpCGI_quF2  Quest-5hmC detection opsin CpG island CGTAAAGCGAGGGGGTATTAGTTGA 
OpCGI_quR2  Quest-5hmC detection opsin CpG island CGTGCTGCCGATTTTAACCGAA 
nppa_TSS_quF1  Quest-5hmC detection nppa TSS CCTTCAGTCTGCATCATTGGCC 
nppa_TSS_quR1  Quest-5hmC detection nppa TSS GAGAAGTCCTGGTAACTCGGACAC 
nppa_TSS_quF2  Quest-5hmC detection nppa TSS ATGAGCCACTGACAGCCAACT 
nppa_TSS_quR2  Quest-5hmC detection nppa TSS TGTCAGAGCTGTGTCTGCTCAA 




nppa_TSS_bsF1  bisulfite sequencing nppa TSS TTATATAGTGTYGTAATAGTGTAGTAAAATATTATGTG 
nppa_TSS_bsR1  bisulfite sequencing nppa TSS TAACTATTTTTCRCAAACCTAAAAAAATCCTAATAAC 
nppa_TSS_bsF2  bisulfite sequencing nppa TSS TTGTTTGTGTTYGAGTTATTAGGATTTTTTTAGGTTTG 
nppa_TSS_bsR2  bisulfite sequencing nppa TSS TTAATTAAACATAAACCCAAATACCTTAAACTTAACC 
nppa_body_quF1  Quest-5hmC detection nppa gene body GGCATCAGAGAGAGCCGTAGATTATG 
nppa_body_quR1  Quest-5hmC detection nppa gene body AGCCAGACAAGCTTTTGCTTCG 
nppa_body_quF2  Quest-5hmC detection nppa gene body GCGCACCACTTTTGTCCAAAGT 
nppa_body_quR2  Quest-5hmC detection nppa gene body GCTCTCAAGACTTACCTGATCTCGG 
nppa_body_bsF1  bisulfite sequencing nppa gene body TTTATAAYGTTATGTTTTTTTTTAGAGTTTGTTGTAG 
nppa_body_bsR1  bisulfite sequencing nppa gene body ATTACAACCRAAAATACTAAAAAACCCTATAC 
nppa_body_bsF2  bisulfite sequencing nppa gene body YGGTAAATTTTTAAGTATGTAAGGGGG 
nppa_body_bsR2  bisulfite sequencing nppa gene body AAACRAAAATATTACCTTATCTCAAACACAATAC 
Table A3: List of primers used for bisulfite sequencing and Quest analysis    
 
A15: ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
Sandwich-based 5hmC ELISA was performed according to the manufacturer’s 
protocol (Zymo Research). Genomic DNA samples were extracted at 5dpf using Purelink 
Genomic DNA extraction kit (Invitrogen), and diluted to 1ng/µl in water, denatured by 
heating at 98°C and cooling on ice, and 5hmC DNA was bound to the ELISA plate 
coated with anti-5hmC polyclonal antibody (1:1,000). Bound DNA was detected with 
anti-DNA HRP antibody (1:100), and was allowed to develop for 20min. 410nm 
absorbance was measured by a plate reader (BioTek), and a standard curve generated 
using linear regression from five DNA samples with known concentrations of 5hmC. 
Percent 5hmC was calculated as follows: %5hmC = (absorbance - y-intercept)/slope.  
Note that percent 5hmC in ELISA is based on the total number of hydroxymethylated 
cytosines, calibrated to standards (set of DNA with known 5hmC%). For example, 0.1% 
5hmC means 1 of every 1,000 cytosines is 5hmC. Percent 5hmC in the site-specific 
glucosylation/digestion (Quest) assay represents the relative amount of ‘protected’ 5hmC 
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at each MspI (CCGG) site analyzed, compared to the two internal controls for each locus: 
fully digested DNA (representing 0% 5hmC) and undigested DNA (representing 100% 
5hmC). Thus, these two numbers are not directly comparable, but should be in agreement 
with each other.   
A16: PHARMACOLOGICAL TREATMENT 
tet2-/-;tet3-/- mutants and sibling embryos carrying isl2b:GFP transgene were 
dechorionated and incubated from 24hpf to 72hpf in embryo medium with 50µM DAPT 
(N-[N-(3,5-difluorophenacetyl)-L-alanyl]- S-phenylglycine-t-butyl ester; InSolution γ-
secretase inhibitor IX, 565784, Calbiochem), 5µM IWR-1-endo (5.04462.0001, 
Calbiochem), or 1% DMSO as vehicle control. For BIO treatment, wildtype embryos 
carrying isl2b:GFP transgene were incubated in 2µM BIO (2’Z,3’E-6-Bromoindirubin-
3’-oxime, B1686-5MG, Sigma-Aldrich) from 24-72hpf. All embryos were fixed at 72hpf 
in 4%PFA 1xPBS, sectioned, and processed for immunostaining. Optic nerve diameter 
measurements were done in 5-7 embryos per condition at optic nerve head, using 
FluoView software (Olympus). P-values were calculated using two-way ANOVA with 
multiple comparison (for DAPT and IWR) and two-tailed unpaired t-test (for BIO) using 
Prism GraphPad.  
A17: RPC ISOLATION BY FACS AND GENOMIC DNA EXTRACTION  
Zebrafish embryos at 22hpf or 27hpf were euthanized in Tricaine solution on ice 
for 5 minutes. Whole eyes were dissected using a flame-polished tungsten needles, rinsed 
in cold PBS. Eye tissues were dissociated using 0.25% trypsin/EDTA for 5 minutes at 
room temperature, passed through a 70um cell strainer, and the reaction was stopped 
using 2mM CaCl2 in 5%FBS in PBS. Cell suspension was then pelleted down using a 
centrifuge at 450g for 5 minutes. Cells were then re-suspended in PBS and stained using 
Live/Dead dye (1ul/mL) according to manufacturer’s instruction (Thermo Fisher), 
washed once with PBS, and resuspended in final solution of 5%FBS/PBS. Cells were 
kept on ice until sorting, typically within two hours after dissection. Cell sorting was 
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done using FACSAria II machine with FACSDiva software. Gates were set to only allow 
live cells (negative for Live/Dead signal) and bright vsx2:GFP signal. Cells were then 
collected into tubes containing 5%FBS in PBS for processing. Genomic DNA was 
extracted using Quick-DNA plus kit (Zymo), and total RNA was extracted using RNeasy 
mini kit (Qiagen) per manufacturer’s protocols.     
A18: OXBS LIBRARY PREPARATION AND SEQUENCING 
After ensuring sufficient starting genomic DNA quantity of 200ng per reaction, 
samples were processed for OXBS library construction using TrueMethyl Whole 
Genome kit (Cambridge Epigenetix). Briefly, starting genomic DNA samples were 
spiked with sequencing and digestion control fragments containing 5mC and 5hmC at 
known sites, then denatured and purified using magnetic beads. For BS/OXBS treatment, 
the samples were divided equally into two halves: OXBS samples were treated using 
oxidizing reagent, while BS samples only undergo mock oxidation. Both samples were 
then processed in parallel through conventional bisulfite conversion reaction, 
desulfonation, and magnetic bead purification. For library construction, both BS and 
OXBS DNA were end activated, complementary strand synthesized, indexed and adapter 
ligated. The finished libraries were then processed for final quantification and 
normalization before loading into Illumina NextSeq 500 (High Output, 150 cycle) for 
deep sequencing.  
 
A19: OXBS DATA PROCESSING AND ALIGNMENT 
Raw fastq files from the sequencing runs were trimmed and quality assessed using 
TrimGalore and FastQC (Babraham Bioinformatics). Trimmed sequences were aligned 
using BWA-meth (Pedersen et al., 2014) with default parameters to the zebrafish bisulfite 
genome (GRCz10), which was prepared to include both unconverted and fully converted 
bases. Mapped reads were then converted from SAM to BAM (Li et al., 2009), imported 
into .mr format for MethPipe (Song et al., 2014), sorted, and duplicated removed. 
Calculation of methylation level and extraction of methylation score was done using 
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bsrate (bsrate -c) and methcount (methcounts -n -c) respectively (Song et al., 
2014). Note that during methcount step, -n and -c flags were specified to generate counts 
for only symmetric CpG and exclude methylation in non-CpG context to ensure data 
compatibility with subsequent analysis steps. Matched BS and OXBS methylation count 
files from each experiment were then processed using MLML (Qu et al., 2013) to 
estimate the 5mC and 5hmC levels at each nucleotide using a maximum-likelihood 
estimation method (mlml -u BS.meth -m OX.meth -o 
22_walt_cpg.mlml).  5mC and 5hmC levels for all CpG across the genome were 
filtered to include only those with at least 1 read coverage for both BS and OXBS 
datasets (i.e. exclude any sites without supporting read evidence from both datasets), and 
this was output into pseudo methcount files (.meth) which function similarly to meth 
count files from a traditional bisulfite experiment.  
 
A20: METHYLOME ANALYSIS AND ANNOTATION  
Identification of regions with hypo-methylated 5mC or hyper-methylated 5hmC 
were done using hmr program within the MethPipe suite (Song et al., 2014). For hyper-
5hmC, meth count files were first inverted and ran through hmr similarly to hypo-5mC 
files. Differential methylation scoring, identification of differentially methylated and 
hydroxymethylated regions (DMRs, DhMRs) were done using methdiff and dmr 
programs within MethPipe, respectively. DMRs and DhMRs were filtered using awk to 
include only site with a minimum of 5 total CpGs and 3 significant CpGs (significant 
cutoff value at default of p=0.05). Regions with intersecting DMRs and DhMRs were 
identified using bedtools intersect (Quinlan and Hall, 2010). For annotation of DMRs and 
DhMRs, region files in bed format were annotated using annotatePeak.pl in Homer 
software suite (Heinz et al., 2010) using default parameters against the zebrafish genome 






Appendix B: au8 and occ mutant mapping  
au8 is a mutant presented with cataract lens phenotype identified from an ENU 
mutagenesis screen within the Gross lab (Lee et al., 2012). Similarly, occ is a mutant 
independently isolated by another forward genetic screen at University of Washington. 
Both mutants display strikingly similar lens phenotype where the lens capsule rupture and 
part of the lens cortex spills out of the capsule.  
To identify causative mutations, au8 and occ mutants were mapped using the 
NGS-based ‘cloning by sequencing’ approach.  au8 heterozygous carriers (AB 
background), identified by pair-wise incrossing, were outcrossed to wildtype TU fish 
(ZIRC) to generate AB/TU F1 hybrid mapping line.   Heterozygous F1 fish were 
identified and incrossed to produce F2 homozygous mutant embryos. Genomic DNA was 
extracted from 48 F2 homozygous mutant embryos at 6dpf using DNeasy Blood and 
Tissue kit (Qiagen) and sent to next-generation sequencing on Illumina HiSeq 2000 
(2x100 paired-end) at the University of Texas at Austin Genomic Sequencing and 
Analysis Facility.   
For occ mutant, mapping line was generated as above, with the exception that the 
outcross was done by crossing occ carriers (AB background) to a TU/WIK mixed 
wildtype background.  Mutants were identified, and genomic DNA extracted as above. 
DNA was sent to Vanderbuilt University Medical Center for sequencing on Illumina 
HiSeq 2500 (2x100 paired-end). Both lines were sequenced to an average genome depth 
coverage of 15X.  
To identify putative mutation site, raw sequencing reads were analyzed at Texas 
Advanced Computing Center using the BSFseq (bulk segregant linkage) mapping 
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function of MegaMapper pipeline (Megason Lab, Harvard Medical School) (Obholzer et 
al., 2012).  Both mutations were predicted to be in col4a5 on chromosome 7.   
au8 mutation was mapped to a C to T conversion (C52621050T) on exon 26, 
which generated a premature stop codon, truncating the protein at 665 amino acids (aa) 
out of 1,659 aa full-length protein [p.Gln665Stop].  Mutation was verified by genomic 
DNA PCR and Sanger sequencing.  For complementation test, au8 heterozygotes were 
crossed to col4a5sa1609, a known col4a5 mutation carrier from the Zebrafish Mutation 
Project (Kettleborough et al., 2013). Resulting mutant embryos (26.9% of total embryos) 
from au8 x col4a5sa1609 displayed lens phenotype similar to au8, thus confirming that both 
mutations are in the same gene.  
occ mutation was mapped to a 5’ splice junction of intron 41-42 where a T to G 
conversion (T50904935G) is predicted to cause intron inclusion and a premature stop 
codon located within the intron. This resulted in a truncation of the protein at 1,315 aa out 
of 1,659 aa full-length [p.Ser1308GlnfsStop6].  Causative mutation was verified by 
Sanger sequencing of occ mutant genomic DNA, and the presence of intron 41-42 in 




Figure B.1: Causative mutation site for occ mutant is located at the downstream splice 
junction of col4a5 exon 41, which resulted in an intron inclusion and a 
premature stop codon within the retained intron (A-C), truncating the 
protein at 1,315aa. Causative mutation of au8 is located within col4a5 exon 
26. The single nucleotide CàT substitution introduces a premature stop 
codon, truncating the protein at 665aa (D-F). Both mutant embryos display 
ruptured lens capsule and disrupted structural integrity of the lens cortex, 
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